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Abstract
This study describes the isolation and structure elucidation of several known
and 13 new compounds from New Zealand marine organisms. Furthermore, it
describes the development of a digital mask program for the analysis of HSQC
spectra of crude sponge extracts. This was used as a screening tool to identify
secondary metabolite producers that warranted further analysis.
As reports of metabolites from New Zealand nudibranchs are poorly repre-
sented in the literature, a study of five New Zealand nudibranch species was
undertaken. These coloured and seemingly undefended nudibranchs are known
to concentrate or sequester toxic metabolites from their prey, facilitating rapid
isolation and structure elucidation of these metabolites. This study resulted
in the isolation of a variety of metabolite classes; two new compounds, 13α-
acetoxypukalide diol (30) and lopholide diol (31) from the nudibranch Tritonia
incerta, are described.
Examination of the sponge Raspailia agminata resulted in the isolation of a
novel family of partially acetylated glycolipids which contain up to six glucose
residues. The chromatographic separation of these compounds was a challenge
due to the similarity of the congeners and their lack of a chromophore. MS-
guided isolation eventually led to the purification of agminosides A–E (145–
149).
An unidentified sponge of the order Dictyoceratida was found to contain
a new isomer (186) of the known sesterterpene variabilin. As variabilin-type
compounds are predominantly found from sponges of the family Irciniidae, the
unidentified sponge is most likely an irciniid. In addition, the sponge contained
two prenylated quinones, one of which, 189, is a new isomer of a known sponge
metabolite.
The sponge Darwinella oxeata contained four new nitrogenous diterpenes of
the aplysulphurane (rearranged spongian) skeleton, oxeatamide A (214), iso-
oxeatamide A (215), oxeatamide A 23-methyl ester (216) and oxeatamide B
(217).
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Chapter 1
Introduction
This thesis gives an account of my research into natural products chemistry.
Specifically, it details the investigation of several New Zealand species of marine
invertebrates (nudibranchs and sponges) for novel, biologically active, secondary
metabolites. The use of NMR spectroscopy as a vital screening tool is discussed.
1.1 Natural products as pharmaceutical leads
Natural products chemistry deals with the isolation, identification, structure
elucidation, and study of the characteristics of chemical substances produced by
living organisms. The fascination with molecules found in nature gave birth to
the field of organic chemistry as a whole (so named for its original definition
as the chemistry of living things).1 Since as far back as 2600 BC in ancient
Mesopotamia, when records show the cultivation of the poppy (Papaver som-
niferum) for opium extraction began, natural products have played a pivotal role
in human history, and particularly in medicine.2 Their vital role in the process
of drug discovery has meant that, in the last century alone, drugs that trace
their origin to natural products “have more than doubled the average lifespan of
human beings.”1
The influence of natural products on medicine remains substantial. Close to
two-thirds of the new drugs approved by the U.S. Food and Drug Administration
(FDA) in the years 1981–2006 were either natural products, natural product
derived, or synthetic compounds mimicking the action and/or pharmacophore
of a natural product.3 The fraction is closer to three-quarters when considering
only the areas of cancer and infectious diseases.3 This raises the questions: why
do natural products have biological effects on humans? Why does a polyketide
from a fungus lower cholesterol? Why does a peptide from a snail alleviate pain?
1
These drugs are actually secondary metabolites produced by living organ-
isms. Secondary metabolites are defined as those naturally produced substances
(often specific to a particular species or a family) not involved in normal growth,
development or reproduction of an organism, and therefore not essential to life.4
As their production involves enormous biochemical expense, however, they would
not make evolutionary sense unless they had advantageous function.5 The com-
pounds are in fact used for interactions with other organisms, often for defense.
Organisms lacking an immune system are prolific producers of secondary meta-
bolites (which are thought to act as an alternative defense mechanism), hence
the wide variety of antifungal, antibacterial and cytotoxic natural products being
isolated.
Natural products have been fine-tuned by nature through evolutionary se-
lection to be precise, well-defined, three-dimensional structures for interaction
with specific biological targets. These biological targets (such as protein bind-
ing sites) are “often well conserved among proteins of markedly different genetic
sequences.”6 The 100,000 to 450,000 human proteins fall into only 600–8000
topologically distinct “folds” (three dimensional architectures).7
Furthermore, these so-called protein “folds” may serve different functional
roles in different organisms.8 Secondary metabolites evolved for a particular
purpose may therefore exert a different, but equally potent, effect in another
organism. Simply put, while natural products may not have co-evolved with
human proteins, they have evolved to interact with biomolecules in general.5
Unfortunately, many of the most promising natural product lead compounds∗
are available in only small amounts, and often have complex structures which are
difficult to synthesize. This supply problem has discouraged many pharmaceuti-
cal companies from developing these compounds as potential drugs. Instead, the
industry has embraced combinatorial chemistry and diversity oriented synthesis
as a means of generating large compound libraries in a short time.6 Yet, despite
the early promises of both combinatorial synthesis and high throughput screen-
ing, no real increase in the number of lead compounds has been observed.3,6–8,10,11
Only one compound generated from this method of chemical discovery has been
approved for drug use anywhere: the antitumour drug sorafenib† (1).3
A study by Feher and Schmidt compared a range of natural products, drugs
on the market and combinatorial synthetic molecules, and proposed that the
failure of combinatorial synthesis lies in the “significant deficiencies in the types
∗A lead compound is the pharmacologically active molecule from which synthetic analogues
are developed in an effort to find safer and more effective alternatives.9
†Nexavar (Bayer)
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of chemical structures generated using combinatorial approaches.”10 On average,
natural products tend to be of higher molecular weight, have more chiral cen-
tres and more polar functional groups that can act as hydrogen bond acceptors.
Combinatorial compounds, on the other hand, are decidedly more hydrophobic,
incorporate more nitrogen, sulfur and halogen atoms, and have more unsat-
uration (usually aromatic rings). They tend to be more rigid, and have less
emphasis on chirality. As a result, they often show less specific binding charac-
teristics, leading to more undesirable side effects.6 Compared in the same way,
the properties of pharmaceuticals usually fall somewhere in between the two
groups, reflecting the mixed origins of these compounds from natural and syn-
thetic sources. Clearly, “natural product structures have the characteristics of
high chemical diversity, biochemical specificity and other molecular properties
that make them favourable as lead structures for drug discovery.”8
Identifying lead compounds
Several criteria are used for selection of animal, plant or microbial material for
screening. Commonly, a random sampling of species will be undertaken, al-
though this method is often laborious and time-consuming. Some plants or
animals are chosen because of their use in traditional medicines, or because they
are closely related to organisms previously shown to contain active secondary
metabolites. More recently, the emerging field of genomics has provided a pow-
erful tool for predicting the secondary metabolite composition of an unknown
organism.12
Once the species to screen are chosen, “in the vast majority of industrial natu-
ral product discovery programs, compounds with desirable characteristics (hits)
are identified by bioactivity assays.”13 This well-established method is the testing
of crude or partially fractionated extracts in cell-based or biochemical assays.12
Cell-based biological activity assays are generally preferred, because activity can
be assessed within the context of a living cell. Unfortunately, cell-based assays
may be more variable, less sensitive and more resource intensive.13 Biochemical
assays (for example with cloned receptors or enzymes) are the alternative, pro-
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viding particular, target-specific activity information. Regrettably, such in vitro
assays do not always predict accurately the in vivo activity of molecules.12
The process then calls for the isolation of the active constituent(s) through
the use of chromatographic separation, often requiring numerous cycles of frac-
tionation in order to obtain sufficient quantities of the pure molecule.13 At each
step, the fractions have to be submitted to bioassay to track the biological activ-
ity to the pure compound. Bioassay directed isolation can be a long and tedious
process, financially costly and requiring significant manpower, even though more
recently it is becoming increasingly automated.12,14
As natural product extracts are complex mixtures of many compounds, bio-
assay-guided fractionation may be complicated by false positives from non-
specific interferences, fluorescent compounds and insoluble components.15 The
presence of interesting, but low-level, constituents may be masked by the mild ac-
tivity of compounds at high concentrations. As the number of described natural
products increases, so does the probability of rediscovery of known compounds
(the so-called dereplication∗ problem).14 In addition, at times the activity be-
ing tracked does not increase during the separation, but spreads among many
fractions. This is often attributed to synergistic effects of compounds in the mix-
ture, but may also be due to loss of active ingredients through degradation or
simply through irreversible adsorption to the solid phase during the separation
process.16
One way to avoid the problem of crude extract screening is to test pure
compound libraries (collections of individually isolated chemical compounds).
Building up such a library can be time consuming and labour intensive, but
avoids some of the above mentioned problems. The first systematic approach in
this direction is the German Natural Product Pool.17 Spearheaded by the Hans-
Kno¨ll-Institut (Jena, Germany), the Pool now contains about 9,000 compounds18
obtained from more than 70 commercial and academic laboratories, being used
by several pharmaceutical and agrochemical companies.17
Such an approach involves activity-independent isolation and characteriza-
tion of compounds. The idea of ignoring the desired biological activity of meta-
bolites during screening and isolation was first postulated by Umezawa in the
1970s and later developed by Za¨hner and co-workers.19 They used TLC and
colourization with a staining reagent for the discovery and isolation of new sec-
ondary metabolites in a strategy later named “chemical screening.”
∗Dereplication is the process of identifying previously isolated compounds as early as pos-
sible to eliminate wasted effort and resources.
4
A logical extension of this method is the use of physico-chemical screening,
with selection criteria based on chromatographic behaviour as well as spectro-
scopic characteristics. A typical example is the screening for secondary meta-
bolites by HPLC in combination with multi-wavelength UV/vis (diode-array)
detection (HPLC-DAD). Unfortunately, the dependence of this method on a
UV/vis detectable chromophore limits its applicability, and alternate detection
methods like mass spectrometry and NMR spectroscopy have been applied.19
1.2 Marine environment
The origins of natural product chemistry can be traced back to the study of
plants, which led to the isolation of such medically important compounds as
morphine (from the opium poppy), aspirin (willow tree), digitoxin (foxglove) and
quinine (the chinchona tree).20 The true blossoming of natural product chemistry
occured after the success of penicillin during World War II, when pharmaceu-
tical companies shifted their focus to drug discovery from microorganisms.13
Since then, between 30,000 and 50,000 compounds have been discovered from
microorganisms, many of them biologically active, but the rate of discovery is de-
creasing.21 More recently, therefore, researchers have turned to alternate, more
exotic sources such as the marine environment, which is considered a largely
untapped store of chemical diversity.14
The vast oceans cover about 70% of the earth’s surface, and current estimates
suggest the majority of all species on this planet actually live in the oceans.22
Of the 38 animal phyla described, 26 are exclusively aquatic, and of those, 19
are marine. In contrast, only one living animal phylum (Onchyophoria, or velvet
worms) is exclusively terrestrial.22
While marine life has been found down to the deepest abyss, the majority
of marine species diversity occurs at the ocean fringe. This land-sea interface
with its high biodiversity constitutes one of “the most species rich and biologi-
cally productive regions of the world.”23 In certain marine ecosystems, such as
coral reefs, the biological diversity is estimated as higher than in the tropical
rainforest.22
5
Figure 1.1. New Zealand Exclusive Economic Zone. Image courtesy of the
National Institute of Water and Atmospheric research (NIWA).
The New Zealand marine ecoregion
New Zealand is a relatively long and narrow archipelago, forming the western
boundary to the South Pacific ocean south of 34◦ S. Its Territorial Sea and
Exclusive Economic Zone comprises more than 4.2 million km2, and spans over 30
degrees of latitude (Figure 1.1). The New Zealand marine environment extends
from subtropical waters to the subantarctic, and from the shallows to the deep
sea. This range and complexity of habitats, coupled with the number of major
ocean currents and New Zealand’s geographical isolation, has created diverse
marine communities, home to an estimated 23,000 species including approx.
16,000 marine invertebrates.24
Marine natural products
Scientific investigation of marine organisms was initially limited to easily ac-
cessible and readily collectable specimens, for example macro-algae collected by
hand at low tide or using a snorkel.25 Marine natural products emerged as a
fully fledged discipline only in the 1970s, after the introduction and widespread
use of SCUBA. Initially, the field was dominated by the study of toxins such
as saxitoxin (2) (isolated from a dinoflagellate), and tetrodotoxin (3) (isolated
from a pufferfish∗).23,26 More recently, complex polyether toxins such as maito-
∗The true origin of 3 is now believed to be microbial.21
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toxin (4), the largest and most lethal non-proteinaceous toxin known, has been
isolated from the dinoflagellate Gambierdiscus toxicus. The structure elucida-
tion of this highly complex molecule was a feat that required a combination of
both spectroscopy and synthesis to achieve. Due to the increasing frequency of
algal blooms and associated shellfish contamination, these marine toxins with a
“ladder-like” polyether skeleton remain of great interest to researchers.27
O
O
O
O
O O
O O
O
O O O
O
O
O
O
O
O
O
OH
OH
O
OO
O
O
O
OO
O
O
O
O
O
H H H H H H
H
H
H
H
H
H
OH
H
H
H
H
H
H
OH
HO H
H
OH
OH
OH
HHO
H
OH
H
HHH
OH
OH
OHHHH
H
HO OH
OHOSO3Na
OH
OH
OH H
HO
H H H OHH H H
NaO3SO OH
H H OHH
H
OH
OHH
H
OH
OHH
H
HO
H
H
H
H
4
Parallel to the study of toxins was the search for marine biomedicinals, al-
though early efforts“prioritized description of unique structural chemistry rather
than discovering drugs or drug leads.”23 More recently, the emphasis has shifted
to a more interdisciplinary approach. Chemists and pharmacologists together
utilize these metabolites as molecular probes that provide key insights into com-
plex cellular events.26 The additional integration of the study of marine chemical
ecology with chemistry and pharmacology has resulted in what is now known
collectively as marine natural products chemistry.27
Chemical defense in the marine environment
The majority of marine bioactive secondary metabolites are produced by inver-
tebrates. Most of them are slow-moving or completely sessile, and often lack
physical means of defense. Instead, many species have evolved chemical means
of repelling or deterring predators, through accumulation of toxic or distasteful
7
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secondary metabolites.23,27–29
While protection against predation is very important for sessile organisms
such as sponges, equally important is defense against the overgrowth of com-
petitors. Sponges are filter-feeding organisms that cannot tolerate settlement of
other organisms such as barnacles or bryozoans on their surface. To protect their
water-pumping capacity, some sponges produce a level of cytotoxic compounds
that is high enough to create a bare zone around them.30 Compounds (for ex-
ample pheromones) are also produced for communication between organisms.
In addition, secondary metabolites can protect against bacterial, fungal and
parasitic infections.29,30 Finally, some species of invertebrates—like the Conus
snails—are able to use highly potent toxins for immobilizing prey. These fierce
predators are able to overpower their physically much stronger prey by launch-
ing a specialized radular tooth (a kind of harpoon), which delivers a paralyzing
peptide.22
Not surprisingly, this marine chemical arsenal has proven to be a rich source
of interesting and bioactive secondary metabolites.31 Many new carbon skeletons
have been described, most being unique to the marine environment.27,32 Several
functional groups, such as the dichloroimine functionality of 5 and the sulfamate
group of haplosamate A (6), are either uniquely or predominantly marine as
well.33 Another feature of marine natural products is the high incorporation of
covalently bound bromine and chlorine (presumably due to their availability in
seawater),23 giving rise to such highly halogenated molecules as 7.27
Marine secondary metabolites need to be highly potent as they may be re-
leased into the water and rapidly diluted.25 This, coupled with immense biolog-
ical (and therefore chemical) diversity, means the oceans provide a huge number
8
of novel and potently bioactive chemical entities that can be useful in the search
for new drugs for the treatment of many human diseases.22
Marine natural products in clinical trials
One of the earliest forays into the realm of marine natural products by Bergman
and Feeney in the 1950s34,35 yielded the arabinosyl nucleosides spongothymidine
(8) and spongouridine (9). Isolated from the sponge Cryptotethia crypta, these
unusual nucleosides spurred researchers to synthesize analogues, which resulted
in the antiviral drug Ara-A (10) and the anticancer agent Ara-C (11), still in
use today.30
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Mayer et al. reviewed36,37 the most recent marine natural products in pre-
clinical and clinical trials; 150 are antitumour and cytotoxic compounds; 67
show a range of activities such as antibacterial, anticoagulant, antimalarial or
antiviral; 45 are being tested for effects on the cardiovascular, immune and
nervous systems; and 54 compounds are reported to act on a variety of cellular
targets. A significant number of marine-derived molecules are in, or approaching,
Phase II/III clinical trials in cancer, allergy and cognitive diseases, and may see
regulatory approval in the near future.25
The latest success story, and in fact the first true marine natural product to
be approved by the FDA, is ziconotide,∗ the synthetic equivalent of ω-conotoxin
MVIIA. The 25 amino acid peptide 12 was isolated from the piscivorous “magi-
cian’s snail”Conus magus, a marine mollusc which uses numerous toxic peptides
to subdue its fish prey.38 Ziconotide is a non-opioid analgesic; it is a highly
selective, very potent blocker of mammalian neuronal N-type voltage-sensitive
calcium channels which usually transmit the pain signal.39 Ziconotide was ap-
proved as an intrathecal infusion for severe, chronic pain by the FDA on Decem-
∗Prialt (Elan Pharmaceuticals)
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ber 28, 2004, and by the EU on February 22, 2005. It is the first new intrathecal
analgesic approved in two decades.40
1.3 Sponges
Sponges are sedentary, filter-feeding organisms. They are invertebrates and the
most primitive phylum of multicellular animals. They have neither true orga-
nized tissues nor organs, and their cells show extensive independence from each
other.41 They have indeterminate growth, much like a terrestrial plant, and a
variable body plan. Sponges show considerable plasticity in response to environ-
mental variables—such as available space, current, habitat—which can drasti-
cally affect their morphology. This variability has made classification of sponges
a difficult task, with debate at the class level still appearing in the literature.42,43
The most recent classification by Hooper and van Soest43 (Figure 1.2) recognizes
three classes within the phylum Porifera: Calcarea (calcareous sponges), Hex-
actinellida (glass sponges) and Demospongiae (spongin sponges), based on the
type of spicule (skeletal element) they possess. Calcarea have a skeleton of cal-
cium carbonate, while the spicules of Hexactinellida are siliceous, arranged in
a hexactine (six-rayed) structure. The Demospongiae, which are the largest
group of sponges accounting for over 90% of sponge species, are characterized
by mono- and tetractine spicules, and/or by an organic skeleton of the collagen
protein spongin.42
Since the first discovery of the arabinosyl nucleosides 8 and 9, sponges have
become a rich source of interesting and biomedically important metabolites.
Well over 5,000 new compounds have been isolated from sponges to date,44 with
anti-inflammatory, antitumour, immunosuppresive, antiviral, antimalarial and
antibiotic activities represented.
Microbial symbiosis in marine sponges
Interestingly, many sponge derived natural products closely resemble those char-
acteristic of microbes.45 Microbial symbionts can constitute up to 60% of the
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Kingdom Animalia
Phylum Porifera (sponges)
Class Calcarea (calcareous sponges)
Order Clathrinida
Order Murrayonida
Order Leucosolenida
Order Lithonida
Order Baerida
Class Hexactinellida (glass sponges)
Order Amphidiscosida
Order Hexactinosida
Order Aulocalyoida
Order Lychniscosida
Order Lyssacinosida
Class Demospongiae (spongin sponges)
Order Homosclerophorida
Order Spirophorida
Order Astrophorida
Order Hadromerida
Order Chondrosida
Order Poecilosclerida
Order Halichondrida
Order Agelasida
Order Haplosclerida
Order Dictyoceratida
Order Dendroceratida
Order Halisarcida
Order Verongida
Order Verticillitida
Figure 1.2. Taxonomic classification of sponges, after Hooper and van Soest.43.
Orders examined in this study are printed in blue.
biomass of some sponges and are often suspected to be the true producers of the
secondary metabolites. Unfortunately, most of these symbionts are presently
unculturable,46 so the microbial origin of some natural products is assumed
from indirect evidence, such as: one sponge species containing different classes
of metabolites; taxonomically different organisms containing the same metabo-
lite; free-living microorganisms producing similar or identical compounds; or ex-
tremely low metabolite concentration.47 Nevertheless, as collection or cultivation
of large amounts of sponge for drug production is often a problem, cultivation of
symbionts or the transfer of symbiont biosynthetic genes into culturable bacteria
remains an intriguing and lucrative proposition.46
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1.4 Nudibranchs
The phylum Mollusca (for taxonomy, see Figure 1.3), encompasses all types
of mollusks, including squid and octopus (class Cephalopoda), bivalves (class
Pelecypoda) and snails (class Gastropoda). Slugs are snails that have lost their
shell (or only have a very rudimentary one), and include both land (Pulmonata)
and sea (Opisthobranchia) species. The sea-slugs that lack a shell are called
“nudibranchs”, a term that comes from the Latin nudus meaning “naked” and
Greek brankhia meaning “gills”, as they have “naked gills” in full view on their
back. The order Nudibranchia is usually divided into four suborders: Doridina
(dorids), Dendronotina (dendronotids), Arminina (arminaceans) and Æolidina
(aeloids). The dorids usually have gills situated towards the rear, grouped in a
circle or semi-circle. The majority can withdraw them into pockets beneath the
mantle surface. The aeolids, dendronotids and arminaceans have gills formed
by various outgrowths from the body, and are never retractile into pockets. All
nudibranchs are hermaphrodites (they have both sets of sex organs) and their
heads always have a pair of rhinophores (sensory tentacles). Most common
nudibranchs grow from one to five centimetres in size.48
Nudibranchs are found in most habitat types throughout the world’s oceans,
occuring at all depths and latitudes, including beneath the Antarctic ice. The
greatest diversity, however, is found in the tropical seas such as the Indo-Pacific
region, where 800 of the approximately 3,000 world-wide species of nudibranch
can be found.48
Nudibranch defense
Due to their lack of a shell, nudibranchs should be vulnerable to predation.
Few nudibranch predators are in fact known, as the sea-slugs have developed
numerous defense strategies.48 Some are behavioural adaptations: for instance
many nudibranchs are mainly active at night. Some, like Discodoris lilacina
(often called D. fragilis) are capable of autotomy (casting off of one’s body parts
when threatened). Camouflage is also a widely employed defense tactic, with
some nudibranchs not only taking on the colour but also the texture of their
common food or habitat. Others show countershading (dark dorsal and light or
silver ventral surface) like that of many fish, or are outright mimics of toxic or
poisonous species.48,49
The aeolids have perhaps the most unusual method of defense. They feed on
hydroids or corals that possess nematocysts (stinging cells), but are not affected
12
Kingdom Animalia
Phylum Mollusca (mollusks)
Class Pelecypoda (bivalves)
Class Cephalopoda (squid, octopus)
Class Gastropoda (snails, sea slugs)
Subclass Opisthobranchia (sea slugs)
Order Anaspidea (sea hares)
Order Acochlidiacea (caddis-slugs)
Order Cephalaspidea (headshield slugs)
Order Gymnosomata (sea angels)
Order Nudibranchia (nudibranchs)
Suborder Doridina (dorids)
Suborder Dendronotina (dendronotids)
Suborder Arminina (arminaceans)
Suborder Æolidina (aeolids)
Order Notaspidea (side-gilled slugs)
Order Sacoglossa (sap-sucking slugs)
Order Thecosomata (sea butterflies)
Subclass Pulmonata (land slugs)
Figure 1.3. Taxonomic classification of nudibranchs, after Rudman.49 Subor-
ders examined in this study are printed in blue.
by their poison. Instead, the nudibranchs separate and transport these cells to
their extremities, where they use them for their own protection.48
Of particular interest to the natural product chemist are the chemical meth-
ods of defense employed by some nudibranchs. Certain species are known to
contain distasteful and sometimes toxic chemicals in their skin.48 Many of these
species show aposematic (warning) colouration, resulting in an array of beautiful,
bright colour patterns that have earned nudibranchs the nickname “butterflies
of the sea.”
Examination of nudibranchs and their food sources has revealed that many
sea-slugs obtain defensive chemicals from their food.50,51 The presence in nudi-
branchs of secondary metabolites identical to those isolated from their sponge
(or other organism) food source cannot be just incidental; the defensive meta-
bolites are sequestered (selectively accumulated), often localized in the mantle
or in special glands where they can be most effective at deterring predators.
The acquisition of a chemical mode of defense appears to predate the loss of the
shell. The mechanical protection of the shell became obsolete as the nudibranchs
switched from a physical to a chemical mode of protection.50
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Unfortunately, this leaves the nudibranch dependent on its food as the source
of defensive metabolites. Clearly the ability to synthesize its own feeding deter-
rents would be quite advantageous, and indeed, Cimino et al. demonstrated—
through feeding experiments with carbon-14 labelled mevalonic acid—that the
nudibranch Dendrodoris limbata synthesizes the defensive sesquiterpene polygo-
dial.52 Since then, de novo biosynthesis has been shown in many nudibranch
species.51,53
1.5 Research aims
This research aims to discover new, bioactive, secondary metabolites from ma-
rine invertebrate sources. Several dive trips will be undertaken to collect New
Zealand species of sponge and nudibranch. These will be screened according
to the protocol developed by the Marine Natural Products Group at Victoria
University. Crude extract fractions will be evaluated by 1D and 2D NMR spec-
troscopy, and the mask used to screen the spectra will be updated and developed
further. Interesting species will be examined in detail, leading to the isolation
of pure compounds whose structure will be elucidated using a range of spectro-
scopic techniques. Compounds isolated will be subjected to biological activity
testing.
1.6 Concluding remarks
With its coastline spanning a range of latitudes and its varied marine environ-
ment with high biodiversity, New Zealand is an excellent place to study marine
natural products. Many marine invertebrates, such as sponges and nudibranchs,
do not have physical means of defense and so have developed a rich chemical ar-
senal that can be exploited in the search for new pharmaceutical leads. Although
the pharmaceutical industry focuses on activity screening and bioassay-guided
isolation for their lead structure discovery, activity-independent screening can
lead to the isolation of novel compounds (with interesting biological activity)
that would otherwise have been missed.
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Chapter 2
Chemical Analysis of New
Zealand Nudibranchs
2.1 Natural products from nudibranchs
When faced with a plethora of seemingly similar invertebrates, the diver’s eye is
often attracted to the brightly coloured nudibranchs. The seemingly undefended
sea-slugs are excellent candidates for natural products research because they of-
ten concentrate the most biologically-active defensive metabolites derived from
their diet. These molluscs are able to direct the researcher towards the most in-
teresting chemistry, and the high concentration of these metabolites (sometimes
four orders of magnitude higher than that present in the food source25) facili-
tates isolation and structure elucidation. Unsurprisingly, a number of important
marine metabolites were first isolated from nudibranchs.
As most nudibranch metabolites are sequestered from their diet, the variety
of compound classes isolated from sea-slugs reflects the wide range of metabo-
lites present in sponges and other species on which nudibranchs prey. Selected
examples will be discussed.
Terpenes
A multitude of regular, rearranged, and degraded sesquiterpenes, diterpenes,
sesterterpenes, and triterpenes have been isolated from nudibranchs. Interesting
instances are presented below.
The nudibranch Phyllidia varicosa has long been known to secrete a strong
and unusual-smelling, heat-stable, volatile substance that is lethal to fish. In
1975, Scheuer et al. reported the isolation of the sesquiterpene metabolite 9-
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isocyanopupukeanane (13) from 20 P. varicosa individuals, which they “milked”
through gentle squeezing and repeated rinsing to obtain enough exudate for
further purification. Compound 13 was later isolated from the prey sponge
Hymeniacidon sp., collected from Pupukea, Hawaii.54 The structure of 13 was
solved by X-ray diffraction and was the first member of the unusual isotwistane
(tricyclo[4.3.1.03,7]decane) carbon framework.55 It is one of the early examples
of an isocyanide reported from the marine environment.
NC
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A variety of diterpenes, often related to the spongian skeleton, have been
isolated from nudibranchs. A rearranged spongian metabolite norrisolide (14)
was isolated from the dorid nudibranch Chromodoris norrisi in 1983.56 It has an
unusual structure with a perhydroindane core bridged via a one carbon bridge
to an acetylated γ-lactol-γ-lactone ring system. Norrisolide has attracted recent
interest due to its unusual biological activity: it is the only known compound to
induce irreversible vesiculation of the Golgi apparatus in intact cells by binding to
the Golgi membranes.57 Experiments with several norrisolide-based fluorescent
probes have shown that the unfunctionalized perhydroindane moiety is essential
for this activity.57
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Several bioactive sesterterpenoids have been isolated from nudibranchs, most
of them scalarane-type, or linear furanoterpenes. The Japanese nudibranch
Chromodoris inornata, however, was found to contain inorolides A and B (15,
16) two cytotoxic sesterterpenes with a novel carbon skeleton containing an
unusual seven-membered ring.58
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The first example of a triterpenoid metabolite isolated from a nudibranch is
the degraded triterpene lovenone (17), isolated from the North Sea nudibranch
Adalaria loveni in 1995. This compound possesses a steroidal carbon skeleton
with an unusual degraded ring A, which appears to be without precedent.59
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Macrolides
Ulapualide A and B (18, 19) and kabiramide C (20) were the first isolated mem-
bers of an extraordinary family of macrolides, characterized by three contiguous
oxazole rings.60,61 The ulapualides were isolated from the egg masses of the bril-
liantly coloured nudibranch Hexabranchus sanguineus collected from Pupukea,
Hawaii,60 while kabiramide C was isolated from the egg mass of an unidentified
nudibranch species,∗ collected from Kabira Bay, Ishagaki-jima Island, Japan.61
These were subsequently followed by the halichondramides, mycalolides and
jaspisamides, exemplified by halichondramide (21),63 mycalolide A (22)64 and
jaspisamide A (23)65 from sponges of the genus Halichondria,Mycale and Jaspis
respectively. To date, approximately 35 congeners have been reported.62
These compounds are all based on a 25-membered macrolide with a tris-
oxazole unit; a lipid-like side chain is attached to the macrolide core, terminating
in a formyl enamide residue. The differences between the molecules are mostly
in the oxygenation patterns and alkyl group substitution of the aliphatic chain
portion of the structures. Their complex configuration has been established
∗later identified as a Hexabranchus sp.62
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through a combination of X-ray diffraction, chemical degradation and NMR
spectroscopy.62,66,67
Members of this family of macrolides have shown a range of interesting bi-
ological activities, including ichthyotoxic and ichthyodeterrent properties. All
show pronounced antifungal activity and cytotoxicity, but no antibacterial ac-
tivity, suggesting they act on eukaryote-specific cellular components. A range
of experiments has shown that the trisoxazole macrolides depolymerize F-actin,
and form a 1:1 complex with G-actin.62 As they interfere with actin filament
dynamics, these compounds may be useful as cellular probes for actin-mediated
cell functions.66
Peptides
While the opistobranch sea hare Dolabella auricularia is not strictly a nudibranch
as it posesses the remanants of a shell and belongs to the order Anaspidea, it
nevertheless deserves mention because of the remarkably potent antineoplas-
tic peptides it contains. The anticancer properties of D. auricularia extracts
have been known since the 1970s, but due to the extremely small quantities
(∼1.0 mg/100 kg of collected organism) of the active compound, dolastatin 10
(24), the structure was not elucidated until 1987.68
Several other members of this peptide family have been isolated since this
report, including those from the Symploca marine cyanobacterium (on which the
sea hare grazes), indicating an exogenous, dietary origin of the peptides in D.
auricularia.23 Investigation of the potent biological activity of the dolostatins
has shown they strongly affect microtubule assembly.36
Dolastatin 10 (24) progressed to Phase II clinical trials, but unfortunately
was withdrawn as it did not demonstrate significant in vivo antitumour activ-
ity in humans.25 Other members of the dolostatin family (including synthetic
analogues), however, are currently being evaluated in clinical trials.25
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2.2 New Zealand nudibranchs
New Zealand is home to over 150 species of nudibranch, mostly found in the
warmer northern region, particularly on the eastern coast of the northern tip of
the North Island. Although diversity in New Zealand waters is low in comparison
to the tropical Pacific, most nudibranch families are represented by at least one
species.48,69
When this study began, no metabolites had been reported in the literature
from New Zealand nudibranchs. A subsequent review of the published chemistry
of Australian and New Zealand molluscs, by Garson in 2006, revealed a lack
of studies on natural products from New Zealand nudibranchs, concluding that
there continues to be much scope for further research.70 More recently, Grkovic et
al. reported several known compounds from some common New Zealand opistho-
branch molluscs, including some of those species covered below.71
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2.3 Tritonia incerta
The nudibranch Tritonia incerta (see Figure 2.1 for taxonomy) is an apricot-
orange to vermilion-pink coloured nudibranch, such as that shown in Figure 2.2,
that can grow up to 130 mm in size. It has non-retractile gills in tufts on a lateral
ridge, and its oral veil is a fringed border of finger-like tentacles. T. incerta is
found in the sea around the northern half of the North Island of New Zealand,
extending from subtidal to beyond 200 m depths at the edge of the continental
shelf. It is usually found in open, rocky situations, often clustered on the soft
coral Alcyonium aurantiacum which is its food source.48,69
Order Nudibranchia (nudibranchs)
Suborder Doridina (dorids)
Suborder Dendronotina (dendronotids)
Family Tritoniidae
Genus Tritonia
T. incerta
Suborder Arminina (arminaceans)
Suborder Æolidina (aeolids)
Figure 2.1. Taxonomic classification of T. incerta, after Rudman.49
Figure 2.2. Underwater photo of T. incerta (courtesy of Ian Skipworth).
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(a) 10% EtOAc/CH2Cl2 (b) 50% EtOAc/CH2Cl2
Figure 2.3. TLC plates (visualized by dipping in 5% H2SO4 and heating) of
(a) a silica gel column on the mixture and (b) the mixture (left) and the two
more polar compounds (right).
Metabolites isolated from T. incerta
Nineteen T. incerta individuals were collected from Rauhomaumau Island, Tu-
tukaka, New Zealand, in December 2003. They were extracted in MeOH, and
cyclic loaded onto reversed-phase HP20 beads, which were eluted with increas-
ing concentrations of Me2CO in H2O. The 75% Me2CO in H2O fraction showed
interesting features in the NMR spectra, and was purified further on a normal
phase (DIOL) column eluted with CH2Cl2 in pet. ether. The pet. ether fractions
yielded the cembranoid diterpene (−)-epi -thunbergol (25).
Fractions eluting with 30% CH2Cl2 contained a mixture of two compounds
with a similar Rf on TLC (0.55 and 0.51 in 10% EtOAc/CH2Cl2) but distinct
pink and green chars when visualized by dipping in 5% methanolic H2SO4 and
heating. The two compounds were purified on a silica gel column (eluted with
EtOAc/CH2Cl2 mixtures); unfortunately only differential enrichment of the com-
pounds was achieved (see Figure 2.3(a)). The fractions were combined on the
basis of TLC into three parts: early eluting (pink charring), the mixture, and
late eluting (green charring). The column was repeated multiple times on the
mixture to eventually afford 13α-acetoxypukalide (26) and lopholide (27), each
in about 90–95% purity.
The less polar fractions of the DIOL column eluting with 20% CH2Cl2 showed
a mixture of two minor compounds by TLC. Further purification of these frac-
tions on a DIOL column (CH2Cl2 in pet. ether) resulted in the isolation of
pukalide (28) and 11β, 12β-epoxypukalide (29).
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The final “wash” elutions from the multiple silica columns showed a mixture
of two compounds, which charred pink and green like 27 and 26, but were
significantly more polar (see Figure 2.3(b)). The two compounds were separated
on an analytical DIOL HPLC column (eluted with 20% IPA in hexane) to afford
13α-acetoxypukalide diol (30) and lopholide diol (31).
The soft coral Alcyonium aurantiacum is preyed upon by T. incerta. Previous
examination of the soft coral in our lab has led to the isolation of lopholide (27).72
Examination of another collection of the soft coral also resulted in the isolation
of (−)-epi -thunbergol (25).
The major compound isolated from T. incerta was 13α-acetoxypukalide (26),
and its structure was elucidated first. The connectivity of 26 was established
through a series of COSY and HMBC correlations as depicted in Figure 2.4.
It contained an epoxide bridging positions 7 and 8, indicated by the unusual
chemical shifts and large 1JCH recorded (CH-7: δC 54.9, δH 4.09,
1JCH 183 Hz;
C-8: δC 56.7). A review of the literature revealed 26 was first isolated from the
Australian soft coral Sinularia polydactyla in 1989.73 Comparison of NMR data
confirmed they were identical.
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Figure 2.4. Key COSY and HMBC correlations establishing the connectivity
of 13α-acetoxypukalide (26).
With the structure of 26 in hand, the structures of four of the other, related
metabolites were quickly identified by comparison of NMR data to those reported
in the literature. Lopholide (13α-acetoxy-11β, 12β-epoxypukalide) (27) had also
been isolated from S. polydactyla concurrently with 26,73 pukalide (28) was first
isolated from Sinularia abrupta,74 while 11β, 12β-epoxypukalide (29) was first
reported from the gorgonian Leptogorgia setacea.75
(−)-epi -Thunbergol (25) is a very non-polar compound, much less function-
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alized than the pukalide-type compounds, with only one allylic alcohol and two
trisubstituted double bonds. It is a common soft coral metabolite, and was
identified through comparison of NMR and optical rotation data with literature
values.73,76
Structure elucidation of two minor diterpenes
Positive ion mode HRESIMS analysis of the two minor, polar, metabolites 30 and
31 indicated they had molecular formulae of C23H28O9 (471.1631 [M + Na]
+,
∆ 1.7 ppm) and C23H28O10 (487.1579 [M + Na]
+, ∆ 0.2 ppm) respectively.
The formulae indicated the presence of an extra oxygen and two hydrogens, as
compared to 13α-acetoxypukalide (26) lopholide (27). Both formulae required
10 double bond equivalents, one less than 26 and 27. Compounds 30 and 31 had
similar NMR characteristics to 13α-acetoxypukalide (26) and lopholide (27),
but conspicuously absent for both were the unusual methine and quaternary
carbon signals of the 7,8-epoxide. A “regular” oxymethine and an oxygenated,
quaternary carbon were present instead. These data suggested that 30 and 31
were the 7,8-dihydroxy-desepoxy analogues of 26 and 27.
A more detailed analysis of the NMR spectra confirmed this assignment.
The majority of the NMR resonances of diol 30 compared favourably to 13α-
acetoxypukalide (26), allowing the construction of the same carbon skeleton.
The methyl H3-19 showed HMBC correlations to an oxymethine carbon (δC 76.1)
and an oxygenated, quaternary carbon (δC 73.7), assigned as CH-7 and C-8 re-
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Figure 2.5. Key NOE enhancements of 13α-acetoxypukalide diol (30) suggest-
ing the relative configuration of the diol. W-coupling is shown in red.
spectively. The one-bond proton-carbon coupling of CH-7 was 146 Hz, consistent
with an oxymethine not in a strained ring, supporting the presence of a 7,8-diol
moiety.
The configuration of the diol was assigned through the use of NOE enhance-
ments and coupling constant considerations. Observed NOE enhancements from
H3-19 to H-11, H-10 and H-5 placed them all in close proximity on the same face
of the molecule. H-9b was assigned anti to H-10 because of the large coupling
(11.4 Hz) between them, and was therefore placed on the opposite face of the
molecule. An NOE enhancement between H-7 and H-9b therefore positioned H-7
on the opposite face as well, anti to CH3-19. This assignment was supported by
the observation of W-coupling in the COSY spectrum between H3-19 and H-7,
as depicted in Figure 2.5.
As a result, the configuration of the diol was tentatively assigned as 7S and
8R. Although a conformation with a 7R configuration is also consistent with the
NOE data, it appears more contrived. A simple examination of a model suggests
this is a higher energy conformer and consequently appears unlikely. The struc-
ture of 13α-acetoxypukalide diol is therefore proposed as (7S,8R)-dihydroxy-
desepoxy-13α-acetoxypukalide (30). Full NMR data are presented in Table 2.1.
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Table 2.1. NMR data (600 MHz, CDCl3) for 13α-acetoxypukalide diol (30).
δC mult
1JCH δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1 41.4 CH 128 2.31 td (10.8, 2.0) 2a, 2b, 14a, 14b (15, 16) 2b, 2b, 16, 17, 14b
2a
32.1 CH2
132 3.60 dd (15.3, 10.8) 1, 2b 1, (3), 14
2b 128 2.75 d (15.3) 1, 2a, (14b) 1, 3, 4, 14, 15 1, 2a, 14b, 16, 17
3 160.6 C - - - - - -
4 115.7 C - - - - - -
5 108.9 CH 181 6.76 s 7 3, 4, 6 11, 19
6 152.3 C - - - - - -
7 76.0 CH 146 4.54 s 5, 19 5, 6, 8, 9a, 19 9b, 19
8 73.7 C - - - - - -
9a
42.7 CH2
132 2.62 dd (14.8, 5.6) 9b, 10 7, 8, 10, 11
9b 130 1.82 dd (14.4, 11.4) 91, 10 7, 8, 10, (19)
10 77.9 CH 151 4.95 dd (11.2, 5.5) 91, 9b, 11 9, 11, 12 9b, 11, 19
11 154.5 CH 174 6.09 s 10 10, (12), 13, 20 5, 10, 13, 19
12 129.8 C - - - - - -
13 66.8 CH 150 5.51 dd (11.2, 5.0) 1, 13, 14b 11, 12, 14, 20 1, 2b, 11, 14a, 14b
14a
36.2 CH2
126 1.91 ddd (13.1, 11.2, 5.1) 1, 13, 14b 1, 2, 12, 13 2b, 13, 14b, 16
14b 130 2.63 td (12.2, 3) 1, (2b), 13, 14a
15 148.7 C - - - - - -
16a
110.7 CH2
154 4.82 s 2, (15), 23
16b 154 4.81 br s 2, (15), 23
17 20.9 CH3 124 1.81 br s 1, 15, 16
18 163.8 C - - - - - -
19 18.8 CH3 126 1.42 s 7 7, 8, 9, (10) 5, 10, 11
20 170.0 C - - - - - -
21 52.0 CH3 148 3.88 s 18
22 170.4 C - - - - - -
23 21.2 CH3 129 1.98 br s 22
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In a similar fashion, the NMR data of diol 31 closely matched those of
lopholide (27), with the exception of positions 7 and 8. Their signals were
now found at δC 73.7, δH 5.21 (
1JCH 148 Hz), and δC 74.2 respectively, based on
HMBC correlations from H3-19 to C-7 and C-8, once again indicating a diol.
Interestingly, NOE enhancements for 31 suggested a different configuration
at position 7. Figure 2.6 shows the NOE enhancements around the stereocen-
tres in question. Once again, H3-19 showed enhancements to H-5 and H-10,
placing those protons on the same face of the molecule. The observation of en-
hancements between H-7 and H-5 and between H-7 and H3-19 indicated H-7 is
pseudo-equatorial (as shown in Figure 2.6), implying an R configuration. No
W-coupling between H3-19 and H-7 was observed in the COSY to refute this
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Figure 2.6. Key NOE enhancements of lopholide diol (31) suggesting the
relative configuration of the diol.
assignment.
Again, the compound with the opposite (that is S ) configuration at position
7 may satisfy the observed NOE enhancements, but its model appears more
forced and it would be expected to exist in a conformation inconsistent with
the observed data. Lopholide diol is therefore tentatively assigned as (7R,8R)-
dihydroxy-desepoxy-lopholide (31); NMR data are shown in Table 2.2.
The similarity of 13α-acetoxypukalide (26) and lopholide (27), the major
compounds isolated, to the minor new compounds 30 and 31 is quite striking.
The only difference is the opening of the 7,8-epoxide, a highly strained and
reactive functional group. Compounds 26 and 27 were separated from each
other on silica gel with the new diol compounds eluting off the column in the
more polar fractions. The separation was repeated multiple times on mixtures
of 26 and 27, and each time more of the new diol compounds was obtained. As
the mixture had already been purified on silica gel, it should not have had any
more polar compounds; the presence of the diols 30 and 31 suggests they are
being generated in situ on the column.
Silica gel has long been known to catalyze a variety of functional group
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Table 2.2. NMR data (600 MHz, CDCl3) for lopholide diol (31).
δC mult
1JCH δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1 37.3 CH 127 3.31 br s 2a, (2b) 16, 17
2a
33.1 CH2
130 3.07 dd (17, 1.8) 1, 2b 1, 3, 4, 14, 15 16
2b 130 3.02 dd (17, 10.8) (1), 2a (1), 3, (4), 14 16, 17
3 160.0 C - - - - - -
4 115.2 C - - - - - -
5 109.0 CH 182 6.65 s (7) 3, 4, 5, 7, 18 19
6 152.7 C - - - - - -
7 73.7 CH 148 5.21 br s (5) (7, 8) 9b, 19
8 74.2 C - - - - - -
9a
41.0 CH2
123 1.74 dd (14.4, 5.9) 9b, 10 7, 8, 19 10
9b 122 1.60 m 9a, 10 7
10 74.6 CH 161 4.82 dd (9.2, 6.4) 9a, 9b 11, 12, 20 9a, 19
11 63.4 CH 4.12 br s
12 59.2 C - - - - - -
13 69.5 CH 148 4.96 dd (6.4, 1.3) 14a, 14b 1, 12, 20, 22 14a
14a
33.2 CH2
124 2.42 m 13, 14b 14b, 16
14b 122 1.73 m 13, 14a 14a, 19
15 147.6 C - - - - - -
16 111.1 CH2 157 4.84 s 17 1, 15, 17 1, 2a, 2b, 17
17 20.9 CH3 126 1.83 s 16 1, 15, 16 1, 2b, 14a, 16a
18 163.9 C - - - - - -
19 22.7 CH3 127 1.39 s 7, 8, 9 5, 7, 10, 14b
20 168.8 C - - - - - -
21 51.7 CH3 148 3.80 s 4, 18
22 170.6 C - - - - - -
23 20.8 CH3 129 2.07 s - - -
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transformations, most likely due to water, present in the form of silicic acid,
acting as a Brønsted acid catalyst.77 It has also been shown to catalyze the
opening of epoxide rings, for example in the synthesis of 2-amino alcohols78 and
β-halohydrins.79 It therefore may have catalyzed the opening of the 7,8-epoxide
of 13α-acetoxypukalide (26) and lopholide (27) during their chromatographic
separation, to form the diols 30 and 31.
An R configuration at position 7 for diol 31 represents an inversion of con-
figuration from the parent compound lopholide (27). This is consistent with
an SN2-like epoxide opening through nucleophilic attack on the less substituted
carbon, lending credence to the assignment. On the other hand, the proposal of
a 7S,8R configuration for compound 30 is more difficult to explain mechanisti-
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cally. Position 7 is next to the aromatic furan ring, and may therefore be more
susceptible to epimerization, equilibrating to the more stable S configuration for
7,8-dihydroxy-desepoxy-13α-acetoxypukalide (30).
Alternatively, the assigned configurations for positions 7 and 8 may be in-
correct, although models of the two compounds 30 and 31 seem to fit the NOE
data better than any alternatives. The other possibilities are much more con-
trived; congeners with other configurations and conformations which may fit the
observed NOE data appear energetically unfavourable.
Cembranoid diterpenes from octocorals
Octocorals (phylum Cnidaria, class Anthozoa, subclass Alcyonaria), so called
for their eight-fold radial symmetry, are colonial invertebrates which do not
have calcium carbonate skeletons and are therefore often termed soft-corals.80
They produce a vast range of terpenoid metabolites, the majority of which are
macrocyclic diterpenes. Of these, cembranoid diterpenes (based on the cembrane
skeleton 32 which is characterized by a 14-membered ring) are most common.80
A significant number have the furanocembranoid skeleton 33, featuring a furan
at C-3 to C-6, and often a butenolide moiety at C-10 to C-12. Their chemistry
and biology are reviewed by Roethle and Trauner.81
Cembranoid diterpenes have also been isolated from plants; a case in point
is thunbergol, isolated both from Douglas fir and soft corals.73,76,80,82,83 Both di-
astereomeric pairs have been reported, although 1S,4R-thunbergol is exclusively
terrestrial.83
Cembranoid diterpenes have been implicated in a range of biological roles.
Experiments have shown that (−)-epi -thunbergol (25) acts as a sperm attractant
for the soft coral Lobophytum crassum.83 Pukalide (28) and 11β, 12β-epoxypu-
kalide (29) have been isolated from the eggs of five Sinularia soft corals.84 No
trace of the compounds was detected in the tissue of the coral itself, suggesting
the compounds were synthesized for a specific role in the eggs, such as a chemical
release factor for ovulation, or as a defensive toxin. The latter is more likely, as
pukalide was later shown to induce vomiting in fish.85
Other furanocembranoids are potent neurotoxins which selectively and irre-
versibly bind to nicotinic acetylcholine receptors through a covalent interaction
with Tyr190 in the α-subunit.86 The first example reported was lophotoxin (34),
isolated from sea whips of the genus Lophogorgia by Fenical et al. in 1981.87
Since then, structure/activity and molecular modelling studies by Abramson et
al. have established a possible pharmacophore: the section from the 7,8-epoxide
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to the lactone carbonyl at C-20. The 7,8-epoxide can conceivably provide a site
for nucleophilic attack by Tyr190. The lophotoxins have aroused interest as they
may provide new insights into the mechanism of irreversible inhibition involving
Tyr190 and lead to the design of novel irreversible nicotinic acetylcholine receptor
antagonists.86
Concluding remarks
The isolation of known octocoral metabolites from the nudibranch T. incerta and
the isolation of two of those metabolites from the soft coral Alcyonium auranti-
acum is good evidence that the nudibranch sequesters the secondary metabolites
of the soft coral. The pukalide-type or lophotoxin family of furanocembranoids
are known to be ichthyotoxic or ichthyodeterrent; they most likely serve a similar
purpose for T. incerta.
A tentative assignment of the configuration of the 7,8-diols has been made
for the two new compounds diol 30 and diol 31, based on observed NOE en-
hancements. Unfortunately, the flexiblility of such macrocycles can make estab-
lishment of configuration unreliable and therefore other diastereomers cannot be
unequivocally excluded.
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2.4 Dendrodoris denisoni
Dendrodoris denisoni (see Figure 2.7 for taxonomy) is a distinctive nudibranch
with a highly convoluted, creamy-brown mantle with raised pustules and smooth,
oval-shaped, peacock-blue areas between the folds, as can be seen in Figure 2.8.
It has large, very finely branched brown gills and brown rhinophores, and grows
up to a maximum size of 70 mm. D. denisoni is found throughout the tropical
and warm temperate Indo-West Pacific. In New Zealand (where it is often called
D. gemmacea), its range is limited to the northern part of the North Island.
Predominantly intertidal, D. denisoni is usually found on semi-sheltered coasts.
Little is known about its feeding habits, but for defense it is known to secrete a
compound with a distinctive sharp and peppery taste from its mantle.48,69
Order Nudibranchia (nudibranchs)
Suborder Doridina (dorids)
Family Chromodorididae
Family Dendrodorididae
Genus Dendrodoris
D. denisoni
Family Dorididae
Family Polyceridae
Suborder Dendronotina (dendronotids)
Suborder Arminina (arminaceans)
Suborder Æolidina (aeolids)
Figure 2.7. Taxonomic classification of D. denisoni, after Rudman.49
Figure 2.8. Underwater photo of D. denisoni (courtesy of Peter Northcote).
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Metabolites isolated from D. denisoni
Two D. denisoni nudibranchs were collected from Rauhomaumau Island, Tu-
tukaka, New Zealand in December 2003. The MeOH extracts were cyclic loaded
onto a reversed-phase HP20 column, and eluted with increasing concentrations
of Me2CO in H2O. NMR analysis of the resulting fractions revealed that the 70%
Me2CO/H2O fraction contained predominantly one compound. Subsequent nor-
mal phase chromatography on DIOL and silica gel resulted in the isolation of
two compounds, the major cinnamolide (35) and the minor dendocarbin A (36).
Examination of the NMR spectra of compound 35 revealed the presence
of 15 carbons and 22 protons. The key features were three methyl singlets, a
trisubstituted double bond, and an oxymethylene pair of protons appearing as
sharp triplets. A series of COSY and HMBC correlations, depicted in Figure 2.9,
allowed construction of the structure of the known sesquiterpene cinnamolide
(35). Comparison of the NMR data with literature values88,89 confirmed the
assignment.
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Figure 2.9. Key COSY and HMBC correlations establishing the connectivity
of cinnamolide (35).
The more polar, minor compound 36 had very similar NMR characteristics
to cinnamolide (35). The main difference was the absence of the two triplets
belonging to the oxymethylene at position 11. A new broadened resonance at
δH 5.65 with a relative integration of one proton was apparent instead, implying
a substitution at C-11. A search of the literature and comparison of the NMR
data revealed 36 was dendocarbin A.90
Drimane sesquiterpenes
Both 35 and 36 possess the drimane sesquiterpene skeleton, so named after
drimenol (37), the first drimane discovered, which was isolated from the bark
of Drimys winteri in 1956.91 Many drimanes have been isolated from vascular
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plants,91,92 and indeed, cinnamolide was first reported from the bark of the
Madagascan tree Cinnamosma fragrans.88 One rich source of drimanes is the
plant Polygonum hydropiper, often known as marsh pepper because of the hot,
peppery taste experienced when chewing its leaves.91 The peppery qualities of
this plant (used in Japanese cuisine and as a pepper substitute in other regions)
have been traced to several drimanic aldehydes such as polygodial (38). Their
role in the plant is thought to be antifeedant and insect repellant.91,92
Drimanes are also common metabolites of sponges of the genus Dysidea,
and have been isolated from several dorid nudibranch species.92 For example,
the Japanese dorid Dendrodoris carbunculosa was found to contain a series of
drimane metabolites: isodrimeninol (39), first isolated from the seeds of P. hy-
dropiper, and the new dendocarbins A–N (36, 40–52).90
D. carbunculosa is described as having a “bitter and sharp peppery taste,”
and Sakio et al. report that 39, the major sesquiterpene isolated from the nu-
dibranch, also has a sharp peppery taste.90 The reports of a peppery taste of
the nudibranch D. denisoni is therefore most likely due to its major drimane
constituent, cinnamolide (35). This hypothesis, however, was not tested in our
laboratory.
Drimanes are typical sponge metabolites suggesting a dietary origin of these
compounds in the nudibranchs.92 Biosynthetic experiments on several dorid
species, however, have unambiguously demonstrated that they are capable of
de novo biosynthesis of drimanes. The first such experiments, by Cimino et al.
in 1982, involved the nudibranch Dendrodoris limbata, injected with carbon-14
labelled mevalonic acid. Subsequent extraction of D. limbata led to the isola-
tion of radiolabelled polygodial (38), proving the nudibranch elaborates its own
chemical defense.52
Concluding remarks
Many reports have implicated drimane sesquiterpenes as a chemical marker
present in all Dendrodoris species.53 Researchers have also demonstrated de novo
biosynthesis of a number of drimanes found in Dendrodoris nudibranchs. This
may mean that all drimanes produced by Dendrodoris nudibranchs, including
cinnamolide (35) and dendocarbin A (36), are biosynthesised rather than se-
questered from their diet.
The ability to synthesize their own metabolites rather than relying on di-
etary sources is an evolutionary adaptation observed in multiple nudibranch
species.51 It is not limited to drimanes but includes the de novo biosynthe-
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sis of unusual lactones of prostaglandins, various terpenoid skeletons and some
polyketide metabolites.53 This “emancipation” from their food source allows nu-
dibranchs with biosynthetic capability to exploit other, chemically undefended,
prey.51 However, “the advantage of not being dependent on specific food sources
for defensive metabolites is balanced against the need to maintain a complex
biosynthetic mechanism.”93
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2.5 Aphelodoris luctuosa
A narrow and elongated nudibranch, Aphelodoris luctuosa (see Figure 2.10 for
taxonomy) is ornamented with chocolate-brown radial bands, streaked concen-
trically with irregular black lines. Its gills and rhinophores are brown and edged
with yellow, as can be seen in Figure 2.11. A. luctuosa is found throughout
New Zealand, and is probably the most common subtidal dorid found around
Northland’s east coast. Usually seen in open and semi-sheltered rocky environ-
ments, the nudibranch can be found as far down as 40 m, unusually deep for a
dorid. Growing up to 75 mm in size, it can show considerable colour variation,
including a cream and white form from Stewart Island.48,69
Order Nudibranchia (nudibranchs)
Suborder Doridina (dorids)
Family Chromodorididae
Family Dendrodorididae
Family Dorididae
Genus Aphelodoris
A. luctuosa
Family Polyceridae
Suborder Dendronotina (dendronotids)
Suborder Arminina (arminaceans)
Suborder Æolidina (aeolids)
Figure 2.10. Taxonomic classification of A. luctuosa, after Rudman.49
Figure 2.11. Underwater photo of A. luctuosa (courtesy of Ian Skipworth).
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Figure 2.12. Two different colour morphs of A. luctuosa. Photos courtesy of
Peter Northcote.
Metabolite isolated from A. luctuosa
Six nudibranchs identified as A. luctuosa were collected off the northern coast
of the North Island of New Zealand in December, 2003. Five similar but lighter-
coloured individuals were also collected at the same time. The two collections
of nudibranchs (shown in Figure 2.12), initially thought to be different species,
were extracted separately in MeOH, and the extracts cyclic loaded onto reversed-
phase HP20. The columns were eluted with increasing concentrations of Me2CO
in H2O. The 30% Me2CO/H2O fractions showed some unusual characteristics:
half of the mass eluted from the column was contained in these fractions (5–25%
is more usual) and the fractions were water soluble, whereas usually the 30%
fraction is a mixture of compounds that do not dissolve fully in any solvent.
The NMR spectra of the 30% fractions was identical for both the dark and
light coloured nudibranchs, confirming that they were colour morphs of the same
species. 1H NMR revealed the presence of one major compound, with four signals
in the aromatic/heteroaromatic region (δH 8.00–9.00), some in the alkyl region,
as well as a “CH2 envelope” at δH 1.29. The major signals were all broadened,
perhaps indicating poor solubility in CD3OD.
Attempts were made to find suitable silica-gel TLC conditions, but in all cases
the compound did not move off the origin. In order to avoid irreversible binding
to normal phase packing material, the sample was purified on an LH-20 size-
exclusion column, with 10% H2O/MeOH as the mobile phase. The compound of
interest (53) eluted with the solvent front, indicating it was fully excluded from
the pores of the resin and was therefore larger than 4000–5000 Da.
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Examination of the NMR spectra revealed the presence five aromatic carbons:
three methines and one non-protonated carbon. One aromatic methine was a
singlet, two were doublets, and one was a triplet; the data were consistent with
a 3-substituted pyridine ring, although the 1H and 13C chemical shifts were
downfield from normal pyridine. A methylene (δC 33.5, δH 2.88) showed an
HMBC correlation to the non-protonated aromatic carbon, and was therefore
placed adjacent to it. A second methylene (δC 62.9, δH 4.63,
1JCH 144 Hz)
also showed several HMBC correlations into the aromatic ring. Based on these
correlations, its unusual chemical shifts, and high 1JCH coupling constant, the
methylene was placed next to the nitrogen establishing a 3-alkyl substituted
pyridinium moiety.
A review of the literature (see below) revealed that several 3-alkyl pyridinium
salts have been reported from marine sponges, all with long alkyl chains. Indeed,
COSY and HMBC correlations from the methylenes attached to the pyridinium
ring allowed the construction of a saturated alkyl chain, with both ends showing
correlations into the CH2 envelope. As the chromatographic behaviour of 53
suggested a polymer, the structure was proposed to be 3-alkyl pyridinium salts
linked head to tail with an alkyl chain consisting of eight methylene units (as
estimated from the 1H integration ratio).
What appeared to be a minor compound in the sample showed similar NMR
characteristics, with five aromatic carbons and several methylenes. The aromatic
resonances were shifted upfield from those of the major compound, being in
good agreement with a 3-alkyl substituted pyridine rather than a pyridinium
salt. This suggested that rather than a separate, minor compound, the 3-alkyl
pyridine moiety may in fact be a terminating unit of the polymer. Comparison of
the 1H signal integrations suggests a ratio of 17:1 “internal” to “terminal” units,
implying an average polymer size of approx. 3200 Da, in agreement with the
early elution with the solvent front from the LH-20 column.
In addition, several features in the NMR spectra (initally attributed to the
“minor” component) suggested the presence of alternate alkyl linking chains,
including some with oxygenation (e.g. a methine δC 80.2, δH 4.62). As no fur-
ther purification was undertaken, these resonances may still be due to a minor
impurity that co-eluted off the LH-20 column.
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Polymeric alkyl-pyridinium salts
Sponges belonging to the order Haplosclerida are known to contain pyridinium
alkaloids, often with potent biological activities. They are all characterized by
3-alkyl pyridinium units, connected via long alkyl chains. Sometimes the alkyl
chains show unsaturation, as in the niphatoxins A and B (54, 55), isolated from
the sponge Niphates sp.94 Cyclic versions have also been isolated, such as the
dimeric cyclostellettamines A–F (56–61) reported95 from the sponge Stelletta
maxima∗ and the trimeric version of 58, viscosamine (62)97 from the Arctic
spongeHaliclona viscosa. Most recently, the alkyl pyridinium alkaloid viscosaline
(63), with the unusual β-alanine covalently bonded to one alkyl chain, was also
isolated from H. viscosa.98
Interestingly, the 3-alkyl pyridinium alkaloids are also found as oligomers or
polymers, with the 3-alkyl chain bound head to tail to the adjacent pyridinium
subunit. The first example isolated was halitoxin (64) from three different Ha-
liclona species of sponge.99 Halitoxin is proposed to be a complex mixture of
molecules of varying sizes, with random variations in the length and structure
of the alkyl chains. Membrane ultrafiltration of aqueous solutions was used to
purify the toxin and separate it into molecular weight range fractions, from 500
to greater than 25,000 Da. All the different molecular weight fractions exhib-
ited the same cytotoxicity against KB cancer cells (ED50 = 5–7 µg/mL).
99 The
crude sponge extracts also showed toxicity to mice (LD50 = 5 mg/kg) and caused
haemolysis at a threshold concentration of 1 µg/mL.99
Re-examination of one of the Haliclona species by a different research group
led to the identification of amphitoxin (65), containing randomly distributed
3-alkyl and 3-alkenyl pyridinium units in an approximate ratio of 1:1.100 The
compound deterred feeding by the bluehead wrasse, a common predatory fish,
strongly suggesting amphitoxin plays a defensive role.100
A similar polymer or oligomer (66) (with unbranched alkyl chains) was iso-
lated from the sponge Callyspongia fibrosa through bioassay-guided fractionation
on LH-20, followed by centrifugal countercurrent chromatography.101 The struc-
ture of 66 was initially proposed to be a cyclic, dimeric, structure on the basis
of ion-spray MS and the absence of any terminal groups in the NMR spectra.
Subsequent synthesis of the dimer refuted that proposal, and the structure of 66
was reassigned as a polymer or oligomer containing at least eight subunits.101
∗Although S. maxima belongs to the order Astrophorida, subsequent examination of the
voucher sample found it to be encrusted by a Haliclona, raising the question of the true origin
of the cyclostellettamines.96
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Compound 66 was a potent (IC50 = 2 µg/mL) inhibitor of the epidermal growth
factor (EGF). As EGF is often overexpressed in carcinomas, EGF inhibitors may
therefore be useful as antitumour agents.101
More recent research on sponges of the genera Amphimedon∗ and Reniera∗
have led to the isolation of 64 and 66 but with differing molecular weight distri-
butions and different biological activity profiles.96,102 As some of the biological
activity of the polymeric complexes was found to vary with molecular weight96,
∗= Haliclona
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researchers believe different extraction procedures result in the isolation of com-
pounds of differing molecular weight and therefore different biological activity.102
Concluding remarks
To the best of our knowledge, this is the first time a polymeric 3-alkyl pyridinium
salt has been isolated from a nudibranch species. It has the same basic structure
as the polymeric pyridinium alkaloid 66 isolated from the sponge C. fibrosa,101
although some subunits may show oxygenation. As these types of compounds
are found exclusively from sponges of the order Haplosclerida, the origin of the
compound in the nudibranch is most likely dietary. On a subsequent dive trip to
the north of the North Island, a search was undertaken for a possible food-source
sponge of A. luctuosa, unfortunately without success.
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2.6 Tambja morosa
Tambja morosa (see Figure 2.13 for taxonomy) is a very dark, usually black,
nudibranch that can be found throughout the tropical Western Pacific. The oral
veil, foot margin and gill bases are highlighted with royal blue lines, while the
highly branched gills are pure black. In the cooler waters of Australia and north-
ern New Zealand, dark green specimens are observed, as shown in Figure 2.14.
T. morosa occurs towards the bases of coral reef slopes (at depths of 9–21 m),
where it feeds on arborescent bryozoans.48,49
Order Nudibranchia (nudibranchs)
Suborder Doridina (dorids)
Family Chromodorididae
Family Dendrodorididae
Family Dorididae
Family Polyceridae
Genus Nembrotha
Genus Roboastra
Genus Tambja
T. morosa
Suborder Dendronotina (dendronotids)
Suborder Arminina (arminaceans)
Suborder Æolidina (aeolids)
Figure 2.13. Taxonomic classification of T. morosa, after Rudman.49
Figure 2.14. Underwater photo of T. morosa (courtesy of Ian Skipworth).
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Metabolite isolated from T. morosa
Three T. morosa individuals were collected from Rauhomaumau Island, Tu-
tukaka, New Zealand in December 2003. They were extracted in MeOH, and
the extract cyclic loaded onto a reversed-phase HP20 column, which was then
eluted with increasing concentrations of Me2CO in H2O. The 30% Me2CO/H2O
fraction, coloured dark green, showed interesting signals in the 1H NMR spec-
trum and was selected for further analysis.
In preparation for a reversed-phase MPLC column, the sample (approx.
40 mg) was cyclic loaded onto a small column of HP20SS. While the major-
ity of colour adsorbed onto the column, the eluent remained a bright yellow. It
was concentrated under reduced pressure to yield 12 mg of material, a significant
portion of the original sample. This suggested that either the column was over-
loaded, or the material was so polar it preferred the mobile phase over adsorption
onto the packing material. Examination of the sample by NMR spectroscopy
revealed it was one compound in >90% purity. Preliminary analysis of spectra
run in CD3OD suggested the presence of exchangeable protons; upon changing
the solvent to DMSO-d6 four new
1H resonances at δH >9.5 became apparent.
In addition, five olefinic or aromatic methines and four non-protonated aromatic
carbons were present, some with unsual chemical shifts (e.g. δC 92.2) indicating
highly polarized double bonds.
Clearly, the molecule had an aromatic or heteroaromatic structure. This
meant that COSY and HMBC spectra—the most common experiments used for
structure elucidation—were of limited utility, as all the 1H resonances showed
numerous correlations via long range coupling. Fortunately, as most aromatic
systems are planar and quite rigid, NOE enhancements (depicted in Figure 2.15)
were instrumental in the elucidation of the structure, proposed to be the bipyrrole
alkaloid 67a.
Figure 2.15. NOE enhancements establishing the structure of tambjamine A
(67a).
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Figure 2.16. Fully coupled 1H–15N HSQC of tambjamine A (67a), including a
trace through NH2-12 (δN −57.2) (inset) showing the
1JNH of H-12a and H-12b.
Also visible is the cis (small) and trans (large) coupling to H-11.
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Figure 2.17. 1H–15N HMBC correlations of tambjamine A (67a).
In order to unequivocally prove the presence of nitrogens, indirectly detected
15N NMR experiments (HSQC and HMBC) were run on the sample. 1H–15N
HSQC experiments (the fully coupled HSQC can be seen in Figure 2.16) proved
the presence of at least three nitrogens. A 1H–15N HMBC experiment con-
firmed the placement of the pyrrole nitrogens, through correlations depicted in
Figure 2.17.
The proposed structure of 67a (see Table 2.3 for full NMR data) is a charged
form of the known compound tambjamine A (67).103 Carte´ and Faulkner report
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that tambjamine A exists as the more stable enamine tautomer; isolation of
67a suggests that when charged, the imine form is preferred. Clearly, this is an
equilibrium process (depicted in Scheme 2.1) that will be pH dependent. The
isolation of the charged form 67a is most likely due to different extraction and
purification protocols.
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Scheme 2.1. Interconversion between tambjamine A (67) and its protonated
form (67a).
Table 2.3. NMR data (600 MHz, d6-DMSO) for tambjamine A (67a).
δC/δN mult
1JXH δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1 −24.5 NH 95 12.03 br s 2, 3, 4 2, 7
2 123.9 CH 191 7.08 td (2.6, 1.4) 1, 3 1 1, 3
3 110.7 CH 174 6.24 dt (4.6, 2.3) 1, 2, 4 1 2, 4
4 111.7 CH 173 7.11 ddd (3.7, 2.5, 1.4) 1, 3 1, 4, 3, 5 3, 10
5 122.4 qC - - - - - -
6 142.2 qC - - - - - -
7 92.2 CH 182 6.58 d (2.0) 10 9, 10 1, 13
8 164.4 qC - - - - - -
9 111.2 qC - - - - - -
10 −42.6 NH 99 13.05 br s 7 7, 8, 9, 11 4, 11, 12a
11 141.9 CH 192 7.78 dd (15.8, 8.2) 12a, 12b 8, 9, 10 10, 12a, 12b, 13
12a
−57.2 NH2
90 9.92 d (16.2) 11, 12b 9 10, 11, 12b
12b 96 9.55 d (8.0) 11, 12a 9 11, 12a
13 58.9 CH3 149 3.89 s - - 7, 11
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The tambjamine alkaloids
Tambjamine-type bipyrrole alkaloid pigments have been isolated from bryozo-
ans,103,104 nudibranchs,103,105 and ascidians.105 Tambjamines A–D (67–70) were
first isolated from three nudibranch species, Tambja abdere, T. eliora and their
predator, Roboastra tigris.103 As with most nudibranch compounds, the tamb-
jamines have been traced to a dietary origin: the bryozoan Sessibugula translu-
cens. Tambjamines C and D (69, 71) were isolated from the marine ascidian
Atapozoa sp. and its associated nudibranch predators (genus: Nebrotha), together
with 67 and 69.105 Finally, the marine bryozoan Bugula dentata was found to
contain tambjamines E–J (72–77).
The tambjamines are all bipyrroles containing a methoxy group (initially
suspected to be an artifact of isolation, but subsequently proven otherwise).
They also contain an imine group, enolized to produce an enamine.103 Tamb-
jamines C–J (69–77) are N -alkyl derivatives, with isobutyl, ethyl, 2-phenylethyl,
propyl and 2-methylbutyl residues on the enamine nitrogen.103–105
The closest relatives of the tambjamines are the prodigiosin (78) family of
alkaloids, tripyrrole metabolites of the bacterium Serratia marcescens.106 They
bear the same “prodiginine” core, with different alkyl substituents, such as 79.
Also isolated from a mutant strain of S. marcenscens was the tetrapyrrole 80,
subsequently found in the bryozoan B. dentata and two ascidians.105,107,108 The
finding of compounds so similar to the tambjamines in bacterial strains suggests a
microbial origin for these metabolites. This is further supported by the isolation
of two tambjamine-like analogues 81 (from a marine bacterium)109 and 82 (from
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a streptomycete),110 both with long alkyl chain enamine substituents.
The role of the tambjamines is thought to be a chemical defense mechanism
against predators. When threatened, the nudibranch T. abdere exudes a mucous
containing high quantities of the tambjamines. This slime is distasteful enough
to deter most predators, although the specialist predator R. tigris can often
breach this defense mechanism, even using the slime trail to track its preferred
prey.103,111
The prodigiosins show a broad range of biological activity, including the
ability to cleave DNA under oxidative conditions.106 While the tambjamines
are less potent, they still show appreciable cytotoxicity,104 antimicrobial103 and
antitumour activity.110
Concluding remarks
The tambjamine class of pyrrole alkaloids has been found in ascidians, bryozoa,
nudibranchs that feed on them, and Roboastra tigris that in turn preys on the
nudibranchs. The isolation of similar compounds from bacteria suggests the
ultimate source of the tambjamines may in fact be microbial.
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As with other members of the genus, T. morosa was found to contain tam-
bjamine A (67), although isolated as the charged imine tautomer. NOE en-
hancements and 15N NMR spectroscopy were crucial to the identification of the
structure.
Nitrogen is an important element in natural products chemistry, appearing
in alkaloids, peptides and other nitrogenous molecules. Unfortunately the low
natural abundance (0.37%) and low gyromagnetic ratio of 15N make it an in-
sensitive nuclide to employ as a structural probe.112 Inverse-detected methods
that use the 1H nucleus for the excitation and detection of the NMR signal can
overcome this difficulty.113 The ability to probe another nuclide can be very use-
ful, especially in heteroaromatic systems where long range 1H–1H and 1H–13C
coupling can make structure elucidation difficult.
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2.7 Ceratosoma amoenum
Ceratosoma amoenum (see Figure 2.18 for taxonomy) is a nudibranch of dis-
tinctly gaudy colouration: a pale mantle with vivid orange and vermilion spots,
with the gills and rhinophores highlighted in magenta. The colour patterns are
unique and can be used to identify individuals. The vermilion spots tend to be
absent and the orange ones larger in New Zealand individuals (see Figure 2.19).
The nudibranch is found only in open, rocky situations, as it is intolerant of silt.
Its range extends from the northern half of New Zealand to temperate southern
and south-eastern Australia, at depths of 0–40 m. C. amoenum can grow up to
60 mm in size, but 25–30 mm is more usual.48,49,69
Order Nudibranchia (nudibranchs)
Suborder Doridina (dorids)
Family Chromodorididae
Genus Ceratosoma
C. amoenum
Family Dendrodorididae
Family Dorididae
Family Polyceridae
Suborder Dendronotina (dendronotids)
Suborder Arminina (arminaceans)
Suborder Æolidina (aeolids)
Figure 2.18. Taxonomic classification of C. amoenum, after Rudman.49
Figure 2.19. Underwater photo of C. amoenum (courtesy of Ian Skipworth).
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Metabolites isolated from C. amoenum
C. amoenum specimens (28 individuals) were collected off the coast of Northland,
New Zealand. They were extracted in MeOH, their extracts cyclic loaded onto
reversed-phase HP20 and eluted with increasing concentrations of Me2CO/H2O.
The 100% Me2CO fraction showed the presence of one major compound by
NMR spectroscopy and was further purified on normal phase silica gel, yielding
furodysinin (83). The 75% fraction was also subjected to normal phase chro-
matography (both silica gel and DIOL), resulting in the isolation of O-methyl-
furodysinin lactone (84) and tetradehydrofurospongin-1 (85). Both 83 and 84
have been previously isolated in our lab from a Dysidea sponge,114 and were
readily identifiable from comparison of NMR data. The compound 85, however,
required de novo structure elucidation.
The key features in the NMR spectra of 85 were the presence of signals con-
sistent with two 3-substituted furan rings: four α-methine signals (δC 138–140,
δH 7.2–7.4) and two β-methine signals (δC 107–111, δH 6.3–6.5). Furthermore,
two trisubstitued double bonds, one disubstituted double bond, two olefinic
methyls, four methylenes and one oxymethine were also apparent.
The COSY spectrum was interpreted cautiously, as many protons exhibited
allylic and homoallylic coupling. The HMBC correlations from the two methyls
allowed the construction of the two trisubstituted double bonds. They were
connected together via the oxymethine and one methylene through COSY cor-
relations from H-10 to H-11, and from H-11 to H2-12. Other COSY correlations
placed two methylenes next to CH-15, and the disubstituted double bond next to
CH2-7, as depicted in Figure 2.20. These assignments were confirmed by HMBC
correlations (not shown).
CH3CH3 OH
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H HH H
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Figure 2.20. Key COSY and HMBC correlations establishing the C5–C17
segment of tetradehydrofurospongin-1 (85).
Using this fragment and the suspected presence of two furan rings, a search of
the literature suggested this compound may be (−)-tetradehydrofurospongin-1
(85), first reported from a Hippospongia sp. sponge in 1989 as untenospon-
gin B,115 and later renamed.116 This was confirmed by comparison of NMR and
optical rotation data.
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The dysin sesquiterpenes
A series of related compounds belonging to the so-called“dysin” family of sesqui-
terpenes has been isolated from Dysidea species (family Dysideidae, order Dicty-
oceratida) and predatory dorid nudibranchs. They are typified by furodysin (86),
and the rearranged furodysinin (83),117 which was isolated in this study. Inter-
estingly, in addition to various oxygenated derivatives, several sulfur-containing
dysin sesquiterpenes have been isolated, such as thiofurodysin acetate (87), thio-
furodysinin acetate (88), methylthiofurodysinin (89) and thiofurodysinin (90)
from sponges of the genus Dysidea and the nudibranch Ceratosoma brevicauda-
tum.117–119 C. brevicaudatum also contained the unusual dimer dithiofurodysinin
disulfide (91), possibly an artifact arising from the oxidative coupling of the free
thiol 90 as thiols readily dimerize in air.118
Notable variants are the butenolide versions furodysin lactone (92) and furo-
dysinin lactone (93), once again isolated from Dysidea sponges.120,121 The O-
methyl version (84) isolated during this research has also been reported from the
nudibranch Chromodoris funerea.122 In addition, Carte´ et al. report that both
93 and 84 can be prepared by singlet oxygen oxidation of furodysinin (83).122
C21 linear furanoterpenes
Many sponges of the family Spongiidae (order Dictyoceratida) are characterized
by C21 linear furanoterpenes, which have two 3-substituted furan moieties con-
nected by a linear isoprenyl portion.116 This is exemplified by the simplest variant
anhydrofurospongin (94).123 These furanoterpenes usually only show variation
in oxygenation or saturation along the linear isoprenyl section.114 As terpenes
are biosynthesized by the sequential addition of five-carbon isoprenoid units,
C21 terpenes are quite unusual; they are most likely derived from degradation of
higher terpenoids.116
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(−)-Tetradehydrofurospongin-1 (85) was first isolated along with compound
95 from the marine sponge Hippospongia sp.; both were reported to exhibit
potent coronary vasodilating activity.115 Fontana et al. later isolated the 11R
enantiomer of tetradehydrofurospongin-1 (96) from the sponge Spongia virgul-
tosa, solving its absolute configuration using Mosher’s method.116
Concluding remarks
Nudibranchs of the family Chromodorididae, as the name suggests, are some
of the most colourful. Their gaudy colouring is thought to be a warning to
predators of their highly distasteful secretions.69 Indeed, several of the dysin
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metabolites show ichthyodeterrent properties.120,122 The isolation of these meta-
bolites from both Dysidea sponges and their predatory nudibranchs (and the
consistent localization of the compounds in the nudibranch’s gut contents124)
imply a dietary origin.
During this study, two dysin metabolites and a linear furanoterpene were iso-
lated from the nudibranch C. amoenum. The concurrent presence of a C21 linear
furanoterpene (which are most often isolated from sponges of the family Spongi-
idae) and dysin metabolites (found in Dysidea sponges) in the same nudibranch
suggests it may feed on several sponge species from different families.
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Chapter 3
The Agminosides: Novel
Glycolipids from Raspailia
agminata
3.1 Secondary metabolites reported from the
genus Raspailia
The genus Raspailia, which is characterized by the absence of microsclere spic-
ules, belongs to the family Raspailiidae (order Poecilosclerida). It contains
more than one hundred described species, distributed world-wide mainly in shal-
low waters.43 Thirty-nine new compounds have been reported from Raspailia
sponges belonging to four major classes: acetylenic glyceryl enol-ethers, cyclic
hemi-ketals, adenine-diterpene asmarines, and clerodane diterpenes.
The first Raspailia compounds to be isolated were a series of long-chain glyc-
eryl enol-ethers from two north-east Atlantic sponges, R. pumila and R. ramosa
in 1986.125,126 The enol double bond is conjugated in sequence to both acetylenic
and olefinic bonds. These raspailynes, as they are known, can be grouped based
on the configuration of their double bonds. Those that have a (1Z,5Z ) configu-
ration are raspailynes A, A1, B, B1, B2 (97–101), and isoraspailynes A, B and
B1 (102–104). The (1Z,5E ) configuration is present in isoraspailyne Ba (105)
and B1a (106), while isoraspailyne B1b (107) is (1E,5Z ). Compound 100 has
also been isolated from the sponge R. agminata.127 While acetylenic and poly-
acetylenic metabolites are frequently isolated from sponges, acetylenic glyceryl
enol-ethers are relatively rare.128
Next to be isolated from a Raspailia sponge were two cyclic hemi-ketals,
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named raspailols A (108) and B (109) from a Palauan sponge of unidentified
species.129 The absolute configuration of the ring portion was determined by
Mosher’s method, but the full stereochemical assignment was only accomplished
by total synthesis.130 Although the crude sponge extract showed mild antibac-
terial activity, no activity has been reported for the pure compounds.
The asmarines A–K (110–120) are nitrogenous metabolites of mixed biogen-
esis: clerodane diterpene and adenine. They were isolated by Kashman and co-
workers from an undescribed Raspailia species from Eritrea,131,132 Kenya133 and
Madagascar134. Two new diterpenes, barekol (121)133 and nosyberkol (122)134
were also isolated, along with the three known diterpenes chelodane (123),
barekoxide (124) and zaatirin (125), previously reported from the sponge Che-
lonaplysilla erecta,135 and a 5β-cholanic acid derivative, methyl 3-oxo-cholan-24-
oate (126).132,133 Of note is that 123 is the biogenetically appropriate diterpene
precursor to form asmarines 110, 113, 114 and 116–119. Two asmarines,
110 and 111, show cytotoxic activity against a number of cell cultures at the
micromolar level; while the other asmarines are also active, they are less po-
tent.131,133,134
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The New Zealand marine sponge R. topsenti is a rich source of secondary
metabolites, with 13 clerodane diterpenes isolated to date.127,136–139 The first
reported were raspailol (127) and raspailenone (128) by West et al. in 1998.136
Since then, raspailenone B (129),137 raspailodanes A–G (130–136)127,138 and
topsentanes A (137) and B (138)137 have been isolated by our research group.
Most recently, another member of this family has been isolated in this lab: a
butenolide version of 127, compound 139.139 Due to the paucity of material,
the configuration of 139 has not been assigned, but is most likely analogous to
127. R. topsenti clearly has more interesting, as yet unidentified metabolites,139
although some are proposed to be degradation products.137
The majority of clerodanes are isolated from terrestrial plants,140 and the
few clerodanes of marine origin (for example the asmarines) often have little
or no oxygenation, and are of mixed biogenesis. In contrast, the metabolites
of R. topsenti are highly unusual. They often have high levels of oxygenation,
often have the uncommon cis ring fusion (compounds 127–131 and 135), and
represent the first 19-norclerodanes (compounds 132–134, 136–138) from the
marine environment. Subsequent to their isolation, raspailol (127) and topsen-
tanes A and B (137, 138) have been shown to possess anti-inflammatory activity
in vitro.127,137 The other metabolites were inactive in the same assay.
Capon et al. isolated esmodil (140), an acetylcholine mimic, from a Ras-
pailia sp. sponge.141 Esmodil is a known synthetic drug investigated in the early
20th century; the ecological role it plays in the sponge remains unresolved. Also
present in the sponge were the known antifungal and cytostatic macrolides phor-
boxazoles A and B (141, 142), previously reported from the marine sponge Phor-
bas sp.142,143 Most recently, during a search for α-glucosidase inhibitors (which
may be useful for the development of AIDS and diabetes treatments), Saludes et
al. report the small molecule inhibitor 1,4-dideoxy-1,4-imino-d-arabinitol (143)
from Raspailia sp. and Haliclona sp.144
One final compound has been isolated from a Raspailia sponge: okadaic acid
(144) from the New Zealand sponge R. agminata.145 As okadaic acid was also
isolated from two other sponge orders from around New Zealand, and is a known
dinoflagellate toxin, it is presumably being taken up by filter-feeding sponges
exposed to algal blooms, as opposed to being a sponge metabolite.145
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3.2 The agminosides
Raspailia agminata (see Figure 3.1 for taxonomy) is usually a massive, somewhat
conical sponge with several finger-like projections, a thick mat with cone-like
projections, or a thick encrustation. It is found throughout New Zealand, usually
under rock ledges, low tidal boulders, or on wharf piles, but never exposed
to direct sunlight.41 Under water it is dark brown with oscules 1.0–2.5 mm in
diameter often situated on the apex of the conical projections41,146 as can be
seen in Figure 3.2. Its skeleton is composed of megascleres only, with styles and
subtylostyles measuring from 500–2500 microns, slender, curved oxeas of 200–
500 microns and strongly spined acanthostyles 80–190 microns long and up to
12 microns thick.146 These can be seen in Figure 3.3.
Apart from the isolation of okadaic acid (144)145 and raspailyne B1 (100),127
no other metabolites from R. agminata have been reported in the literature. The
sponge has, however, been successfully grown in an aquaculture trial.147
R. agminata had been briefly examined in our lab previously.72 As the NMR
spectra showed many interesting signals in the oxymethine and acetate region,
the sponge was re-examined in an effort to isolate these interesting metabolites.
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Order Poecilosclerida
Suborder Microcionina
Family Microcionidae
Family Acarnidae
Family Raspailiidae
Subamily Raspailiinae
Genus Acanthostylotella
Genus Aulospongus
Genus Ectyoplasia
Genus Endectyon
Genus Eurypon
Genus Hymeraphia
Genus Raspaciona
Genus Raspailia
R. typica (type sp.)
R. agminata
Genus Raspailopsis
Genus Rhabdeurypon
Genus Trachostylea
Subfamily Thrinacophorinae
Subamily Plocamioninae
Subamily Echinodictyinae
Subamily Cyamoninae
Family Rhabdermiidae
Suborder Myxillina
Suborder Mycalina
Suborder Latrunculina
Figure 3.1. Taxonomic classification of R. agminata, after Hooper and van
Soest.43
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Figure 3.2. Underwater photo of R. agminata (courtesy of Mike Page).
Figure 3.3. SEM image of R. agminata spicules.
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Figure 3.4. 1H NMR spectrum (600 MHz, CD3OD) of the 60% Me2CO in H2O
fraction.
Isolation of the agminosides
R. agminata was collected from Taheke Reef, Cavalli Islands, New Zealand in
December 2003. The sponge was extracted with MeOH and the extracts were
cyclic loaded onto reversed-phase HP20 beads. The column was eluted with
increasing concentrations of Me2CO in H2O. NMR examination of the resulting
fractions showed that the interesting signals were confined to the 60% Me2CO
in H2O fraction (Figure 3.4). Previous work
72 suggested that the molecules
of interest were quite large, and hence the next step of purification was a size
exclusion column.
Early eluting fractions off the LH20 column were combined based on TLC,∗
affording a mixture of compounds that was free of structurally unrelated impuri-
ties. This was further separated on silica gel columns, using CH2Cl2:MeOH:H2O
mixtures, the only solvent system that gave good chromatographic results. This
observation suggested amphiphilic molecules, and as the NMR spectra showed
multiple oxymethines (including acetal-type signals) and a CH2 envelope at
δH 1.29, they were probably glycolipids.
Initially, the fractions from the normal phase silica gel columns were com-
bined based on TLC char, but NMR analysis quickly revealed they were not as
pure as the TLC would suggest, as shown in Figure 3.5. They were, in fact, still
∗100:20:3 CH2Cl2:MeOH:H2O, visualised by dipping into 5% H2SO4/MeOH and heating.
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Figure 3.5. 1H NMR spectra (600 MHz, CD3OD) of a fraction that looked
pure by TLC (bottom) and purified agminoside A (top).
mixtures of closely related glycolipids with almost identical retention factors.
The glycolipids had no appreciable chromophore, which meant chromatographic
monitoring became a problem. Fortunately, the compounds ionised well in neg-
ative ion mode of an ESI mass spectrometer, which allowed the rest of the
purification to be guided by MS. Even though it is a destructive technique, the
sensitivity of MS meant only a small percentage of the sample was consumed.
Multiple silica gel MPLC and semi-preparative HPLC steps were performed
in an effort to purify the main glycolipid. Each time, the fractions were subsam-
pled and individually subjected to mass spectrometry. As the compounds were
so similar, their rate of ionization in the MS was assumed to be proportional
to their relative concentrations. By plotting the maximum ion count for each
pseudomolecular ion against fraction number, as can be seen in Figure 3.6, a
qualitative measure of the separation achieved can be obtained. Based on this,
enriched fractions were combined, and the process repeated, eventually resulting
in the isolation of agminosides A–E (145–149).
Structure elucidation of agminoside A
The main component of the glycolipid mixture, agminoside A (145) had a low
resolution mass of 1919 Da in negative ion mode. Due to the large size of the
molecule, 145 was subjected to MALDI-TOF analysis, which gave rise to a
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Figure 3.6. A graph of the ion count intensity of glycolipid pseudomolecular
ion signals, plotted vs. MPLC fraction number.
pseudomolecular ion of 1943.7707, consistent with a formula of C85H132O48Na
(∆ 3.8 ppm). Unfortunately a series of other formulae could also have been valid.
The majority could be discounted based on the minimum/maximum number of
carbons visible in the 13C spectrum (82–90), but there were still at least six
formulae to consider. Detailed NMR analysis was required to unequivocally
determine the right molecular formula.
The oligosaccharide
Analysis of the 1H, 13C and HSQC-DEPT spectra revealed the presence of six
anomeric (acetal) methines, as well as 26 oxymethines and eight oxymethylenes,
sufficient for six pyranohexanose sugar moieties. Usually, COSY and HSQC
spectra are sufficient for the assignment of sugar residues, but due to the size
and complexity of agminoside A (150), both spectra were quite complicated (as
shown in Figure 3.7) with a lot of overlapping resonances. When following a
series of COSY correlations, a high degree of overlap can lead to unintentional
crossing over from one spin system to another.
The HSQC-TOCSY was instrumental in the unambiguous identification of
sugar spin systems, as it dispersed any overlapping proton signals in the carbon
dimension. From the proton of each of the anomeric centres four oxymethines
and an oxymethylene were identified for each of the six sugar spin systems (an
example for sugar F is shown in Figure 3.8).
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Figure 3.7. Close-up of the COSY and HSQC-DEPT spectra (CD3OD, 600
MHz) of agminoside A.
64
Figure 3.8. Close-up of the HSQC-TOCSY spectrum (CD3OD, 600 MHz) of agminoside A, identifying the sugar F spin system
through HSQC (red) and TOCSY (green) correlations.
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Starting with sugar F, which was most distinctive and was therefore eluci-
dated first, the spin system (see Table 3.1) was identified through HSQC-TOCSY
correlations to contain the anomeric oxymethine CH-F1 (δC 102.1, δH 5.07), four
oxymethines CH-F2 (δC 73.3, δH 4.86), CH-F3 (δC 74.2, δH 5.18), CH-F4 (δC 69.8,
δH 5.00) and CH-F5 (δC 72.7, δH 3.78) as well as an oxymethylene CH2-F6
(δC 63.5, δHa 4.78, δHb 4.14). In the COSY spectrum, correlations were observed
between H-F1/H-F2, H-F2/H-F3, H-F3/H-F4, H-F4/H-F5, and H-F5/H-F6a,b,
establishing the sequence of positions in the sugar. HMBC correlations from H-
F2 to C-F1 and C-F3, from H-F3 to C-F2 and C-F4, from H-F4 to C-F3, C-F5
and C-F6, from H-F5 to C-F4 (weakly), and from H-F6b to C-F4 and C-F5,
confirmed this sequence.
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Figure 3.9. Key COSY, HMBC and ROESY correlations used to establish the
structure of sugar F.
The coupling constants observed between the oxymethines were all large (H-
F1/H-F2 J = 7.9 Hz, H-F2/H-F3 J = 9.8 Hz, H-F3/H-F4 J = 9.4 Hz, H-F4/H-
F5 J = 9.7 Hz), indicating a 1,2-trans relationship between the oxymethine
protons. This is consistent with a β-glucopyranoside, and an NOE enhance-
ment between H-F1 and H-F5 observed in the ROESY spectrum confirmed the
presence of the pyran ring. The 1,3-diaxial relationship between all the pro-
tons was proven by correlations in the ROESY spectrum (H-F1/H-F3/H-F5 and
H-F2/H-F4).
Table 3.1. NMR data (600 MHz, CD3OD) for glucose F.
a
δC mult δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
F1 102.1 CH 5.07 d (7.9) F2 F2,F3 F2,F3,F5
F2 73.3 CH 4.86 dd (9.8,7.9) F1,F3 F1,F3 F1,F3,F4,F5 F1,F4
F3 74.2 CH 5.18 t (9.4) F2,F4 F2,F4 F1,F2,F4,F5 F1,F2,F4,(F5)
F4 69.8 CH 5.00 t (9.7) F3,F5 F3,F5,F6 F1,F2,F3,F5 F2,F3,F5
F5 72.7 CH 3.78 ddd (9.6,4.1,2.7) F4,F6a,F6b (F4) F3,F4,F6a,F6b F1,F3,F6a,F6b
F6a
63.2 CH2
4.30 m F5
F4,F5
F5,F6b
F6b 4.11 m F5 F4, F5 F5, F6a
aOnly correlations within the sugar spin system are listed.
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In a similar fashion, the HSQC-TOCSY identified the spin system of sugar B
(see Table 3.2) as consisting of the anomeric oxymethine CH-B1 (δC 102.0,
δH 4.81), four oxymethines CH-B2 (δC 73.0, δH 4.88), CH-B3 (δC 74.5, δH 5.27),
CH-B4 (δC 79.6, δH 3.78) and CH-B5 (δC 74.2, δH 3.94), and the oxymethylene
CH2-B6 (δC 64.6, δHa 4.31, δHb 4.80). Correlations in the COSY spectrum were
observed between H-B1/H-B2, H-B2/H-B3, H-B3/H-B4, H-B4/H-B5, and H-
B5/H-B6a,b. Together with HMBC correlations from H-B2 to C-B1 and C-B3,
from H-B3 to C-B2 and C-B4, from H-B4 to C-B3, C-B5, and C-B6 and from
H-B5 to C-B4 (weakly) they established the sequence of carbons in the sugar.
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Figure 3.10. Key COSY, HMBC and ROESY correlations used to establish
the structure of sugar B.
Large coupling constants between the oxymethines (H-B1/H-B2 J = 8.2 Hz,
H-B2/H-B3 J = 8.2 Hz, H-B3/H-B4 J = 9.4 Hz, H-B4/H-B5 J = 9.4 Hz) showed
all the ring protons were in the axial orientation, and so suggested another β-
glucopyranoside. The presence of the pyran ring was established through NOE
enhancements observed between H-B1 and H-B5. The axial positioning of the
protons was confirmed through correlations observed in the ROESY spectrum
between H-B1, H-B3, and H-B5 and between H-B2 and H-B4.
Table 3.2. NMR data (600 MHz, CD3OD) for glucose B.
a
δC mult δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
B1 102.0 CH 4.81 d (8.2) B2 B2,B3 B3,B5
B2 73.0 CH 4.88 t (8.2) B1,B3 B1,B3 B1,B3,B4 B4
B3 74.5 CH 5.27 t (9.4) B2,B4 B2,B4 B1,B2,(B4,B5) B1,B2,B4,B5
B4 79.6 CH 3.78 t (9.4) B3,B5 B3,B5,B6 B2,B3,B5,B6b B2,B3,B6b
B5 74.2 CH 3.94 ddd (9.6,7.2,1.8) B4,B6a,B6b (B4) B2,B3,B4,B6a B1,B3,(B4),B6a
B6a
64.6 CH2
4.80 m B6b,B5 B5
B4,B5
B4
B6b 4.31 m B6a,B5 B5
aOnly correlations within the sugar spin system are listed.
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The spin system of sugar C (see Table 3.3) (CH-C1: δC 103.6, δH 4.53;
CH-C2: δC 79.8, δH 3.50; CH-C3 δC 76.5, δH 5.08; CH-C4: δC 69.9, δH 4.81;
CH-C5 δC 72.5, δH 3.90; CH2-6: δC 64.4, δHa 4.33, δHb 4.07) was once again
identified through the use of the HSQC-TOCSY experiment. COSY correlations
between H-C1/H-C2, H-C2/H-C3, H-C3/H-C4, H-C4/H-C5 and H-C5/H-C6a,b
established the order of positions in the sugar, and were corroborated by HMBC
correlations from H-C2 to C-C1 and C-C3, from H-C3 to C-C2 and C-C4, from
H-C4 to C-C3, C-C5 and C-C6, from H-C5 to C-C4 (weakly) and from H-C6b
to C-C4 and C-C5.
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Figure 3.11. Key COSY, HMBC and ROESY correlations used to establish
the structure of sugar C.
The protons of sugar C also exhibited all large coupling constants (H-C1/H-
C2 J = 7.8 Hz, H-C2/H-C3 J = 8.4 Hz, H-C3/H-C4 J = 9.5 Hz, H-C4/H-C5 J
= 10.0 Hz), indicative of a β-glucopyranoside. This stereochemical assignment
was once again confirmed through ROESY correlations between H-C1, H-C3
and H-C5 and between H-C2 and H-C4, indicating 1,3-diaxial relationships.
The observation of NOE enhancements between H-C1 and H-C5 supported the
assignment of a pyran ring.
Table 3.3. NMR data (600 MHz, CD3OD) for glucose C.
a
δC mult δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
C1 103.6 CH 4.53 d (7.8) C2 C2,C3 C3,C5
C2 79.8 CH 3.50 t (8.4) C1,C3 C1,C3 C1,C3,C4 C4
C3 76.5 CH 5.08 t (9.5) C2,C4 C2,C4 C1,C2,C4,C5 C1,C2,C4,C5
C4 69.9 CH 4.81 t (10.0) C3,C5 C3,C5,C6 (C1),C2,C3,C5,C6a C2
C5 72.5 CH 3.90 ddd (10.0,3.6,2.3) C4,C6a,C6b (C4) C3,C4,C6a,C6b C1,C3,C6a,C6b
C6a
63.1 CH2
4.33 dd (12.6,4.2) C6b,C5
(C4),C5
C5,C6b
C6b 4.07 d (12.0) C6a,C5 C4,C5 C5,C6a
aOnly correlations within the sugar spin system are listed.
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The HSQC-TOCSY correlations identified the spin system of sugar D (see
Table 3.12) as containing the anomeric position CH-D1 (δC 103.1, δH4.46),
four oxymethines CH-D2 (δC 83.8, δH 3.22), CH-D3 (δC 77.9, δH 3.49), CH-D4
(δC 71.5, δH 3.23) and CH-D5 (δC 75.3, δH 3.44), and an oxymethylene CH2-D6
(δC 64.4, δHa 4.51, δHb 4.24). Unfortunately this sugar has two protons that
are severely overlapping (δH 3.22 and 3.23). This made the interpretation of
the COSY more difficult, as H-D1, H-D3 and H-D5 all showed correlations to
δH ∼3.22. In the HMBC spectrum, however, the more upfield proton (δH 3.22)
correlated to C-D1, and was therefore assigned as H-D2. The more downfield
proton (δH 3.23) showed HMBC correlations to C-D5 and C-D6, and was as-
signed as H-D4. δH 3.49 showed HMBC correlations to both C-D2 and C-D4,
and was assigned as H-D3, completing the sequence of the sugar.
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Figure 3.12. Key COSY, HMBC and ROESY correlations used to establish
the structure of sugar D.
The overlap of H-D2 and H-D4 also made the interpretation of their coupling
constants more difficult. Fortunately, the coupling of H-D1 (d, J = 7.8 Hz) H-D3
(t, J = 7.9 Hz) and H-D5 (ddd, J = 9.4, 7.0, 1.5 Hz) could be resolved, and once
again pointed to a 1,2-trans relationship of the neighbouring oxymethine protons,
and therefore to another β-glucopyranoside. ROESY correlations between H-
D1 and H-D5 (indicating the pyran ring), and H-D1 and H-D3 supported this
assignment.
Table 3.4. NMR data (600 MHz, CD3OD) for glucose D.
a
δC mult δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
D1 103.1 CH 4.46 d (7.8) D2 C2 D2,D3 D3,D5
D2 83.8 CH 3.22 m D1, D3 D1 D1,D3,D4,D5
D3 77.9 CH 3.49 t (7.9) D2,D4 D2,D4 D1,D2,D4,D5 D1
D4 71.5 CH 3.23 m D3,D5 D3,D5,D6 D3,D5,D6a,D6b
D5 75.3 CH 3.44 ddd (9.4,7.0,1.5) D4,D6a,D6b D3,D4,D6a,D6b D1,D6a,D6b
D6a
64.4 CH2
4.51 dd (11.0,7.5) D6b,D5 D5
D4,D5
D5,D6b
D6b 4.24 dd (10.3, 1.6) D6a,D5 D5,D6a
aOnly correlations within the sugar spin system are listed.
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The fifth sugar, sugar E (see Table 3.13), consisted of the anomeric oxyme-
thine CH-E1 (δC 106.1, δH 4.40), four oxymethines CH-E2 (δC 75.2, δH 3.19),
CH-E3 (δC 78.2, δH 3.34), CH-E4 (δC 70.7, δH 3.46) and CH-E5 (δC 75.6, δH 3.36),
and an oxymethylene CH2-E6 (δC 63.5, δHa 4.78, δHb 4.14 ), as identified from
the HSQC-TOCSY. Correlations were observed in the COSY spectrum between
H-E1/H-E2, H-E2/H-E3, H-E3/H-E4, H-E4/H-E5 and H-E5/H-E6b, allowing
the assignment of the sequence of positions. This order was further supported
by HMBC correlations from H-E2 to C-E1 and C-E3, from H-E3 to C-E2 and
C-E4, from H-E4 to C-E5 and C-E6, and from H-E6a to C-E4 and C-E5.
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Figure 3.13. Key COSY, HMBC and ROESY correlations used to establish
the structure of sugar E.
Protons H-E1–H-E4 had large coupling constants (H-E1 J = 7.9 Hz; H-E2
J = 8.1 Hz; H-E3 8.6 Hz; H-E4 9.7 Hz), once again suggesting a β-glucopyrano-
side. The pyran ring was established through observation of NOE enhancements
between H-E1 and H-E5. 1,3-Diaxial interactions were also observed in the
ROESY spectrum, which showed correlations between H-E1 and both H-E3 and
H-E5, and between H-E2 and H-E4, supporting the stereochemical assignment
of the sugar as β-glucopyranoside.
Table 3.5. NMR data (600 MHz, CD3OD) for glucose E.
a
δC mult δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
E1 106.1 CH 4.40 d (7.9) E2 E2,E3 E3,E5
E2 75.2 CH 3.19 t (8.1) E1,E3 E1,E3 E1,E3,E4,E5 E1,E3,E4
E3 78.2 CH 3.34 t (8.6) E2,E4 E2,E4 E1,E2,E4,E5 E1,E2,E4
E4 70.7 CH 3.46 t (9.7) E3,E5 E5,E6 E1,E2,E3,E5 E2,E3,E5
E5 75.6 CH 3.36 m E4,E6b E2,E3,E4 E1,E6a,E6b
E6a
63.5 CH2
4.78 m E6b E5,E4
E5
E5,E6b
E6b 4.14 m E6a,E4 E5,E6a
aOnly correlations within the sugar spin system are listed.
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Finally, the spin system of sugar A (see Table 3.6) was revealed by the
HSQC-TOCSY to consist of the anomeric position CH-A1 (δC 101.9, δH 4.39),
four oxymethines CH-A2 (δC 81.1, δH 3.46), CH-A3 (δC 77.3, δH 3.58), CH-A4
(δC 82.4, δH 3.53) and CH-A5 (δC 75.7, δH 3.32), and the oxymethylene CH2-
A6 (δC 61.6, δHa 3.76, δHb 3.62). The sequence of positions in the sugar was
established through COSY correlations between H-A1/H-A2, H-A2/H-A3, H-
A3/H-A4, H-A4/H-A5, H-A5/H-A6a (weakly) and H-A5/H-A6b. They were
further supported by observed HMBC correlations from H-A2 to C-A1 and C-
A3, from H-A3 to C-A2 and C-A4, from H-A4 to C-A3, C-A5, and C-A6, and
from H-A6a to C-A4 and C-A5.
O O
OH
OO
HO
Ha Hb
H H
H
HH
O
H
O
H
HO
H
H
OH
O
OH
HMBC
COSY
NOEA
1
1
6
6
Figure 3.14. Key COSY, HMBC and ROESY correlations used to establish
the structure of sugar A.
Due to overlap of multiple signals of this sugar, only the coupling constants
of H-A1 (d, J = 7.8 Hz) and H-A2 (t, J = 8.3 Hz) were determined. These
suggest that the protons of the oxymethines CH-A1–CH-A3 exist in a 1,2-trans
relationship. An NOE enhancement between H-A1 and H-A5 as well as 1,3-
diaxial interactions observed in the ROESY (correlations between H-A1/H-A3,
H-A1/H-A5 and between H-A2/H-A4) together with the observed coupling con-
stants imply the final sugar is also a β-glucopyranoside.
Table 3.6. NMR data (600 MHz, CD3OD) for glucose A.
a
δC mult δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
A1 101.9 CH 4.39 d (7.8) A2 17 A2,A3,(A4) A3,A5
A2 81.1 CH 3.46 t (8.3) A1,A3 A1,A3 A1,A3,A4,A5 A4
A3 77.3 CH 3.58 m A2,A4 A2,A4 A1,A2,A4,A5 A1
A4 82.4 CH 3.53 m A3,A5 A3,A5,A6 A1,A2,A3,A5,A6a,A6b A2
A5 75.7 CH 3.32 m A4,(A6a),A6b A3,A4,A6 A1,A6a
A6a
61.6 CH2
3.76 d (11.9) A6b,(A5) A4,A5
A4,A5
A5,A6b
A6b 3.62 dd (11.9,3.8) A6a,A5 A6a
aOnly correlations within the sugar spin system are listed.
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H-A1 also showed an HMBC correlation to an oxymethine (δC 81.7, δH 3.63)
which did not belong to any sugar spin system. It was therefore identified as the
connection point to the aglycon.
Seven of the oxymethines, H-B2 (δH 4.88), H-B3 (δH 5.27), H-C3 (δH 5.08),
H-C4 (δH 4.81), H-F2 (δH 4.86), H-F3 (δH 5.18) and H-F4 (δH 5.00), and five of
the oxymethylenes, H2-B6 (δHa 4.81, δHb 4.31), H2-C6 (δHa 4.33, δHb 4.07), H2-D6
(δHa 4.51, δHb 4.24), H2-E6 (δHa 4.78, δHb 4.14) and H2-F6 (δHa 4.30, δHb 4.11)
had proton chemical shifts 1–2 ppm downfield from normal. These data, together
with the presence of acetate methyls and ester carbonyls in the proton and carbon
spectra indicated acetylation at those positions. HMBC correlations from each
of the oxymethylene and oxymethine protons to the acetate carbonyls confirmed
this assignment (for all acetate assignments see the full NMR data, Table 3.9).
In summary, the six sugar substructures were established through a com-
bination of HSQC-TOCSY, COSY and HMBC experiments. All sugars were
assigned as β-glucopyranoside based on large (7.8–10.0 Hz) coupling constants
between the oxymethines, and 1,3-diaxial interactions observed in the ROESY
spectrum.
Five of the sugar oxymethines showed lower field carbon chemical shifts (C-
A2 δC 81.1, C-A4 δC 82.4, C-B4 δC 79.6, C-C2 δC 79.8, C-D2 δC 83.8) character-
istic of glycosidic linking carbons. The sugar linkages were established through
key HMBC and ROESY correlations, shown in Figure 3.15. Reciprocal HMBC
correlations were observed between positions A2 and F1 (H-A2 to C-F1 and
H-F1 to C-A2), A4 and B1, B4 and C1, C2 and D1 and D2 and E1. The in-
terglycosidic linkages were further confirmed by NOE cross-peaks between H-A2
and H-F1, H-A4 and H-B1, H-B4 and H-C1, and H-D2 and H-E1 observed in
the ROESY spectrum. As detailed above, the anomeric proton doublets all had
large coupling constants (7.8–8.2 Hz) suggesting β-glycosidic linkages. 1JCH cou-
pling constants of about 160 Hz further supported the axial positioning of the
anomeric proton.148 The oligosaccharide can therefore be described as: Glcβ1-
2Glcβ1-2Glcβ1-4Glcβ1-4(Glcβ1-2)Glcβ1-aglycon.
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Figure 3.15. Key HMBC and ROESY correlations establishing the linkages between the sugars.
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The aglycon
The oligosaccharide portion accounted for the majority of the NMR signals. The
remaining two oxymethylenes, two oxymethines, one acetate, a methyl triplet,
six methylenes and the CH2 envelope were attributed to the aglycon. Based
on COSY and HSQC-TOCSY correlations, they were assigned to three separate
spin systems.
Starting from the methyl triplet, COSY and HSQC-TOCSY correlations al-
lowed the construction of the first substructure, consisting of the methyl triplet
(CH3-20: δC 14.8, δH 0.92) attached to two methylenes (CH2-19: δC 18.9, δH 1.48;
CH2-18: δC 37.2, δH 1.48), next to the oxymethine CH-17 (δC 81.7, δH 3.63) fol-
lowed by the methylene CH2-16 (δC 35.9, δHa 1.57, δHb 1.49) and CH2-15 (δC 26.2,
δH 1.37). H2-15 showed correlations to the CH2 envelope (δC 30.7, δH 1.29).
The second substructure consisted of the oxymethylene CH2-1 (δC 72.8,
δHa 3.54, δHb 3.47) which showed COSY correlations to the proton resonances
of methylene CH2-2 (δC 30.7, δH 1.56), which in turn showed both COSY and
TOCSY cross-peaks to the methylene CH2-3 (δC 27.2, δH 1.34). H2-3 also cor-
related to the CH2 envelope, ending the substructure.
The remaining oxymethine CH-2′ (δC 74.3, δH 5.14) showed a correlation
to the last oxymethylene CH2-3
′ (δC 70.9, δHa 3.83, δHb 3.78) in the COSY
spectrum. The 1H chemical shift of H-2′ was indicative once again of acetylation,
and indeed, a correlation from H-2′ to the acetate carbonyl δC 172.4 was observed
in the HMBC spectrum, and from the acetate methyl (δC 20.8, δH 2.13) to the
same carbonyl.
The three substructures accounted for all the remaining visible signals in the
NMR spectra. The first two substructures were clearly connected through a long
CH2 chain of unknown length (the integration of the CH2 envelope suggested a
further 11–12 methylenes). The final substructure was connected to the rest
through observations of reciprocal HMBC correlations from H-3′a and H-3′b to
C-1, and from H-1a and H-1b to C-3′, establishing an ether linkage between the
two parts. The final aglycon substructure is depicted in Figure 3.16.
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Figure 3.16. Key correlations establishing the aglycon substructure.
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The connectivity between the aglycon and the oligosaccharide was established
through observation of a correlation in the HMBC spectrum from H-A1 to C-17,
as previously mentioned, which indicated the anomeric position of sugar A was
connected to position 17 of the aliphatic chain of the aglycon. This assigment
was confirmed by an NOE enhancement between H-17 and H-A1 observed in a
ROESY experiment.
At this point, the observed NMR signals suggested a minimum molecular
formula of C84H131O46, and at least 19 double bond equivalents (six sugars and 13
acetate carbonyls). These data narrowed down the possible molecular formulae
to one: C85H132O48Na. This is consistent with a [M + Na]
+ pseudomolecular
ion, with the negative ion mode ESIMS showing a [M − H]− pseudomolecular
ion at 1919. With the molecular formula established, one further carbon, two
oxygens, a hydrogen and a double bond equivalent remained unaccounted for,
and were not apparent in the NMR spectra.
Chemical derivatization reactions
In order to fully assign the structure of the aglycon, a methanolysis of the glyco-
lipid was performed to remove the attached sugars. Agminoside A (145) (1 mg)
was heated in methanolic HCl for 48 h, and the reaction was worked up by
cyclic loading onto HP20SS. The resulting free aglycon (151) had a [M + Na]+
pseudomolecular ion of 439.3381 in positive ion mode HRESIMS, indicating a
formula of C24H48O5 (∆ 3.0 ppm). Due to the paucity of material, a similar
methanolysis was performed on a mixture of glycolipids to obtain 11 mg of the
aglycon, which had identical 1H NMR and the same pseudomolecular ion by MS.
Analysis of the 1H and 13C NMR spectra revealed the presence of a carbonyl
carbon (which accounted for the one double bond equivalent indicated by the
molecular formula), two oxymethines, two oxymethylenes, a series of methylenes,
a methyl triplet, and a new O-methyl resonance that was not apparent in the
original 1H spectrum of 145 (see Figure B.23). The COSY spectrum indicated
the presence of three spin systems, as were found in the aglycon of agminoside
A (145). From methyl CH3-20 (δC 14.3, δH 0.92), COSY and HMBC correla-
tions allowed the assignment of two contiguous methylenes CH2-19 and CH2-18
(δC 19.0, δH 1.44; δC 39.8, δH 1.41) followed by the oxymethine CH-17 (δC 71.9,
δH 3.59), which correlated to methylene CH2-16 (δC 37.6, δH 1.41) and methylene
CH2-15 (δC 25.8, δH 1.40). From the other side of the aglycon, COSY and HMBC
correlations established that oxymethylene CH2-1 (δC 72.0, δHa 3.49, δHb 3.42)
was attached to methylene CH2-2 (δC 29.5, δH 1.54) followed by methylene CH2-
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Figure 3.17. Key COSY and HMBC correlations establishing the structure of
the aglycon methyl ester (151).
3 (δC 26.1, δH 1.26). Both methylene CH2-3 and CH2-15 showed correlations to
the CH2 envelope at δC 29.7 and δH 1.24, indicating they were connected via a
long chain of CH2 units. The integration in the
1H spectrum indicated a further
11 methylenes, a number that matched exactly with the molecular formula.
The remaining oxymethylene, oxymethine, carbonyl carbon and oxymethyl
resonances constituted the final substructure. Oxymethylene CH2-3
′ (δC 72.1,
δH 3.70) and oxymethine CH-2
′ (δC 71.0, δH 4.30) were placed next to each other,
based on a correlation between their respective protons observed in the COSY
spectrum. The carbonyl resonance C-1′ was assigned as an ester, based on a
strong HMBC correlation from the OMe (δC 52.7, δH 3.79) to δC 173.3. HMBC
correlations from H2-3
′ and H-2′ to the carbonyl, and from the OMe to C-2′ and
C-3′ established the final substructure as the methyl ester derivative of glyceric
acid (2,3-dihydroxypropanoic acid).
Observation of HMBC correlations from H2-3
′ to C-1 and from H2-1 to C-3
′
linked the substructures together through an ether, as can be seen in Figure 3.17.
As the OMe resonance was not observed in the original NMR spectra of the nat-
ural product, it is most likely a product of the methanolysis, indicating the
original functional group present in the aglycon was actually a carboxylic acid.
A carboxylic acid carbon resonance was not apparent in the NMR spectra of
145, possibly due to one or more of the following: overlap (with one of the 13
carbonyl resonances of the acetates), slow relaxation (resulting in a weak signal
indistinguishable from the baseline noise) and long range deuterium-carbon cou-
pling (which would reduce the signal intensity due to coupling). Interestingly
though, the HMBC spectrum of the glycolipid mixture (which is mainly 145)
did show a correlation from δH 5.11 (oxymethine CH-2
′) to δC 173.2 (carbonyl
C-1′) (as marked in Figure 3.18(a)).
In order to unequivocally prove the presence of a free carboxylic acid moiety
in the aglycon, a methylation was performed on a mixture of the glycolipids.
Diazomethane is a common reagent for methylations; since the conditions are
mild and the reaction is high yielding, it is very useful for methylation of natural
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(a) A section of the HMBC of the glycolipid mixture.
(b) A section of the HMBC of the methylated glycolipid mixture.
Figure 3.18. Close-up of the carbonyl region in the HMBC spectra (600 MHz,
CD3OD) of the glycolipids and the methylated glycolipids.
products (which are often temperature sensitive and scarce).149 Unfortunately,
diazomethane is highly toxic, thermally labile and explosive. Trimethylsilyldia-
zomethane (TMSCHN2) has been developed as a safer, more stable alternative
for the methylation of carboxylic acids and alcohols.150
The mixture of glycolipids was therefore subjected to TMSCHN2. Analysis
of the NMR spectra of the resulting product mixture revealed the presence of a
new signal at δC 51.6 and δH 3.74. A correlation from δH 3.74 to δC 170.3 was
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observed in the HMBC spectrum (see Figure 3.18(b)), indicating the successful
formation of a methyl ester. Correlations from δH 3.86, 3.76 and 5.18 to the
same carbonyl resonance were attributed to H-3′a, H-3′b and H-2′ respectively.
The remaining question to be answered was that of the configuration of the
two chiral centres of the aglycon; as they were both secondary alcohol deriva-
tives, Mosher’s method was ideal for this purpose.151 Two portions of 151 were
subjected to esterification with (R)- and (S )-MTPA chloride ((R)- or (S )-α-
methoxy-α-trifluoromethylphenylacetic acid chloride) according to standard pro-
cedure.152 The reaction was incomplete, and the products consisted of a mixture
that probably included unreacted starting material, the 17-MTPA ester, the 2′-
MTPA ester and the di-ester derivatives. As the two chiral centres are quite
remote, however, they should have no effect on each other; the mixture could be
treated simply as containing either the starting material, or the ester product.
They were assigned fully by NMR spectroscopy without further purification.
The difference between the chemical shift (the ∆δ) of the (S )- and the (R)-
MTPA derivative was calculated (see Table 3.7). For the most part, the results
were consistent, showing positive (blue) and negative (red) ∆δ values at either
side of the chiral centre. Two anomalous values (of the two carbons on either
side of the ether bridge) were excluded from the analysis. Assuming the ester
exists predominantly in one conformation (as first proposed by Mosher153,154 and
later confirmed by X-ray155), the data suggest the absolute configuration of the
aglycon is 17R and 2′R.
As final confirmation of the stereochemical assigment, 19F NMR was run on
the two MTPA derivatives. For both centres, an upfield shift of δF was observed
supporting the assignment of positions 17 and 2′ as R. Fluorine NMR is the orig-
inal NMR experiment proposed by Mosher for determination of configuration,
as it showed larger chemical shift differences than for the proton signals and was
best suited for the low field NMR available at the time.154 The advent of high
field NMR spectroscopy and the use of sophisticated 2D experiments now allow
the resolution and full assignment of all proton and carbon resonances. The
advantage of using proton and carbon resonances for the stereochemical assign-
ment is that the shielding effect can be observed on multiple centres, rather than
relying on a single measurement. Nevertheless, 19F NMR spectroscopy can be a
useful tool as the fluorine spectrum is simple and easy to interpret, even if its
accuracy is sometimes called into question.154
The assignment of the centre 2′ as R is credible, as this is the configuration
for the natural (d) glyceric acid. Therefore, the final structure of the aglycon
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Table 3.7. NMR data (600 MHz, CDCl3) with the ∆δ values for the two
Mosher’s derivatives of the aglycon methyl ester.
(S )-MPTA derivative (R)-MPTA derivative ∆δ
δC mult δH position
δC mult δH δS – δR
(ppm) (ppm) (ppm) (ppm) ∆δC ∆δH
71.92 CH2
3.492 1a
72.04 CH2
3.402
-0.12
0.090
3.423 1b 3.308 0.115
29.65 CH2 1.517 2 29.56 CH2 1.431 0.09 0.086
26.07 CH2 1.266 3 25.98 CH2 1.212 0.09 0.054
29.7 CH2 1.26 4–14 29.7 CH2 1.26 0 0
24.97 CH2 1.157 15 25.36 CH2 1.286 -0.39 -0.129
33.60 CH2 1.540
16a
33.86 CH2
1.580
-0.26
-0.040
16b 1.638 -0.098
77.54 CH 5.098 17 77.55 CH 5.099
36.00 CH2
1.642 18a
35.68 CH2
1.568
0.32
0.074
1.556 18b 1.509 0.047
18.68 CH2 1.333
19a
18.25 CH2
1.245
0.43
0.088
19b 1.176 0.157
14.06 CH3 0.910 20 13.96 CH3 0.844 0.10 0.066
69.10 CH2
3.879 3′a
69.17 CH2
3.859
-0.07
0.020
3.853 3′b 3.762 0.091
73.64 CH 5.495 2′ 73.99 CH 5.427
167.46 C - 1′ 167.74 C - -0.28 -
52.79 CH3 3.751 1
′-OMe 52.85 CH3 3.800 -0.06 -0.049
O O
O
OR
OR
(-0.28)
-0.049
(-0.06)
0.020
0.091
(-0.07)
0.090
0.115
(-0.13)
0.086
(0.09)
0.054
(0.09)
0.066
(0.10)
0.088
0.157
(0.43)
0.074
0.047
(0.32)
-0.040
-0.098
(-0.26)
-0.129
(-0.39)
methyl ester is assigned as 151; NMR data are presented in Table 3.8.
The methanolysis of the glycolipids to obtain the aglycon also resulted in
the methanolysis of the oligosaccharide portion. Only one methyl glucoside was
obtained (41:9 α to β anomer) and assigned as 1-O-methyl-glucose, consistent
with the assignment of all the sugars as glucose in agminoside A (145). The
measured optical rotation of these sugars in H2O was +209. This is comparable
(in sign if not in magnitude) to the literature value of [α]20D = +158.9 for 1-
O-methyl-α-d-glucose.156 While this suggested that the glucose sugars were d-
glucose, further evidence was obtained through chiral derivatization and GC
analysis.
A mixture of the glycolipids was subjected to acid catalyzed hydrolysis. The
aglycon was extracted with CH2Cl2 and the aqueous residue was evaporated to
dryness under reduced pressure. A portion of these hydrolysed sugars was sub-
jected to reductive amination with (S )-1-amino-2-propanol and peracetylated,
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Table 3.8. NMR data (600 MHz, CDCl3) for aglycon methyl ester (151).
δC mult δH mult, COSY HMBC
position (ppm) (ppm) J (Hz)
1a
72.0
CH2 3.49 dt (9.4, 6.6) 1b, 2 3
′
1b CH2 3.42 dt (9.4, 6.6) 1a, 2 3′
2 29.5 CH2 1.54 quin (6.7) 1a, 1b, 3 3, 4
3 26.1 CH2 1.26 m 2, 4
4–14 29.7 CH2 1.24 m
15 25.8 CH2 1.40 m
16 37.6 CH2 1.41 m 17
17 71.9 CH 3.59 m 16, 18 15, (16, 18), 19
18 39.8 CH2 1.41 m 17, 19
19 19.0 CH2 1.44 m 18, 20
20 14.3 CH3 0.92 t (6.9) 19 18, 19
3′ 72.1 CH2 3.70 d (3.5) 2
′ 1, 1′, 2′
2′ 71.0 CH 4.30 t (3.5) 3′ 1′, 3′
1′ 173.3 C - - - -
1′-OMe 52.7 CH3 3.79 s 1’ (2
′, 3′)
MeO O
O
OH
OH
1 17
20
1'
2' 3'
151
as previously described.157 The resulting product was subjected to GC analy-
sis and compared to a d-glucose standard derivatized in a similar fashion. The
product and the standard had the same retention time, and in fact co-eluted
when co-injected, proving conclusively that the sugars were indeed d-glucose.
The complete structure of agminoside A is therefore assigned as 145, with
NMR data presented in Table 3.9.
O
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A
B
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E
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1
1
1
1
1
1
6
6
6
6
6
20
17
6
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Table 3.9. NMR data (600 MHz, CD3OD) for agminoside A (145).
δC mult
1JCH δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
Aglycon
1a
72.8 CH2
141 3.54 m 1b, 2 3′ 2, 3
1b 141 3.47 m 1a, 2 3′ 2, 3 2
2 30.7 CH2 125 1.56 m 1a, 1b, 3 1, 3 1, 3 1b, 3
3 27.2 CH2 124 1.34 m 2, 4 2 1, 4 2
4–14 30.7 CH2 120 1.29 m 3
15 26.2 CH2 124 1.37 m 16
16a
35.9 CH2
119 1.57 m 16b 15
16b 124 1.49 m 16a
17 81.7 CH 141 3.63 m 16a, 16b 19 16, 18 18, A1
18 37.2 CH2 120 1.48 m
19 18.9 CH2 120 1.48 m 18, 20 18, 20
20 14.8 CH3 124 0.92 t (6.9) 19 18, 19 18, 19 19
3′a
70.9 CH2
144 3.83 dd (11.2, 5.6) 3′b 1, 2′ 2′ 2′
3′b 144 3.78 m 3′a 1, 2′ 2′ 2′
2′ 74.3 CH 151 5.14 dd (5.9, 2.6) 3′a, 3′b 2′-Ac, 3′ 3′ 3′a, 3′b
1′ a C - - - - - -
2′-Ac
172.4 C - - - - - - -
20.8b CH3 - 2.13 s - 2
′-Ac -
Glucose A
A1 101.9 CH 158 4.39 d (7.8) A2 17 A2, A3, (A4) 17, A3, A5
A2 81.1 CH 146 3.46 t (8.3) A1, A3 A1, A3, F1 A1, A3, A4, A5 A4, F1
A3 77.3 CH 145 3.58 m A2, A4 A2, A4 A1, A2, A4, A5 A1
A4 82.4 CH 147 3.53 m A3, A5 A3, A5, A6, B1 A1, A2, A3, A5, A6a, A6b A2, B1
A5 75.7 CH 140 3.32 m A4, (A6a), A6b A3, A4, A6 A1, A6a
A6a
61.6 CH2
144 3.76 d (11.9) A6b, (A5) A4, A5
A4, A5
A5, A6b
A6b 142 3.62 dd (11.9, 3.8) A6a, A5 A6a
Glucose B
B1 102.0 CH 166 4.81 d (8.2) B2 A4 B2, B3 A4, B3, B5
B2 73.0 CH 153 4.88 t (8.2) B1, B3 B1, B3, B2-Ac B1, B3, B4 B4
B3 74.5 CH 151 5.27 t (9.4) B2, B4 B2, B4, B3-Ac B1, B2, (B4, B5) B1, B2, B4, B5
B4 79.6 CH 148 3.78 t (9.4) B3, B5 B3, B5, B6, C1 B2, B3, B5, B6b C1, B2, B3, B6b
B5 74.2 CH 147 3.94 ddd (9.6, 7.2, 1.8) B4, B6a, B6b (B4) B2, B3, B4, B6a B1, B3, (B4), B6a
continued on the next page
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Table 3.9. – continued from previous page
δC mult
1JCH δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
B6a
64.6 CH2
150 4.80 m B6b, B5 B5, B6-Ac
B4, B5
B4
B6b 148 4.31 m B6a, B5 B6-Ac B5
B2-Ac
171.2c C - - - - - - -
20.7 CH3 - 2.06 s - B2-Ac -
B3-Ac
171.7 C - - - - - - -
20.8b CH3 - 2.01
d s - B3-Ac -
B6-Ac
172.5 C - - - - - - -
21.2 CH3 - 2.21 s - B6-Ac -
Glucose C
C1 103.6 CH 160 4.53 d (7.8) C2 B4 C2, C3 B4, C3, C5
C2 79.8 CH 148 3.50 t (8.4) C1, C3 C1, C3, D1 C1, C3, C4 C4
C3 76.5 CH 152 5.08 t (9.5) C2, C4 C2, C4, C2-Ac C1, C2, C4, C5 C1, C2, C4, C5
C4 69.9 CH 152 4.81 t (10.0) C3, C5 C3, C5, C6, C4-Ac (C1), C2, C3, C5, C6a C2
C5 72.5 CH 143 3.90 ddd (10.0, 3.6, 2.3) C4, C6a, C6b (C4) C3, C4, C6a, C6b C1, C3, C6a, C6b
C6a
63.1 CH2
145 4.33 dd (12.6, 4.2) C6b, C5 C6-Ac
(C4), C5
C5, C6b
C6b 148 4.07 d (12.0) C6a, C5 C4, C5, C6-Ac C5, C6a
C3-Ac
171.2c C - - - - - - -
21.3 CH3 - 1.99 s - C3-Ac -
C4-Ac
171.5 C - - - - - - -
20.8b CH3 - 1.93 s - C4-Ac -
C6-Ac
172.2e C - - - - - - -
20.6 CH3 - 2.04 s - C6-Ac -
Glucose D
D1 103.1 CH 163 4.46 d (7.8) D2 C2 D2, D3 D3, D5
D2 83.8 CH 145 3.22 m D1, D3 D1, E1 D1, D3, D4, D5 E1
D3 77.9 CH 144 3.49 t (7.9) D2, D4 D2, D4 D1, D2, D4, D5 D1
D4 71.5 CH 143 3.23 m D3, D5 D3, D5, D6 D3, D5, D6a, D6b
D5 75.3 CH 140 3.44 ddd (9.4, 7.0, 1.5) D4, D6a, D6b D3, D4, D6a, D6b D1, D6a, D6b
D6a
64.4 CH2
144 4.51 dd (11.0, 7.5) D6b, D5 D5, D6-Ac
D4, D5
D5, D6b
D6b 148 4.24 dd (10.3, 1.6) D6a, D5 D6-Ac D5, D6a
D6-Ac
173.0 C - - - - - - -
21.4 CH3 - 2.19
f s - D6-Ac -
Glucose E
E1 106.1 CH 161 4.40 d (7.9) E2 D2 E2, E3 D2, E3, E5
E2 75.2 CH 146 3.19 t (8.1) E1, E3 E1, E3 E1, E3, E4, E5 E1, E3, E4
E3 78.2 CH 143 3.34 t (8.6) E2, E4 E2, E4 E1, E2, E4, E5 E1, E2, E4
E4 70.7 CH 148 3.46 t (9.7) E3, E5 E5, E6 E1, E2, E3, E5 E2, E3, E5
E5 75.6 CH 137 3.36 m E4, E6b E2, E3, E4 E1, E6a, E6b
continued on the next page
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δC mult
1JCH δH mult, COSY HMBC TOCSY ROESY
pos. (ppm) (ppm) J (Hz)
E6a
63.5 CH2
151 4.78 m E6b E5, E4, E6-Ac
E5
E5, E6b
E6b 156 4.14 m E6a, E4 E6-Ac E5, E6a
E6-Ac
173.1 C - - - - - - -
21.6 CH3 - 2.19
f s - E6-Ac -
Glucose F
F1 102.1 CH 165 5.07 d (7.9) F2 A2 F2, F3 A2, F2, F3, F5
F2 73.3 CH 152 4.86 dd (9.8, 7.9) F1, F3 F1, F3, F2-Ac F1, F3, F4, F5 F1, F4
F3 74.2 CH 150 5.18 t (9.4) F2, F4 F2, F4, F3-Ac F1, F2, F4, F5 F1, F2, F4, (F5)
F4 69.8 CH 152 5.00 t (9.7) F3, F5 F3, F5, F6, F4-Ac F1, F2, F3, F5 F2, F3, F5
F5 72.7 CH 141 3.78 ddd (9.6, 4.1, 2.7) F4, F6a, F6b (F4) F3, F4, F6a. F6b F1, F3, F6a, F6b
F6a
63.2 CH2
146 4.30 m F5 F6-Ac
F4, F5
F5, F6b
F6b 149 4.11 m F5 F4, F5, F6-Ac F5, F6a
F2-Ac
171.3 C - - - - - - -
20.6 CH3 - 2.00 s - F2-Ac -
F3-Ac
171.6 C - - - - - - -
20.5 CH3 - 1.98 s - F3-Ac -
F4-Ac
171.2c C - - - - - - -
20.9 CH3 - 2.01
d s - F4-Ac -
F6-Ac
172.2e C - - - - - - -
20.8b CH3 - 2.05 s - F6-Ac -
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Table 3.10. Array of significant glycolipid pseudomolecular ions observed in
the MS, indicating sugar and acetate composition.
no. of sugars
6 5 4 3
n
o.
of
ac
et
at
es
14 1962
13 1920 1758
12 1878 1716 1554
11 1836 1674 1512
10 1794 1632 1470
9 1590 1428 1266
8 1548 1386 1224
7 1182
6 1140
Structure elucidation of agminosides B–E
While agminoside A (145) was the main glycolipid in the mixture, a multitude
of other signals was apparent in the MS, indicating many related congeners. A
single aglycon and only d-glucose sugars were obtained from either the methanol-
ysis or hydrolysis of the glycolipid mixture, meaning the congeners had the same
aglycon and were comprised of the same sugar. The only difference could be in
the position and number of acetates, the sugar number, and perhaps the sugar
connectivity. A closer look at the masses apparent in the MS of various fractions
supported this idea: they were all related to each other either via a combination
of 42 (an acetyl) or 162 (a sugar) mass units, as illustrated by Table 3.10.
In order to confirm the close structural relationship of the glycolipids, the
mixture as well as agminoside A was peracetylated and analysed by MS. Nega-
tive ion mode ESIMS analysis of peracetylated agminoside A showed two major
peaks, at 2214.8 (full acetylation, 20 acetates) and 2172.8 (19 acetates) as can
be seen in Figure 3.19(a). MS analysis of the peracetylated glycolipid mix (Fig-
ure 3.19(b)) showed a pattern of peaks 288 units apart, which correspond to
peracetylated glycolipids with 3, 4, 5, and 6 sugars. Peaks corresponding to gly-
colipids with one less acetate were also apparent by the fully acetylated glycolipid
masses, just as was seen for peracetylated 145. These data indicate that one
hydroxy group may be difficult to acetylate and only the glycolipid with three
sugars shows full acetylation. Alternatively, this may simply be a MS artifact.
The four agminoside congeners isolated were assigned in a similar fashion to
145. Starting from the anomeric positions, spin systems were identified through
a combination of COSY, HSQC-TOCSY and HMBC correlations. Sugar linkages
were confirmed through key HMBC correlations.
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(a) MS plot of peracetylated agminoside A (145).
(b) MS plot of the peracetylated glycolipid mix.
Figure 3.19. MS analysis of the acetylation reactions.
Agminoside B
Negative ion mode HRESIMS analysis of agminoside B (146) indicated a molec-
ular formula of C83H130O47 (1877.7734 [M − H]
−, ∆ 1.6 ppm) implying a loss of
one acetate with respect to agminoside A. Indeed, only 12 acetate signals were
observed in the 1H and 13C NMR spectra. The chemical shifts of the aglycon and
most of the sugar positions were within 0.02 ppm of those for agminoside A. Sig-
nificant differences were observed for sugar F, the biggest change being at H-F2
(δH 3.43 vs. δH 4.86 in 145). This indicated the loss of the acetate at that posi-
tion, and explained the changes in chemical shift for that sugar. The structure
of agminoside B is given as 146, with NMR data presented in Table 3.12.
85
Agminoside C
Agminoside C (147) also had a molecular formula of C83H130O47 (1877.7721
[M − H]−, ∆ 0.9 ppm) and only 12 acetate signals in the NMR spectra. However,
it had a different retention time on the HPLC, implying it was an isomer of
agminoside B (146). Close examination of the NMR data revealed that the
sugar portion of 147 was identical (within 0.02 ppm) to that of agminoside A
(145). The major difference was the absence of the signals characteristic of the
acetylated oxymethine CH-2′ and the 2′-Ac. A resonance at δH 4.34 was present
instead, suggesting the acetate was absent from the 2′ position. Agminoside C
is therefore assigned as 147, with NMR data given in Table 3.13.
Agminoside D
A pseudomolecular ion peak observed in negative ion mode HRESIMS for agmi-
noside D (148) indicated a molecular formula of C81H128O46 (1835.7599 [M− H]
−
∆ 0.4 ppm), suggesting a loss of two acetates compared to agminoside A. Only
11 acetate signals were observed in the 1H and 13C spectra, supporting this as-
sumption. Changes in chemical shift of sugar F resonances analogous to that in
146 indicated a loss of the F2-acetate. Once again, the δH of CH-2
′ was shifted
higher upfield to 4.11 ppm and the signals characteristic of the 2′-Ac were absent
as well, suggesting this position was no longer acetylated. The remainder of the
1H and 13C signals were very similar to agminoside A. The structure of agmi-
noside D is therefore assigned as 148, with NMR data detailed in Table 3.14.
Agminoside E
The final glycolipid isolated was agminoside E (149). A pseudomolecular ion
peak of 1715.7176 observed in negative ion mode HRESIMS indicated a formula
of C77H119O42 ([M − H]
−, ∆ 1.2 ppm), consistent with a loss of a whole sugar
and one acetate. Observation of only five anomeric signals and 12 acetates in
the NMR spectra supported this assumption. Again, the majority of signals
remained similar to that of agminoside A, although signals characteristic for
sugar E were totally absent and some differences were apparent for sugar D. The
most distinct change was in the chemical shift of C-D2. In agminoside A (145)
C-D2 is at δC 83.8, being a glycosidic linking carbon. In 149 it is at δC 74.7, con-
sistent with the loss of sugar E. The absence of sugar E also accounts for the loss
of one acetate (E6-Ac); the remaining acetylation is identical to agminoside A.
Agminoside E is assigned as 149, NMR data are listed in Table 3.15.
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Table 3.11. Comparison of proton chemical shifts (δH) for the agminosides A–E
(145–149). Significant chemical shift differences from agminoside A (145) are
highlighted in yellow.
compound compound
position 145 146 147 148 149 position 145 146 147 148 149
1a 3.54 3.52 3.48 3.52 3.51 C1 4.53 4.53 4.53 4.52 4.52
1b 3.47 3.45 3.45 3.45 3.45 C2 3.50 3.49 3.50 3.49 3.56
2 1.56 1.55 1.57 1.57 1.55 C3 5.08 5.07 5.07 5.07 5.22
3 1.34 1.34 1.34 1.34 1.34 C4 4.81 4.81 4.80 4.80 4.87
4–14 1.29 1.29 1.29 1.29 1.29 C5 3.90 3.90 3.90 3.90 3.81
15 1.37 1.37 1.37 1.37 1.36 C6a 4.33 4.34 4.34 4.34 4.35
16a 1.57 1.58 1.58 1.59 1.57 C6b 4.07 4.07 4.06 4.07 4.03
16b 1.49 1.49 1.49 1.49 1.48
17 3.63 3.65 3.66 3.66 3.62 D1 4.46 4.45 4.46 4.45 4.31
18 1.48 1.48 1.53 1.53 1.48 D2 3.22 3.21 3.22 3.21 3.09
19 1.48 1.48 1.47 1.47 1.47 D3 3.49 3.48 3.48 3.48 3.29
20 0.92 0.92 0.92 0.92 0.95 D4 3.23 3.21 3.22 3.22 3.19
3′a 3.83
3.79
3.69
3.78 3.78
D5 3.44 3.43 3.43 3.43 3.44
3′b 3.78 3.62 D6a 4.51 4.52 4.53 4.51 4.46
2′ 5.14 5.11 4.34 4.11 5.08 D6b 4.24 4.24 4.23 4.24 4.29
A1 4.39 4.46 4.39 4.45 4.38 E1 4.40 4.39 4.40 4.39
A2 3.46 3.50 3.44 3.50 3.45 E2 3.19 3.18 3.18 3.18
A3 3.58 3.76 3.57 3.76 3.55 E3 3.34 3.33 3.33 3.33
A4 3.53 3.58 3.52 3.58 3.53 E4 3.46 3.45 3.46 3.45
A5 3.32 3.35 3.31 3.35 3.30 E5 3.36 3.35 3.35 3.36
A6a 3.76 3.77 3.75 3.77 3.75 E6a 4.78 4.79 4.80 4.78
A6b 3.62 3.64 3.62 3.63 3.61 E6b 4.14 4.13 4.12 4.13
B1 4.81 4.83 4.81 4.82 4.78 F1 5.07 4.80 5.07 4.80 5.07
B2 4.88 4.88 4.87 4.88 4.86 F2 4.86 3.43 4.85 3.43 4.85
B3 5.27 5.26 5.27 5.26 5.23 F3 5.18 5.07 5.18 5.07 5.17
B4 3.78 3.78 3.78 3.78 3.78 F4 5.00 4.91 4.99 4.91 4.99
B5 3.94 3.93 3.95 3.93 3.92 F5 3.78 3.74 3.77 3.75 3.78
B6a 4.80 4.80 4.79 4.80 4.75 F6a 4.30 4.27 4.30 4.26 4.29
B6b 4.31 4.26 4.31 4.26 4.30 F6b 4.11 4.09 4.11 4.10 4.10
Agminosides B–E (146–149) showed the same reciprocal HMBC correlations
(detailed in Tables 3.12–3.15) between the anomeric positions and their attach-
ments as for agminoside A (145), indicating the sugar connectivity is identical
for all congeners isolated. The majority of chemical shifts were very similar to
145, with changes appearing at and near points of difference. The proton chem-
ical shifts of the five compounds are compared in Table 3.11, with the significant
differences highlighted.
The agminoside glycolipids all have the same aglycon, the same sugars (glu-
cose), and even the same sugar connectivity. The differences were only in the
number and placement of acetylation, and a loss of one sugar moiety. Analysis
of other fractions by MS indicated the presence of further glycolipid congeners
with four or even three sugars, but as they were present in very low quantities,
they were not isolated. The agminosides constituted the majority of the sponge
extract; what biological role they play for the sponge is an interesting, and as
yet unanswered, question.
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Table 3.12. NMR data (600 MHz, CD3OD) for agminoside B (146).
δC mult δH mult, COSY HMBC TOCSY
pos. (ppm) (ppm) J (Hz)
Aglycon
1a
72.5 CH2
3.52 m 2 2, 3
2
1b 3.45 m 2 2, 3
2 30.7 CH2 1.55 m 1a, 1b, 3
3 27.2 CH2 1.34 m 2, 4
4–14 30.7 CH2 1.29 m
15 26.3 CH2 1.37 m 16a 14, 16a, 16b
16a
35.9 CH2
1.58 m 15, 16b, 17 17
15
16b 1.49 m 16a, 17 17
17 81.5 CH 3.65 m 16a, 16b 19
18 37.3 CH2 1.48 m 17 20
19 19.1 CH2 1.48 m 20 20 20
20 14.8 CH3 0.92 t (7.2) 19 18, 19 19
3′ 71.5 CH2 3.79 m 2
′ 1, 1′ 2′
2′ 75.3 CH 5.11 dd (5.5, 3.6) 3′ 1′, 3′, 2′-Ac 3′
1′ 173.6 C - - - - -
2′-Ac
172.5 C - - - - -
20.9 CH3 2.11 s - 2
′-Ac -
Glucose A
A1 102.0 CH 4.46 d (7.7) A2 (A3, A5), 17
A2 82.5 CH 3.50 m A1, A3 A1, A3, F1 A1, A3
A3 76.7 CH 3.76 m A2, A4 A2, A4 A2, A4, (A5)
A4 81.9 CH 3.58 t (9.5) A3, A5 A3, A5, A6, B1 A3, A5
A5 75.8 CH 3.35 m A4, A6a, A6b (A1, A4, A6)
A6a
61.6 CH2
3.77 m A5, A6b
A5
A6b 3.64 dd (12.4, 4.7) A5, A6b (A5)
Glucose B
B1 101.9 CH 4.82 d (8.2) B2 A4
B2 73.1 CH 4.88 dd (9.8, 8.2) B1, B3 B1, B3, B2-Ac B1, B3
B3 74.5 CH 5.26 t (9.4) B2, B4 B2, B4, B3-Ac B2, B4
B4 79.7 CH 3.78 m B3, B5 B3, B5, B6, C1 B3, B5
B5 74.4 CH 3.93 ddd (9.3, 7.0, 1.6) B4, B6a, B6b (B4) B4, B6a, B6b
B6a
64.7 CH2
4.80 m B5, B6b (B5), B6-Ac
B5
B6b 4.26 m B5, B6a B5, B6-Ac
B2-Ac
171.3a C - - - - -
20.6 CH3 2.06 s - B2-Ac -
B3-Ac
171.8 C - - - - -
20.8b CH3 2.00 s - B3-Ac -
B6-Ac
172.7 C - - - - -
21.2 CH3 2.15 s - B6-Ac -
Glucose C
C1 103.6 CH 4.52 d (7.8) C2 (C5), B4
C2 79.9 CH 3.49 m C1, C3 C1, C3, D1 C1, C3
C3 76.5 CH 5.07 t (9.3) C2, C4 C2, C4, C3-Ac C2, C4
C4 69.9 CH 4.81 dd (8.3, 6.8) C3, C5 C3, C5, C6, C4-Ac C3, C5
C5 72.5 CH 3.90 ddd (6.2, 4.1, 2.3) C4, C6a, C6b (C1, C4) C4, C6a, C6b
C6a
63.1 CH2
4.34 dd (12.8, 4.4) C5, C6b C5, C6-Ac
C5
C6b 4.07 dd (12.7, 1.7) C5, C6a C4, C5, C6-Ac
C3-Ac
171.3a C - - - - -
20.8b CH3 1.99 s - C3-Ac -
C4-Ac
171.7 C - - - - -
20.7c CH3 1.93 s - C4-Ac -
C6-Ac
172.3 C - - - - -
20.8b CH3 2.04 s - C6-Ac -
Glucose D
D1 103.2 CH 4.45 d (7.8) D2 (D3, D5), C2
D2 83.9 CH 3.21 m D1, D3 D1, D3, E1 D1, D3
D3 77.9 CH 3.48 m D2, D4 D2, D4 D2, D3
D4 71.5 CH 3.21 m D3. D5 D5, D6 D3, D5
D5 75.3 CH 3.43 m D4. D6a, D6b D6a
D6a
64.4 CH2
4.52 m D5, D6b D6-Ac
D5
D6b 4.24 dd (13.0, 2.5) D5, D6a (D4), D6-Ac
continued on the next page
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Table 3.12. – continued from previous page
δC mult δH mult, COSY HMBC TOCSY
pos. (ppm) (ppm) J (Hz)
D6-Ac
173.0 C - - - - -
21.4 CH3 2.18 s - D6-Ac -
Glucose E
E1 106.2 CH 4.39 d (8.3) E2 (E5), D2
E2 75.3 CH 3.18 dd (8.9, 7.9) E1, E3 E1, E3 E1, E4
E3 78.2 CH 3.33 m E2, E4 (E1), E2, E4 E2, E4
E4 70.8 CH 3.45 m E3, E5 E3, E5, E6 E5
E5 75.6 CH 3.35 m E4, E6a, E6b (E1) E4
E6a
63.6 CH2
4.79 dd (12.0, 3.7) E5, E6b E4, E5, E6-Ac
E6b 4.13 m E5, E6a E6-Ac
E6-Ac
173.2 C - - - - -
21.4 CH3 2.19 s - E-6Ac -
Glucose F
F1 105.2 CH 4.80 m F2 A2
F2 74.3 CH 3.43 m F1, F3 F1, F3 F1, F3
F3 76.1 CH 5.07 t (9.3) F2, F4 (F1), F2, (F5), F3-Ac F2, F4
F4 70.0 CH 4.91 t (9.9) F3, F5 F3, F5, F6, F4-Ac F3, F5
F5 73.1 CH 3.74 m F4, F6a, F6b (F1, F4) F4, F6a
F6a
63.4 CH2
4.27 m F5, F6b F4, F5, F6-Ac
F5
F6b 4.09 dd (12.1, 2.2) F5, F6a F4, F5, F6-Ac
F3-Ac
172.1 C - - - - -
20.7c CH3 2.03
d s - F3-Ac -
F4-Ac
172.1 C - - - - -
20.8b CH3 2.02 s - F4-Ac -
F6-Ac
172.3 C - - - - -
20.7 CH3 2.03
d s - F6-Ac -
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Table 3.13. NMR data (600 MHz, CD3OD) for agminoside C (147).
δC mult δH mult, COSY HMBC
pos. (ppm) (ppm) J (Hz)
Aglycon
1a
72.4 CH2
3.51 m 1b, 2 2, 3, 3′
1b 3.45 m 1a, 2 2, 3, 3′
2 30.8 CH2 1.56 m 1a, 1b, 3 3
3 27.2 CH2 1.34 m 2 4
4–14 30.8 CH2 1.28 m
15 26.3 CH2 1.37 m 16
16a
35.8 CH2
1.55 m 16b, 17
16b 1.48 m 16a (15)
17 81.7 CH 3.63 m 16a, 18 19
18 37.2 CH2 1.47 m
19 18.8 CH2 1.48 m 20 18, 20
20 14.8 CH3 0.95 m 19 18, 19
3′a
71.4 CH2
3.69 dd (10.2, 2.6) 2′
3′b 3.62 dd (10.9, 5.5) 2′
2′ a CH 4.34 m 3′a, 3′b
1′ a C - - - -
Glucose A
A1 102.0 CH 4.39 d (7.6) A2 17
A2 81.1 CH 3.44 m A1, A3 A1, A3, F1
A3 77.4 CH 3.57 m A2, A4
A4 82.4 CH 3.52 m A3, A5 A3, A5, A6, B1
A5 75.7 CH 3.31 m A4, (A6a), A6b
A6a
61.7 CH2
3.75 m (A5), A6b
A6b 3.62 m A5, A6a
Glucose B
B1 102.0 CH 4.81 d (8.3) B2 A4
B2 73.0 CH 4.87 m B1, B3 B3, B2-Ac
B3 74.5 CH 5.27 t (9.4) B2, B4 B2, B4, B3-Ac
B4 79.7 CH 3.78 m B3 B3, B5, B6, C1
B5 74.3 CH 3.95 ddd (9.5, 7.1, 1.9) (B6a), B6b
B6a
64.5 CH2
4.79 m (B5), B6b B6-Ac
B6b 4.31 m B5, B6a B5, B6-Ac
B2-Ac
171.3 C - - - -
20.8b CH3 2.06 s - B2-Ac
B3-Ac
171.7 C - - - -
21.4 CH3 2.01 s - B3-Ac
B6-Ac
172.1 C - - - -
21.4 CH3 2.20 s - B6-Ac
Glucose C
C1 103.4 CH 4.53 d (7.4) C2 B4
C2 79.8 CH 3.50 m C1, C3 C1, D1
C3 76.5 CH 5.08 t (9.4) C2, C4 C2, C4, C3-Ac
C4 69.9 CH 4.80 m C3, C5 C3, C5, C6, C4-Ac
C5 72.5 CH 3.90 ddd (10.0, 4.0, 2.1) C4, C6a
C6a
63.1 CH2
4.34 m C5, C6b C6-Ac
C6b 4.06 dd (12.6, 1.7) C6a C4, C5, C6-Ac
C3-Ac
171.2 C - - - -
21.4 CH3 1.99 s - C3-Ac
C4-Ac
171.6 C - - - -
20.8b CH3 1.93 s - C4-Ac
C6-Ac
172.2c C - - - -
20.8b CH3 2.04
d s - C6-Ac
Glucose D
D1 103.1 CH 4.46 d (7.9) D2 C2
D2 83.8 CH 3.22 m D1 D1
D3 77.9 CH 3.48 m D4
D4 71.6 CH 3.22 m D5
D5 75.3 CH 3.43 m D6a
D6a
64.5 CH2
4.53 dd (11.8, 5.0) D5, D6b D5
D6b 4.23 dd (11.7, 1.8) D6a
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δC mult δH mult, COSY HMBC
pos. (ppm) (ppm) J (Hz)
D6-Ac
172.9 C - - - -
21.5 CH3 2.19 s - D6-Ac
Glucose E
E1 106.1 CH 4.40 d (7.8) E2 D2
E2 75.3 CH 3.18 m E1, E2 E1, E3
E3 78.2 CH 3.33 m E2, E4 E1, E2, E4
E4 70.7 CH 3.46 m E3, E5 E5, E6
E5 75.6 CH 3.35 m E4, (E6a), E6b
E6a
63.3 CH2
4.80 m (E5), E6b E4, E5, E6-Ac
E6b 4.12 dd (12.0, 3.4) E5, E6a E6-Ac
E6-Ac
173.1 C - - - -
21.7 CH3 2.19 s - E6-Ac
Glucose F
F1 102.1 CH 5.07 d (8.3) F2 A2
F2 73.3 CH 4.85 m F1, F3 F1, F2-Ac
F3 74.2 CH 5.18 t (9.5) F2, F4 F2, F4, F3-Ac
F4 69.8 CH 4.99 t (9.8) F3, F5 F3, F5, F6, F4-Ac
F5 72.7 CH 3.77 m F4, F6a
F6a
63.2 CH2
4.30 m F5, F6b F6-Ac
F6b 4.11 dd (12.4, 2.0) F6a F4, F5, F6-Ac
F2-Ac
171.2e C - - - -
20.6 CH3 2.00
f s - F2-Ac
F3-Ac
171.6 C - - - -
20.6 CH3 1.97 s - F3-Ac
F4-Ac
171.2e C - - - -
21.1 CH3 2.00
f s - F4-Ac
F6-Ac
172.2d C - - - -
20.8d CH3 2.04
d s - F6-Ac
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Table 3.14. NMR data (600 MHz, CD3OD) for agminoside D (148).
δC mult δH mult, COSY HMBC TOCSY
pos. (ppm) (ppm) J (Hz)
Aglycon
1a
72.5 CH2
3.52 m 2 2, 3
2, 3
1b 3.48 m 1, 3 2, 3
2 30.8 CH2 1.57 m 2 1, 3 1a, 1b
3 27.3 CH2 1.34 m
4–14 30.7 CH2 1.29 m
15 26.7 CH2 1.37 m 16
16a
35.9 CH2
1.59 m
14,15
16b 1.49 m
17 81.4 CH 3.66 m 18 (15), 19 16b, 20
18 37.2 CH2 1.53 m 17 19 16b, 19, 20
19 19.1 CH2 1.47 m 20 20 20
20 15.0 CH3 0.92 t (7.2) 19 18, 19 19
3′ 72.0 CH2 3.78 m 2
′ 1
2′ 73.3 CH 4.11 m 3′
1′ a C - - - - -
Glucose A
A1 102.0 CH 4.45 d (7.9) A2 17 A2, A3
A2 82.4 CH 3.50 m A1, A3 F1, A4 A1, A3, A4, A5
A3 76.7 CH 3.76 m A2, A4 A2, A4 A1, A2, A4, A5
A4 81.9 CH 3.58 m A3, A5 B1 (A1), A2, A4, A5
A5 75.5 CH 3.35 m A4, A6a, A6b A4, A6
A6a
61.6 CH2
3.77 m A5, A6b
A5
A6b 3.63 m A5, A6a
Glucose B
B1 102.0 CH 4.82 m B2 A4 B2, B3
B2 73.0 CH 4.88 m B1, B3 B1, B3, B2-Ac B1, B3
B3 74.5 CH 5.26 t (9.7) B2, B4 B2, B4, B3-Ac B1, B2
B4 79.7 CH 3.78 m B3, B5 B3, B6, C1 B3, B5, B6b
B5 74.4 CH 3.93 m B4, B6a, B6b B2, B3, B4, B6a
B6a
64.7 CH2
4.80 m B5, B6b B5, B6-Ac
B4, B5
B6b 4.26 m B5, B6a
B2-Ac
171.3 C - - - - -
20.8 CH3 2.01
b s - B2-Ac -
B3-Ac
171.8 C - - - - -
20.7c CH3 2.03 s - B3-Ac -
B6-Ac
172.4 C - - - - -
21.1 CH3 2.11
d s - B6-Ac -
Glucose C
C1 103.6 CH 4.52 d (7.7) C2 B4 C2, (C3)
C2 79.9 CH 3.49 m C1, C3 C1, D1 C1, C3, C4
C3 76.5 CH 5.07 t (8.9) C2, C4 C2, C4, C3-Ac C1, C2, C4, C5
C4 69.9 CH 4.80 m C3, C5 C5, C6, C4-Ac (C1), C2, C3, C5
C5 72.5 CH 3.90 m C4, C6a, C6b C3, C4, C6a, C6b
C6a
63.0 CH2
4.34 dd (13.7, 6.8) C5, C6b C6-Ac
C5
C6b 4.07 dd (13.6, 1.9) C5, C6a C6-Ac
C3-Ac
171.2 C - - - - -
20.7c CH3 1.99 s - C3-Ac -
C4-Ac
171.5 C - - - - -
20.7c CH3 1.93 s - C4-Ac -
C6-Ac
172.2e C - - - - -
20.6d CH3 2.04
g s - C6-Ac -
Glucose D
D1 103.2 CH 4.45 d (7.9) D2 C2 D2, D3
D2 83.8 CH 3.21 m D1, D3 D1, D3, E1 D1, D3, D5
D3 77.9 CH 3.48 m D1, D2, D4
D4 71.5 CH 3.22 m D3, D5, D6 (D1), D3, D5, D6a, D6b
D5 75.3 CH 3.43 m D6b
D6a
64.3 CH2
4.51 dd (11.5, 6.5) D5, D6b D5, D6-Ac
D4, D5
D6b 4.24 dd (12.9, 1.8) D5, D6a D6-Ac
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δC mult δH mult, COSY HMBC TOCSY
pos, (ppm) (ppm) J (Hz)
D6-Ac
173.0 C - - - - -
21.5 CH3 2.19 s - D6-Ac -
Glucose E
E1 106.1 CH 4.39 d (7.9) E2 D2 E2, E3
E2 75.3 CH 3.18 m E1, E3 E1, E3 E1, E3, E4
E3 78.2 CH 3.33 m E2, E4 E1, E2, E4 E1, E2, (E4)
E4 70.8 CH 3.45 m E3, E5 E5, E6 (E1), E2, E3, E5
E5 75.7 CH 3.36 m E4, E6a, E6b
E6a
63.5 CH2
4.78 m E5, E6b E4, E5, E6-Ac
E5
E6b 4.13 m E5, E6a E6-Ac
E6-Ac
173.3 C - - - - -
21.4 CH3 2.19 s - E6-Ac -
Glucose F
F1 105.2 CH 4.80 m F2 A2 F2, (F3)
F2 74.3 CH 3.43 m F1, F3 F1, F3 F1
F3 76.1 CH 5.07 t (8.9) F2, F4 F2, F3-Ac F1, F2, F4, F5
F4 70.0 CH 4.91 m F3, F5 F3, F5, F6, F4-Ac F1, F2, F3, F5
F5 73.0 CH 3.75 m F4, F6a, F6b (F4) F6F4, F3, F6a, F6b
F6a
63.4 CH2
4.26 m F5, F6b F6-Ac
F5
F6b 4.10 m F5, F6a F5, F6-Ac
F3-Ac
172.0 C - - - - -
20.7c CH3 2.04
g s - F3-Ac -
F4-Ac
171.4 C - - - - -
20.6 CH3 2.01
b s - F4-Ac -
F6-Ac
172.2e C - - - - -
21.2 CH3 2.11
c s - F6-Ac -
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Table 3.15. NMR data (600 MHz, CD3OD) for agminoside E (149).
δC mult δH mult, COSY HMBC TOCSY
pos. (ppm) (ppm) J (Hz)
Aglycon
1a
72.4 CH2
3.51 m 2 2, 3
2,3,4
1b 3.45 m 2 2, 3
2 30.67 CH2 1.55 m 1a, 1b, 3 1, 3, 4
3 27.2 CH2 1.34 m 2 4
4–14 30.8 CH2 1.29 m
15 26.4 CH2 1.36 m 14
16a
35.8 CH2
1.57 m 16b
14
16b 1.48 m 16a
17 81.7 CH 3.62 m 16a, 16b, 18 19 14, 16b, 20
18 37.1 CH2 1.48 m 20 20
19 18.9 CH2 1.47 m 20 18, 20
20 14.8 CH3 0.95 t (6.5) 19 18, 19
3′ 71.7 CH2 3.78 m 2
′ 1 2′
2′ 76.0 CH 5.08 m 1′ 1′, 2′-Ac 3′
1′ a C - - - -
2′-Ac
172.6 C - - - - -
21.1b CH3 2.11 s - 2
′, 3′-Ac
Glucose A
A1 101.9 CH 4.38 d (7.5) A2 17 A2, A3, A4
A2 81.1 CH 3.45 m A1, A3 A1, A3, F1 A1
A3 77.3 CH 3.55 m A2, A4 A2, A4
A4 82.4 CH 3.53 m A3, A5 A5 A1
A5 75.7 CH 3.30 m A4, A6a A1
A6a
61.6 CH2
3.75 m A6b A4, A5
A6b 3.61 m A5, A6a
Glucose B
B1 102.1 CH 4.78 m B2 A4 B2, B4
B2 73.0 CH 4.86 m B1, B3 B1, B3, B2-Ac B1
B3 74.4 CH 5.23 m B2, B4 B2, B4 B1, B2, B4
B4 79.3 CH 3.78 m B3 B5, B6, C1
B5 74.2 CH 3.92 m B6a
B6a
64.3 CH2
4.75 m B6a, B5, B6-Ac
B5
B6b 4.30 m B6b B6-Ac
B2-Ac
171.2 C - - - - -
20.6c CH3 2.06 s - B2-Ac -
B3-Ac
171.8 C - - - - -
20.6c CH3 2.00
d s - B3-Ac -
B6-Ac
172.6 C - - - - -
21.1b CH3 2.19 s - B6-Ac -
Glucose C
C1 103.6 CH 4.52 d (7.7) C2 C2, C5
C2 80.9 CH 3.56 m C1, C3 C1, D1 C1, C4, C5
C3 76.1 CH 5.22 m C2, C4 C2, C4, C3-Ac C1
C4 69.7 CH 4.87 m C3, C5 C3, C5, C6, C4-Ac
C5 72.6 CH 3.81 m C4, C6a, C6b C1
C6a
63.0 CH2
4.35 dd (12.5, 3.9) C5, C6b C6-Ac
C6b 4.03 dd (12.3, 2.0) C5, C6a C4, C5, C6-Ac
C3-Ac
171.6 C - - - - -
20.8 CH3 2.02
e s - C3-Ac -
C4-Ac
171.4 C - - - - -
20.6c CH3 1.96 s - C4-Ac -
C6-Ac
172.2 C - - - - -
20.8 CH3 2.04 s - C6-Ac -
Glucose D
D1 106.0 CH 4.31 d (8.0) D2 C2 D2, D3, D4
D2 74.7 CH 3.09 dd (9.4, 8.4) D1, D3 D1, D3 D1, D3
D3 77.7 CH 3.29 m D2, D4 D2, D4 D1
D4 71.6 CH 3.19 t (9.4) D3, D5 D3, D5, D6 D1
D5 75.4 CH 3.44 m D4, D6a, D6b D4, D6 D1, D4
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δC mult δH mult, COSY HMBC TOCSY
pos. (ppm) (ppm) J (Hz)
D6a
69.6 CH2
4.46 dd (11.8, 6.9) D5, D6b D6-Ac
D6b 4.29 m D5, D6a D6-Ac
D6-Ac
173.0 C - - - - -
21.4 CH3 2.20 s - D6-Ac -
Glucose F
F1 102.1 CH 5.07 d (8.1) F2 A2 F2
F2 73.3 CH 4.85 m F1, F3 F1, F3, F6-Ac
F3 74.2 CH 5.17 t (9.6) F2, F4 F2, F4, F3-Ac
F4 69.8 CH 4.99 t (9.6) F3, F5 F3, F6, F4-Ac F1, F2
F5 76.7 CH 3.78 m F4, F6a
F6a
63.2 CH2
4.29 m F5, F6b F4, F5, F6-Ac
F5
F6b 4.10 dd (12.1, 2.2) F6a F6-Ac
F2-Ac
171.4 C - - - - -
21.0 CH3 2.02
e s - F2-Ac -
F3-Ac
171.6 C - - - - -
20.5 CH3 1.97 s - F3-Ac -
F4-Ac
171.3 C - - - - -
20.9 CH3 2.00
d s - F4-Ac -
F6-Ac
172.2 C - - - - -
20.7 CH3 2.03 s - F6-Ac -
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3.3 Biological activity
The biological activity of the agminoside glycolipids was investigated by re-
searchers from the School of Biological Sciences, VUW. Agminoside A (145)
was subjected to a 72 h MTT assay against HeLa (cervical cancer) cells. It
showed weak growth inhibitory activity (IC50 = 32µM) that may be due to
non-specific lipid effects.158
The mixture of glycolipids (with 145 being the major constituent) was sub-
mitted to the chemical genetics programme at the School of Biological Sciences,
VUW. The programme surveys genetic interactions in a Saccharomyces cere-
visiae model system as a novel approach to drug discovery. Chemical genetics
is based on the idea that a molecule that is a specific inhibitor of a protein
will functionally act like a mutation of that gene, allowing the identification of
potential new drugs and drug targets.159
The agminosides were tested against approx. 4800 individual haploid mu-
tant yeast strains.160 Unfortunately they did not show any differential activity,
perhaps due to their inability to enter cells because of their large size.161
3.4 Glycolipids from sponges
Lipid is a broad term encompassing biological substances that are generally hy-
drophobic, insoluble or immiscible with water but soluble in organic solvents.162
They can be classified into categories based on the identity of their core lipid:
polyketides, acylglycerols, sphingolipids, prenols, and saccharolipids. In addi-
tion, for historical and bioinformatics reasons, fatty acyls are separated from
other polyketides, glycerophospholipids from other glycerolipids, and sterols from
other prenols, resulting in eight final categories (Table 3.16).162
Table 3.16. Lipid categories.
Core lipid type Lipid category
polyketide
fatty acyl lipids
other polyketide lipids
acylglycerol
glycerolipids
glycerophospholipids
sphingoid sphingolipids
isoprenoid
prenol lipids
sterol lipids
fatty acid linked directly
to sugar backbone
saccharolipids
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Any compound containing one or more monosaccharide residues bound by
a glycosidic linkage to a lipid is termed a glycolipid.163 Glycolipids occur in all
kingdoms of living organisms, as they are important membrane components, and
are involved in cellular trafficking, signalling, external interactions, proliferation,
differentiation and apoptosis.164,165
Usually, glycolipids fall into three categories depending on their lipid moiety:
glycosphingolipids, glycoglycerolipids and isoprenoid glycosides. These have ei-
ther a sphingoid (long chain aliphatic amino alcohol, such as sphingosine (152))
or a ceramide (N -acylsphingoid e.g. 153), an acylated glycerol, or a terpene
alcohol as their lipid moiety respectively.163 Other glycolipids exist that are not
easily categorized. These often contain a glycosyl moiety (one or more saccha-
ride units) linked through an ether bond to a fatty alcohol or a hydroxy fatty
acid, or through an ester bond to the carboxyl of a fatty acid.164
Natural glycolipids are often complex mixtures of homologues differing only
in the length and branching of their alkyl chains.166,167 Because of their similarity,
they are notoriously difficult to separate, and are often reported as mixtures, the
ratio of the various homologues having been determined through chemical degra-
dation. For example, the diglycosylated glycosphingolipid vesparioside (154)
(isolated from the sponge Speciospongia vesparia) is reported as a mixture.167
The sugar residues were assigned by NMR analysis, revealing the presence of
a β-glucopyranoside and a β-arabinopyranoside, the first pentose sugar unit re-
ported from a natural diglycosylceramide. Preliminary NMR analysis revealed
that the alkyl chain mixture differed in length and position of branching; the
exact composition was determined by microscale chemical degradation.167
Of the glycolipids isolated from sponges, the glycosphingolipids are the most
numerous, and no attempt is made here to provide a comprehensive review.
Many show both interesting chemistry and biological activity, such as the plako-
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sides A–D (155–158).168,169 They are the first examples of a natural glycosph-
ingolipid with a prenylated sugar, and the first with a cyclopropane-containing
ceramide.168 Compounds 155 and 156 were isolated from the sponge Plakortis
simplex, while 157 and 158 were reported from Ectyoplasia ferox, raising doubts
about the actual organism responsible for biosynthesis.169 Plakosides A and B
show strong immunosuppressive activity in an activated T cell assay without
any appreciable toxicity, meaning they or their analogues may be quite useful as
therapeutic agents.168
The agelasphins (159–166) are a family of highly biologically active gly-
cosphingolipids.170,171 Isolated from the Japanese sponge Agelas mauritianus,
they were the first naturally occuring α-galactosylceramides isolated.170 They
have all shown antitumour activity, and several analogues have been synthesized
using the most potent compound 162 as the lead structure.172 The culmination
of this research, the agent KRN-7000 (167), is now in clinical trials for cancer
immunotherapy.25
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The myrmekiosides A and B (168, 169) are examples of sponge derived glyco-
glycerolipids.173 They were isolated from the Japanese marine spongeMyrmekio-
derma sp. and were found to reverse tumour cell morphology of ras-transformed
cells at 5 µg/mL.173 While the agminosides contain a glycerol-derived moiety,
they are not true glycoglycerolipids, which are always glycosylated on the glyc-
erol.162
A growing number of steroidal (triterpene) glycolipids (often termed gly-
cosides or saponins) are being isolated from sponges,∗ but being significantly
∗for a recent example see Afiyatullov et al.174
99
HO
HO O
OH
O O
HO
OH
O
170
O
OHO
O
OHO
O
OHO
O
OHO
OHO
HO
OH OH OH OH OH
O O
HO
OH
O
171
different to the agminosides, they will not be discussed here. The linear ter-
pene glycolipids are represented by plakopolyprenoside (170) and plaxyloside
(171) from the sponge P. simplex.175,176 They are composed of a C35 polyprenyl
alcohol and two or six xylose sugar residues. As with many glycolipids, they
were peracetylated in order to facilitate their isolation and subsequent structure
elucidation.175 Peracetylation reduces the amphiphilic nature of the glycolipid,
resulting in better chromatographic separation. In addition, acetylation of a
hydroxy position moves the δH approx. 1 ppm downfield. This results in the
spreading out of the 1H signals, reducing overlap and easing structure elucida-
tion. The major drawback of this procedure is that while the introduced acetates
can be removed through mild hydrolysis, any naturally present acetates will be
removed also, leading to uncertainty about the actual structure of the natural
glycolipid.175 To overcome this, Costantino and co-workers take a small portion
of the crude glycolipid, acetylate it with trideuteroacetic anhydride instead of
acetic anhydride, and subject the sample to the same purification procedure
as the normally peracetylated compound. Once pure, comparison of the the
1H NMR spectra of the two peracetylated compounds will reveal any naturally
present acetates, as they will be apparent in both spectra.175,176
Not very many sponge glycolipids are naturally acetylated. The erylusamines
A–E (172–176) have been isolated by Fusetani and co-workers from the Japanese
sponge Erylus placenta, and consist of a tetrasaccharide (l-arabinopyranose and
d-xylopyranose sugars, partially acetylated) and a long chain fatty amide deriva-
tive, terminated with a N,N -dimethylpentanediamine unit.177,178 The position of
the ketone and the two hydroxyls was deduced from positive FAB-MS data, the
absolute configuration of the sugars was assigned through the use of chiral GC
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analysis of the hydrolysate, and the configuration of the two hydroxyls was deter-
mined through the use of CD spectroscopy in the presence of Eu(fod)3.
178 Com-
pounds 173–176 were found to be strong inhibitors of interleukin-6, a multifunc-
tional cytokine involved in many biological functions and disease processes.177,178
Soon after, Kashman et al. isolated related glycolipids from Erylus cf. lenden-
feldi collected from the Red Sea (Eritrea).179 They differ in their sugar por-
tion, which is composed of two galactopyranoses and a glucopyranose sugar
acetylated at one position at most. Erylusamine TA (177) possesses the same
aglycon structure as 176, while erylusine (178) and erylusidine (179) have a
ω-N,N -dimethylaminobutyl-N -methyl-1,3-propanediamine or a 4-(aminobutyl)-
guanidine (agmatine) unit respectively, terminating the fatty chain.179
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Pachymoside A (180) is one member of a family of related glycolipids found in
the marine sponge Pachymatisma johnstonia.180 The pachymosides contain four
glucose and two galactose residues, with varying levels and positions of acetyla-
tion. The aglycon is very similar to that of 176, except the amino component
of the amide is acidic, not basic.
A final family of partially acetylated glycolipids is the caminoside family
(181–184). They were isolated from the marine sponge Caminus sphaeroconia
collected from the Toucari Caves in Dominica. Fractionation using a bioassay
for the inhibition of the secretion of proteins by enteropathogenic Escherichia
coli (which is the major cause of infantile diarrhoea) for guidance, yielded the
active components 181–184.181,182 All four caminosides share the same four
sugars (two glucoses, a quinovose, and the unusual 6-deoxytalose residue) and
the same C19 linear chain with a methyl ketone terminus. They differ only
in the number and position of acetates and butyrates attached to the sugar
residues.181,182 The absolute configuration of the aglycon portion of the molecules
proved a challenge to determine. Normally, configuration of secondary alcohols
can be assigned through NMR analysis of their Mosher’s esters. Unfortunately,
the stereocentre in question was separated from the chain termini by at least
seven CH2 groups. Assigning configuration at remote stereocentres in acyclic
molecules is a well-known problem in natural product structure elucidation. In
this case, the stereochemical assignment was achieved through the use of exciton-
coupling circular dichroism, using liposomes to limit conformation averaging and
obtain partial ordering of the lipid chain.183
Perhaps the most unusual glycolipid to be isolated from marine sponges is the
highly sulfated lipopolysaccharide axinelloside A (185). It was isolated from the
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marine sponge Axinella infundibula through bioassay guided fractionation using
a telomerase inibition assay.184 The structure of this very large glycolipid (molec-
ular weight of 4780.4) was determined mainly through spectroscopic methods.
Axinelloside A was found to consist of 12 sugars (including a scyllo-inositol, a
polyol rarely found in natural products) with 19 sulfates and four fatty acids.184
As (R)-3-hydroxy fatty acids (such as that present in 185) are typically found in
bacterial lipopolysaccharides, axinelloside A is likely the product of a symbiont
bacterium.184 Its function in the sponge remains unknown.
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3.5 Concluding remarks
A varied range of secondary metabolites has been isolated from sponges of the
genus Raspailia. These include such structural classes as acetylenic glyceryl enol-
ethers, cyclic hemi-ketals, adenine-diterpenes, and clerodane diterpenes. The
agminosides, partially acetylated glycolipids with up to six sugar residues, have
been isolated from R. agminata, and are the first reported glycolipids from this
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genus. They were purified through multiple cycles of normal phase chromato-
graphy monitored by MS as the glycolipids did not possess a chromophore.
Although challenging, the chromatographic separation of the agminosides was
successful, and Costantino’s peracetylation method of glycolipid isolation175,176
was not required. All the acetates present in the agminosides are therefore of
natural origin. The partial acetylation was useful as it dispersed the 1H sig-
nals sufficiently for NMR assignment. Confirmation of the structure and the
assignment of absolute configuration was achieved through semi-synthetic mod-
ifications.
Sponges (or perhaps their symbiotic micro-organisms) produce a variety of
glycolipids, the majority of which are sphingolipids with one or two sugars, and
are often inseparable mixtures of alkyl chain homologues. The agminosides are
therefore highly unusual, as they contain up to six sugar residues and have a
single aglycon, which is glycosylated on the alkyl chain even though the lipid
contains a glycerol derivative. The agminosides show both 1-2 and 1-4 glycosidic
linkages and also display partial acetylation, an unusual feature found in very
few reported sponge glycolipids.
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Chapter 4
NMR Screening
Bioassay remains the most popular screening method employed in drug discovery
programmes, but alternate chemical and physico-chemical screening techniques
are being utilized as complementary methods to gain access to previously unex-
plored chemical diversity. The use of NMR spectroscopy as a mode of detection
was considered “rare” nine years ago19, but since then it has become a vital
screening tool because of its selective advantages.
4.1 Screening with NMR
In contrast to analysis by MS, NMR spectroscopy is a non-destructive technique
that also provides more detailed structural information. This is of particular
importance when searching for novel chemotypes, but can also be used for the
tailoring of chromatographic separation conditions.185,186 In addition, NMR pro-
vides quantitative composition information that is not dependent on ease of
ionization (MS) or chromophore intensity (DAD).186 NMR spectroscopy lacks
the sensitivity of MS, but recent technological advances both in magnetic field
strength and cryogenic techniques have greatly improved the limit of detection.
The combination of HPLC with NMR detection (LC-NMR) has proven to be
a powerful tool in the analysis of complex mixtures, and it is commonly being
used as a method of dereplication. On-flow and stopped-flow or loop-storage
LC-NMR modes are used for the identification of major substances or detailed
structural elucidation of major peaks, respectively. For low concetrations of an-
alytes, solid-phase extraction (SPE) to concentrate the sample, and a cryogenic
probe can increase sensitivity. For small sample amounts, capillary LC-NMR is
the best solution.187
Another approach to NMR screening is the use of diffusion-edited NMR ex-
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periments, which utilize the variance in translational diffusion of organic mol-
ecules as a function of their molecular size.188 For example, diffusion-ordered
NMR spectroscopy (DOSY) disperses a complicated and overlapping 1H spec-
trum of a mixture along a second axis (representing the logarithm of the diffusion
constant).188 In practical terms, the DOSY separates the signals of molecules of
different sizes, and was successfully utilized for the analysis of a partially pu-
rified mixture of bromopyrrole alkaloids, resulting in the isolation of two new
compounds.188
Schro¨der and co-workers approach NMR screening in a slightly different fash-
ion. They argue that analytical methods involving a chromatographic step are
likely to discriminate against some compound classes, while favouring others.189
In their experience, “structurally unique compounds will often not survive ar-
bitrarily chosen chromatographic techniques, which is one reason they have re-
mained undetected.”186 They therefore use NMR analysis of whole crude extracts
for a more “impartial view” of the sample’s contents. NMR spectra of the pure
compounds are later compared with the spectra of the crude sample to deter-
mine whether the metabolites isolated are natural compounds, or degradation
products.186
The complexity of NMR spectra typically obtained from crude extracts makes
their analysis difficult. Dispersion of signals in a second dimension (as in the
DOSY example above) somewhat mitigates the problem. To further simplify
the spectra, Schro¨der at al. used differential analysis of arrays of 2D NMR spec-
tra.185 They examined several unfractionated extracts of the fungus Tolypocla-
dium cylindrosporum (cultured on four different media according to seven dif-
ferent protocols) by double quantum filtered correlation spectroscopy (DQF-
COSY). The DQF-COSY spectra were examined graphically based on multi-
plicative stacking of their bitmaps, clearly distinguishing signals common to
several spectra from signals present in only one.185
The graphical manipulation was accomplished using commonly available im-
age editing software; by manipulating bitmaps derived from the on-screen display
of the DQF-COSY spectra the problems of working with actual 2D NMR data
were avoided. This simple method was able to distinguish compounds produced
by the fungus under most culturing conditions from those produced under a
specific one, allowing the rapid detection of two new natural products.185
This method compared extracts of one organism cultured under different
conditions, looking for changes in metabolite production. A somewhat similar
method using differential 2D NMR has been used by our group for a number
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of years, comparing extracts of different sponge species to identify secondary
metabolite producers warranting further analysis.
4.2 NMR screening of sponges by the VUW
Marine Natural Products Group
The Victoria University of Wellington Marine Natural Products Group has been
using NMR spectroscopy as a tool for the screening of sponge extracts, or rather
the screening of partially fractionated samples (after one chromatography step).
While any chromatography will discriminate against some compound classes as
argued by Schro¨der,189 this can be advantageous. Extracts are solutions of com-
plex mixtures of many types of metabolites, from highly polar carbohydrates,
salts and amino acids, to non-polar fats, steroids and triglycerides. Secondary
metabolites, on the other hand, are often of intermediate polarity. They need
both hydrophilic and hydrophobic character to be easily transportable across bi-
ological membranes (often a requirement for biological activity). This difference
in polarity is exploited to achieve separation of the majority of primary from sec-
ondary metabolites at a very early stage of purification. Using the cyclic loading
technique (discused in detail in Appendix A, page 186), an extract is loaded onto
reversed-phase polymeric resin, and eluted stepwise with 30%, 75% Me2CO in
H2O, and 100% Me2CO.
∗ The most polar salts, amino acids and sugars will be
in the 30% fraction (or even in the eluent, not having adsorbed to the column
in the first place), while the non-polar fats and triglycerides will be in the 100%
fraction. Secondary metabolites of intermediate polarity will most often appear
enriched in the 75% fraction. Removing a significant amount of the usually un-
interesting primary metabolites from the mixture achieves two important goals.
It makes the sample much more soluble for NMR (the solids from a crude extract
are unlikely to dissolve in any solvent due the range in polarity of compounds
in the mixture). In addition, it concentrates the secondary metabolites which
helps with the relative insensitivity of NMR spectroscopy.
History
Screening of the 75% fractions by NMR spectroscopy began with a simple anal-
ysis of the 1D 1H spectra run in CDCl3.
127 This fraction still contained a large
amount of fats, steroids and other metabolites, leading to significant overlap
∗The current sponge screening procedure is detailed on page 179, Section 8.8.
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of signals between 0.5 and 5.5 ppm. Unsurprisingly, the first compounds iso-
lated using this method all contained olefins, furans or aromatic rings, that is
compounds with resonances that were readily observable in the clear portion
of the 1H spectrum at >5.5 ppm.127 The screening protocol was therefore ex-
panded to include 2D NMR experiments (COSY and HSQC), which dispersed
the signals in a second dimension.190 In addition, early results showed that more
interesting resonances were observed in samples dissolved in CD3OD, as many
interesting secondary metabolites were not soluble in CDCl3. CD3OD, although
significantly more expensive, dissolved virtually all the metabolites even at high
concentrations and so became the solvent of choice for subsequent screens.190
The problem
Despite the chromatographic step that separates a significant amount of the
primary metabolites from the compounds of intermediate polarity, the 75% frac-
tion is still a complex mixture leading to highly complicated COSY and HSQC
spectra. In order for the NMR screening to be effective, it must be able to dis-
tinguish between interesting secondary and uninteresting primary metabolites,
and determine how much of the signal in the NMR screen corresponds to each.
In contrast to secondary metabolites, primary metabolites are common to all
sponges. Signals appearing frequently at certain coordinates in sponge screens,
therefore, are most likely to be due to primary metabolites. Conversely, cor-
relations appearing only rarely at a certain coordinate, or observed only once,
are most likely due to a secondary metabolite. The problem can therefore be
reduced to how frequently a signal in an NMR screen has been observed at that
particular coordinate before.
The solution
The solution to this problem has been a “mask”, created from a series of sponge
screen data sets. By overlaying multiple NMR spectral screens for a range of
sponges and counting the number of times a given signal is observed, common
correlations can be identified. The resulting mask of frequently appearing corre-
lations can then be overlaid on a screen spectrum of a specific extract, and used
to differentiate between common and rare signals. More generally, the mask
can be used to determine how many of the signals in a screen are due to com-
monly seen primary metabolites, and how many are most likely due to secondary
metabolites of interest. A decision can thereby be made whether to pursue a
particular sponge extract further.
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Development of the HSQC digital mask
Initially, the mask was just a piece of paper with correlations identified as com-
mon simply drawn on it. It was placed over a printout of a spectrum to be
analyzed (hence its name “mask”), and with the use of a light table interest-
ing correlations (those present in the spectrum but not in the mask) could be
identified. This method allowed the identification of crude sponge extracts with
secondary metabolites that did not necessarily possess olefinic or aromatic reso-
nances (which the 1D 1H spectra singled out), leading to the isolation of a range
of new compounds and therefore “proof of principle.”190
Unfortunately this (fairly primitive) manual mask has some drawbacks. It
has no gradation in the frequency of occurence of the peaks (if they are in the
mask, they are “frequent”). Evaluation of correlations by eye is time-consuming,
tedious and prone to error. In addition, areas with dense correlations are hard
to analyze, and interesting signals may be missed. Screening out common cor-
relations is, however, a job well suited for a computer.
In order to further develop this technique and maximize the sponge “hit”
rate for this study, a computer programmer was employed to write a program to
generate a digital mask, specifically for HSQC screen data. While COSY spectra
are good at“fingerprinting”extracts, HSQC spectra can provide functional group
information, giving an idea of chemical novelty.
The principle behind the program is exactly the same as the manual mask,
except it is much more accurate. HSQC screens are added together to give a
digital mask: a numerical representation of how frequently certain correlations
appear in sponge screens (that is each coordinate of the mask matrix stores how
many times that point has been a signal). The mask can then be applied to a
particular screen, establishing whether correlations in the screen are interesting
(appear only rarely), or whether they are common (appear frequently).
Over the course of the last seven years, 206 sponges were screened according
to the standard protocol. A total of 141 were run on a 300 MHz spectrometer,
while 65 were run on the 600 MHz instrument. Several were multiplicity edited
HSQCs (HSQC-DEPTs), and therefore had positive and negative correlations.
Some older HSQCs were run at varying proton and carbon ranges (before the
NMR experiments were standardized). The HSQC mask program was therefore
designed to deal with a range of resolutions and a range of 1H and 13C scales, as
well as HSQC-DEPT experiments.
Figure 4.1 shows the mask generated from the addition of 206 sponge screens.
The top figure shows common correlations (white) that appear in most, if not all,
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(a) The mask showing only the most common correlations.
(b) The full mask, showing all correlations.
Figure 4.1. The final mask, comprising of 206 sponge screens.
of the screens. Several alkyl-type peaks, as well as some oxymethines and a few
olefinic correlations are the most common HSQC signals of sponge screens. They
are probably due to unsaturated triglyceride-type primary metabolites. The full
mask, shown in the bottom figure, displays a wide variety of correlations. The
majority of them, however, are rarely seen (coloured blue).
Some areas are clearly not real correlations but noise (for example the hori-
zontal line through the middle of the spectrum). In some spectra certain noise
(usually T1 noise) was so strong that to eliminate it by raising the threshold
would have resulted in the loss of some real data points.
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The mask can be applied to a screen by overlaying the mask matrix with the
screen. Comparing the two can give an idea of whether a signal in the screen
is common, or rare. This is displayed graphically by colour-coding common
correlations green, and rare correlations red, with an adjustable threshold be-
tween them. Two examples can be seen in Figure 4.2, with the common vs. rare
threshold set at 3%: correlations are coloured red if they appear in less then 3%
(less than six) of the screens. The top image is of a sponge extract with mostly
common correlations, probably containing few compounds of interest, while in
contrast the bottom image shows a multitude of rare signals, making this a very
interesting sponge screen.
Figure 4.2. Example of an uninteresting (top) and a promising sponge screen
(bottom).
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Figure 4.3. The mask applied to screen CAG1 33H.
Applying the HSQC Mask program
The mask was applied to a series of HSQC spectra from sponge screens that
had not yet been examined. Below, in Figures 4.3, 4.6 and 4.7, are three screens
that were chosen for further examination based on the high number of rare and
interesting correlations, as revealed by application of the mask. Their “common”
vs. “rare” threshold was set at 3%.
Screen CAG1 33H
Figure 4.3 shows the mask applied to screen CAG1 33H. It shows some strong
signals in the aromatic area, as well as a multitude of oxymethine-type signals.
A range of interesting alkyl, as well as “N -methyl” type (δC 40–50, δH 2.5–3.5)
correlations were also apparent.
The sponge was extracted in bulk for a more detailed analysis. Approx. 500 g
of sponge was extracted in MeOH, and cyclic loaded onto reversed-phase HP20
beads. The column was then eluted with 20%, 40%, 60%, 80% Me2CO in H2O,
and 100% Me2CO, and the individual fractions were backloaded onto HP20.
During backloading, the sample is usually diluted once with H2O before loading
onto the column. At times when a sample is very rich in metabolites, however,
addition of the H2O causes the more non-polar components to precipitate. In
such cases, the fraction is passed through the column without dilution first. The
H2O is added to the eluent, before being passed through the column again.
Both the 60% and the 80% fractions showed this behaviour, and had to
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Figure 4.4. Round-bottom flask containing the backloading eluent of the 80%
Me2CO in H2O fraction.
be passed through the column before dilution. In addition, the elution of the
backloaded 60% was problematic. The backloading column is always washed
with H2O before elution with an organic solvent. Additon of 100% Me2CO to
the washed beads generated a milky white precipitate that clogged the column.
The sample was probably only partially soluble in acetone; upon mixing with the
remnants of water still on the column, any compounds that had moved into the
mobile phase precipitated. The solvent was switched to MeOH, the precipitate
redissolved, and the column eluted with an Me2CO/MeOH mixture.
The 80% fraction also exhibited unusual behaviour during backloading. As
there is always some H2O remaining on the column, the first few mililitres that
elute have a high percentage of H2O. Often, as compounds start eluting with
the organic solvent front, they precipitate in the flask before redissolving once
enough organic solvent passes through the column. The 80% fraction eluting
from the backloading column initially turned milky white, reminiscent of the
precipitate on the column of the 60% fraction backloading. As more Me2CO
passed through, the eluent turned into an unusual, gelatinous precipitate, shown
in Figure 4.4. The jelly-like substance eventually dissolved.
Problems with solubility became apparent almost immediately. Although
soluble at high dilution, upon concentration the 60% and 80% fractions (and to
a lesser degree the 20% and 40% fractions) were not fully soluble in any solvent
tried. Figure 4.5 shows 1H NMR spectra of the 20, 40, and 60% fractions run in
DMSO-d6. Despite the broadening of the signals due to the solubility issues, the
NMR spectra show a multitude of signals in the aromatic and heteroaromatic
region, as well as the oxymethine area. Undoubtedly the sponge contains some
very interesting secondary metabolites and warrants further investigation, but
due to the solubility issues and the availability of two other, very promising,
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Figure 4.5. 1H NMR spectra (600 MHz, DMSO-d6) of the 20, 40, and 60%
Me2CO in H2O fractions.
sponges, the decision was made to focus on the other screens instead.
Screen JMH1 17F
The mask applied to screen JMH1 17F (Figure 4.6) revealed a multitude of
interesting correlations. A significant number of them were in the aromatic and
olefinic region of the spectrum, showing widely varying 1H and 13C chemical
shifts. In addition, a series of oxymethine and “N -methyl” type correlations
were apparent, as well as unusual alkyl-like chemical shifts. This sponge was
also chosen for bulk extraction and detailed examination. The analysis of this
sponge is discussed in Chapter 5 (page 117).
Screen CAG1 36A
Figure 4.7 is of the mask applied to screen CAG1 36A. The screen displays
several strong correlations indicative of one major compound. Particulaly inter-
esting are the pairs of methylene protons, indicating chirality and/or restricted
rotation. A series of methylene pairs at unusual chemical shifts (δC 40–50), and
several interesting aromatic and alkyl correlations make this a highly interesting
screen. The sponge was therefore examined in detail; Chapter 6 (page 130) deals
with the isolation of new secondary metabolites from this sponge.
114
Figure 4.6. The mask applied to screen JMH1 17F.
Figure 4.7. The mask applied to screen CAG1 36A.
4.3 Future directions
While the HSQC mask program has been very successful in this research, it
can be expanded upon and improved further, for example by applying the same
principles to a COSY mask. Screening by COSY has the major advantage of
significantly shorter NMR acquisition times (COSY: 20 min vs. HSQC: 4 hrs).
The COSY can also provide some connectivity information through the identi-
fication of spin systems, allowing the construction of substructures and aiding
dereplication efforts early in the isolation.
Dereplication is a common problem in natural product discovery.14 While
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the HSQC mask program is very good at differentiating primary from secondary
metabolites (common vs. rare correlations), it currently has no mechanism to
identify previously examined (duplicate) screens or compounds already known
from the literature. The program does offer large scope for further development
in this area. For example, with advanced pattern recognition the program could
compare screens, looking for patterns of correlations that would indicate dupli-
cate screens, or related metabolite types. In theory, it could also identify known
compounds from their unique HSQC correlation “fingerprint”, without the need
for any further purification. This would be an invaluable dereplication method.
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Chapter 5
New Metabolites from a Sponge
of the order Dictyoceratida
5.1 Order Dictyoceratida
Dictyoceratida is an order that does not have any silicaceous spicules, making
taxonomic identification of dictyoceratid sponges more difficult. The sponges are
tough and flexible, typically with a conulose (marked by conules or cone-shaped
elevations) surface. Often they will have a marked difference in external and
internal pigmentation, with a dark exterior and the interior ranging from white,
cream, through to pale brown or yellow. The order consists of four families:
Dysideidae, Irciniidae, Spongiidae and Thorectidae, as shown in Figure 5.1.43
A variety of metabolites has been isolated from dictyoceratid sponges,44 and
a full review is beyond the scope of this report. In addition, the taxonomy
of the Dictyoceratida has been revised multiple times.43 The restructuring of
the phylogeny has resulted in taxonomic inconsistencies within the literature,
making a detailed review of dictyoceratid secondary metabolites problematic.
Order Dictyoceratida
Family Dysideidae
Family Irciniidae
Family Spongiidae
Family Thorectidae
Subfamily Phyllospongiinae
Subfamily Thorectinae
Figure 5.1. Taxonomic classification of the order Dictyoceratida, after Hooper
and van Soest.43
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Figure 5.2. Surface photo of the dictyoceratid sponge (courtesy of Peter North-
cote).
5.2 Terpenes from a dictyoceratid sponge
The sponge examined in this research (shown in Figure 5.2) was a soft, massive
sponge with large oscules and tented surface. It was dark grey on the surface with
a beige internal colour, somewhat slimy due to an exuded mucous. It contained
no silicaceous spicules, and has tentatively been identified as belonging to the
order Dictyoceratida.
Isolation of new metabolites
The sponge was collected from Dowd Rock, Tutukaka, New Zealand in Decem-
ber 2003. It was extracted in MeOH and cyclic loaded onto a reversed-phase
HP20 column. The column was eluted with increasing concentrations of Me2CO
in H2O. The 60% Me2CO in H2O fraction showed interesting NMR signals, in-
dicating one major compound. The sample was purifed on a silica gel column
eluted with CH2Cl2/MeOH mixtures to yield ∆18,20-isovariabilin (186) (struc-
ture shown on page 121).
NMR of the 100% Me2CO fraction also indicated the presence of one major
compound. A portion (400 mg) of this sample was subjected to chromatographic
separation on silica gel. Eluting in 100% pet. ether was 100 mg of the ubiquitous
linear furanosesterterpene furospinosulin-1 (187), first isolated from the sponge
Ircinia spinosula in 1972.191
O
187
118
The 100% CH2Cl2 fraction from the silica gel column was further purified on
silica gel, and finally on reversed-phase C18 HPLC eluted with MeCN/H2O to
yield two merosesquiterpene quinones 188 and 189.
Structure elucidation of ∆18,20-isovariabilin
The observation of a pseudomolecular ion by positive mode HRESIMS indi-
cated a molecular formula of C25H34O4 for ∆18,20-isovariabilin (186) (421.2354
[M + Na]+, ∆ 0.2 ppm), requiring nine double bond equivalents. Examination
of the 1H and 13C spectra revealed the presence of 25 distinct carbons and 33
of the 34 protons. The salient features of the NMR spectra were four olefinic
methyl singlets, three signals with chemical shifts consistent with a 3-substituted
furan ring, three trisubstituted double bonds and one oxymethine.
Three methines CH-1 (δC 142.6, δH 7.33), CH-2 (δC 111.2, δH 6.27), CH-4
(δC 138.9, δH 7.20) and one non-protonated carbon C-3 (δC 125.1) were charac-
teristic of a 3-substituted furan ring and showed COSY and HMBC correlations
supporting that assignment. Furthermore, coupling was observed between H-
4 and H2-5 in the COSY spectrum and between H2-5 and H2-6, allowing the
construction of the first fragment of 186, depicted in Figure 5.3.
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Figure 5.3. Key COSY and HMBC correlations establishing the furan moiety
of ∆18,20-isovariabilin (186).
Two signals showed unusual chemical shifts: methyl CH3-25 (δC 6.2, δH 1.72)
and the non-protonated carbon C-23 (δC 97.0). Together with the carbons C-24
(δC 177.3), C-22 (δC 174.7) and the oxymethine CH-21 (δC 75.6, δH 5.37), the
five signals were consistent with a 3-methyl substituted tetronic acid.192 HMBC
correlations from H3-25 to C-22, C-23 and C-24, and from H-21 to C-22, C-23
and C-24 supported this assignment.
Further HMBC correlations from H-21 to the olefinic carbon C-18 (δC 147.6),
olefinic methine CH-20 (δC 118.2, δH 4.97) and olefinic methyl CH3-19 (δC 23.8,
δH 1.78) placed a double bond adjacent to the tetronic acid moiety. The methyl
placement on the double bond was established through HMBC correlations from
H3-19 to C-20, C-18, and the carbon of CH2-17 (δC 32.2, δHa 2.16, δHb 2.10).
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Observation of a COSY correlation between H2-17 and the protons of CH2-16
(δC 26.5, δH 1.55) extended the partial structure, shown in Figure 5.4.
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Figure 5.4. Key COSY and HMBC correlations establishing the tetronic acid
moiety of ∆18,20-isovariabilin (186).
The remaining fragment of the structure was difficult to assign due to overlap
of several resonances in both the 1H and 13C spectra. Two olefinic methyls were
almost identical in chemical shift (δC 16.1, δH 1.58 and δC 15.9, δH 1.58) as were
two allylic methylenes (δC 39.7, δH 1.98 and δC 39.5, δH 1.98). These, as well as
two olefinic methines (δC 123.8, δH 5.15 and δC 124.8, δH 5.10) are typical signals
of an underivatized isoprene chain; together with the furan and tetronic acid
moieties they suggested 186 was a linear furanosesterterpene of the variabilin
class of compounds. The NMR data of the C-1 to C-16 fragment compared
favourably to literature values of related compounds;193 the connectivity of 186
was confirmed by HMBC correlations detailed in Table 5.1.
Due to spectral overlap, NOE enhancements were of limited utility in deter-
mining the geometry of the double bonds. Fortunately, methyl groups on isolated
trisubstituted double bonds of linear polyprene chains show characteristic NMR
shifts: δH <1.6 and δC <20 for the E, and δH >1.6 and δC >20 for Z geometry.
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Based on this, and the similarity of chemical shifts with related compounds, all
double bonds were assigned as E. The final structure of ∆18,20-isovariabilin is
given as 186.
Structure elucidation of two merosesquiterpene quinones
Analysis of the quinone 188 by positive ion mode HRESIMS gave rise to three
pseudomolecular ions: 365.2096, 397.2358 and 707.4269 indicating a molecular
formula of C22H30O3 ([M + Na]
+, ∆ 2.3 ppm; [M + MeOH + Na]+, ∆ 2.3 ppm;
[2M + Na]+, ∆ 1.9 ppm), requiring eight double bond equivalents. Twenty-two
distinct carbon resonances were observed in the 13C spectrum and the 1H spec-
trum accounted for all 30 protons required by the molecular formula. Analysis
of the 1H, 13C and HSQC-DEPT spectra revealed the presence of four olefinic
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Table 5.1. NMR data (600 MHz, CDCl3) for ∆18,20-isovariabilin (186).
δC mult
1JCH δH mult, COSY HMBC
pos. (ppm) (Hz) (ppm) J (Hz)
1 142.6 CH 203 7.33 t (1.6) 2, 4 2, 3, 4
2 111.2 CH 174 6.27 s 1, 4 1, 3, 4, 5
3 125.1 C - - - - -
4 138.9 CH 203 7.20 s 1, 2, 5 1, 2, 3, (5)
5 25.1 CH2 127 2.43 t (7.4) 4, 6 2, 3, 4, 6, 7
6 28.5 CH2 125 2.23 q (7.5) 5, 7, 9, (10) 3, 5, 7, 8
7 123.8 CH 150 5.15 t (7.3) 6, 9 5, 6, 9, 10
8 135.8 C - - - - -
9 16.1 CH3 122 1.58 s 6, 7 7, 8
10 39.7 CH2 123 1.98 t (7.5) (6), 11 7, 8, 9, 11
11 26.6 CH2 116 2.07 q (7.2) 10, 12, 14 8, 10, 12, 13
12 124.8 CH 152 5.10 t (6.9) 11, 14 14, 15, 16
13 134.5 C - - - - -
14 15.9 CH3 122 1.58 s 11, 12 12, 13
15 39.5 CH2 123 1.98 t (7.5) 16 12, 13, 14, 16, 17
16 26.5 CH2 125 1.55 quin (8.2) 15, 17a, 17b 13, 15, 17, 18
17a
32.2 CH2
125 2.16 dt (14.0, 8.0) 16, 17a 15, 16, 18, 19, 20
17b 125 2.10 t (7.8) 16, 17b 15, 16, 18, 19, 20
18 147.6 C - - - - -
19 23.8 CH3 124 1.78 s 20 (16), 17, 18, 20, (22)
20 118.2 CH 159 4.97 d (9.4) 19, 21 17, 19, 21, 22
21 75.6 CH 150 5.37 d (9.4) 20, 25 18, (19), 20, 22, 23, 24
22 174.7 C - - - - -
23 97.0 C - - - - -
24 177.3 C - - - - -
25 6.2 CH3 126 1.72 s 21 (20, 21), 22, 23, 24
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methyl singlets, five olefinic methines, an oxymethyl resonance and two carbonyl-
type resonances.
HMBC correlations from one of the methyl singlets (CH3-12: δC 25.9, δH 1.67)
to C-10 (δC 124.5, δH 5.09), C-11 (δC 131.5) and the carbon of another methyl
singlet (CH3-13: δC 17.8, δH 1.59) implied the presence of geminal methyls on
a trisubstituted double bond. Sequential COSY correlations from the olefinic
proton H-10 to H2-9 (δC 26.8, δH 2.05), and from H2-9 to H2-8 (δC 39.8, δH 1.98)
positioned two contiguous methylenes next to the double bond. Correlations
observed in the HMBC spectrum from the adjacent methylene H2-9 to C-10
and C-11 confirmed the placement of the two methyls CH3-12 and CH3-13 in a
geminal position at the terminus of the molecule.
CH2-8 showed HMBC correlations to
13C resonances attributed to another
trisubstituted double bond: C-7 (δC 135.6), the carbon of the olefinic methine
CH-6 (δC 123.9, δH 2.11) and the carbon of the methyl CH3-14 (δC 16.2, δH 1.59).
The proton chemical shift of CH3-14 was identical to that of CH3-13, making
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interpretation of their HMBC correlations difficult. As the C-8 to C-13 fragment
was already established through other means, any correlations observed from
δH 1.59 to signals not consistent with that fragment were attributed to CH3-14.
In that fashion, HMBC correlations to C-7, C-6 and C-8 allowed the placement
of the double bond next to CH2-8.
Two further methylenes (CH2-5: δC 26.5, δH 2.11; CH2-4: δC 39.8, δH 2.06)
were placed next to the double bond based on COSY correlations observed from
H-6 to H2-5 and from H2-5 to H2-4. The structure was unveiling itself again
as an isoprene chain; unsurprisingly HMBC and COSY correlations established
the presence of another trisubstituted double bond adjacent. The final isoprene
substructure (which accounts for three double bond equivalents) with key COSY
and HMBC correlations is presented in Figure 5.5.
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Figure 5.5. Key COSY and HMBC correlations establishing the isoprene por-
tion of 6-((2E,6E )-3,7,11-trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-quinone
188.
The remaining signals were two carbonyls C-1′ (δC 188.0), C-4
′ (δC 182.4),
an oxymethyl CH3-2
′-OMe (δC 56.4, δH 3.81), a double bond (CH-5
′: δC 133.0,
δH 6.45; C-6
′: δC 146.6) and a polarized double bond (C-2
′: δC 159.0; CH-3
′:
δC 107.3, δH 5.87), consistent with a 2,5-substituted p-quinone, which accounts
for the remaining five double bond equivalents required by the molecular formula.
This assignment was further supported by meta coupling (J = 2.0 Hz) observed
between the two methines.
The oxymethyl showed HMBC correlations to the polarized double bond C-2′
and C-3′, and was therefore placed as the 2′-substituent. NOE enhancements
between it and H-3′ confirmed the placement. C-6′ was established as the attach-
ment point to the rest of the isoprene chain based on allylic coupling between
H2-1 and H-5
′ observed in the COSY spectrum. This was further confirmed by
HMBC correlations from H-2 to C-6′ and from H-5′ to C-1 and observed NOE
enhancements between H-5′ and H-1 and H-2. The quinone moiety is depicted in
Figure 5.6, with more detailed COSY and HMBC correlations listed in Table 5.2.
The structure of 188 is therefore 6-((2E,6E )-3,7,11-trimethyl-2,6,10-dodeca-
trienyl)-2-methoxy-p-quinone. A review of the literature revealed that quinone
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Figure 5.6. Key COSY and HMBC correlations and NOE enhancements es-
tablishing the p-quinone moiety of 6-((2E,6E )-3,7,11-trimethyl-2,6,10-dodecatri-
enyl)-2-methoxy-p-quinone 188.
188 was first reported from a southern Australian sponge identified as Thorecta
choanides.195 Comparison of NMR data revealed them to be identical.
Table 5.2. NMR data (600 MHz, CDCl3) for 6-((2E,6E )-3,7,11-trimethyl-
2,6,10-dodecatrienyl)-2-methoxy-p-quinone 188.
δC mult δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1 27.3 CH2 3.13 br d (7.4) 2, 5
′ 2, 3, 1′, 5′, 6′ 2, 4, 15, 5′
2 117.8 CH 5.15 t (7.3) 1, 4, 15 1, 4, 15, 6′
3 140.3 C - - - - -
4 39.8 CH2 2.06 m 2, 5 2, 3, 5, 6, 15
5 26.5 CH2 2.11 q (6.9) 4, 6, 14 3, 4, 6, 7
6 123.9 CH 5.09 t (6.9) 5, 14 4, 5, 14
7 135.6 C - - - –
8 39.8 CH2 1.98 t (1.98) 9 6, 9, 14
9 26.8 CH2 2.05 m 8, 10, 13 8, 10, 11
10 124.5 CH 5.09 t (6.9) 9, 12 12, 13
11 131.5 C - - - - -
12 25.9 CH3 1.67 s 10 10, 11, 13 10, 13
13 17.8 CH3 1.59 s 9 10, 11, 12
14 16.2 CH3 1.59 s 5, 6 6, 7, 8
15 16.3 CH3 1.63 s 2 2, 3, 4 1, 4, 5, 5
′
1′ 182.4 C - - - - -
2′ 159.0 C - - - - -
3′ 107.3 CH 5.87 d (2.4) 5′, 2′-OMe 1′, 2′, 4′, 5′ 2′-OMe
4′ 188.0 C - - - - -
5′ 133.0 CH 6.45 q (2.0) 1, 3′ 1, 3′, 4′ 1, 2, 15
6′ 146.6 C - - - - -
2′-OMe 56.4 CH3 3.81 s 3
′ 2′, 3′ 3′
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During the purification of 188, a minor compound 189 which showed similar
NMR characteristics was also isolated. The pseudomolecuar ions observed in the
HRESIMS (365.2095 [M + Na]+, ∆ 0.5 ppm; 397.2341 [M + MeOH + Na]+,
∆ 3.5 ppm) suggested a molecular formula of C22H30O3, isomeric with quinone
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188. Examination of the 1H, 13C and HSQC-DEPT spectra revealed that the
majority of signals were very similar if not identical to the major compound 188,
allowing the construction of the same connectivity for the molecule. The main
difference was the chemical shift change of CH3-15, now at the more deshielded
chemical shift of δC 23.8, δH 1.76.
As previously mentioned, the methyl of a trisubstituted double bond with
Z geometry is more deshielded than one on an E double bond.194–196 This
implies that the minor quinone 189 is the 2Z -isomer of quinone 188. NOE
enhancements observed from H3-15 to H-2 (depicted in Figure 5.7) support
the assignment of the double bond as Z. The structure of the new compound
189 is therefore 6-((2Z,6E )-3,7,11-trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-
quinone, with full NMR data presented in Table 5.3.
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Figure 5.7. Key COSY and HMBC correlations and NOE enhancements es-
tablishing the p-quinone moiety and the Z configuration of the ∆2,3 double bond
of 6-((2Z,6E )-3,7,11-trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-quinone 189.
5.3 Variabilins
∆18,20-Isovariabilin (186) is a double-bond positional isomer of the known com-
pound variabilin (190), first reported by Faulkner in 1973 from the sponge Ircinia
variabilis.197 Variabilin was the first member of a group of sesterterpene tetronic
acids; since then, several geometric, stereo- and regioisomers have been reported,
and are reviewed by Liu et al.198
Most of the marine sesterterpene tetronic acids have a ∆20,21 double bond,
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and both E and Z isomers have been reported as for 190 and 191.193 Some
examples with the tetronic acid not further conjugated have been isolated, such
as palinurin (192) isolated from I. variabilis collected from the Mediterranean199
and the tetronic acid 193, from the Australian marine sponge Spongia sp.200
∆18,20-Isovariabilin (186) is unusual in that it possesses a ∆18,20 double bond.
Only one other example of a variabilin compound with a double bond in that
location has been reported: ircinic acid (194), isolated from a Fijian sponge of
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Table 5.3. NMR data (600 MHz, CDCl3) for 6-((2Z,6E )-3,7,11-trimethyl-
2,6,10-dodecatrienyl)-2-methoxy-p-quinone 189.
δC mult δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1 27.2 CH2 3.14 br d (7.7) 2, 15, 5
′ 2, 3, 1′, (4′), 5′, 6′ 2, 4, 5′
2 118.2 CH 5.14 t (7.2) 1, 15 1, 4, 15, (6′)
3 140.4 C - - - - -
4 32.2 CH2 2.04 m 5 2, 3, 5
5 26.7 CH2 2.10 q (7.0) 4, 6 3, 6, 7, 8
6 123.9 CH 5.09 t (6.7) 5, 14 (4), 8
7 135.6 C - - - - -
8 39.8 CH2 1.97 m 9 6, 7, 9, 10, 14
9 26.8 CH2 2.05 m 8, 10, 12 7, 11
10 124.5 CH 5.08 t (7.3) 9, 12 12, 13
11 131.6 C - - - - -
12 25.9 CH3 1.67 s 10 10, 11, 13
13 18.0 CH3 1.59 s 10, 11, 14
14 16.3 CH3 1.59 s 6 6, 7, 8
15 23.8 CH3 1.76 s 1, 2 2, 3, 4, 5 2, 4
1′ 182.4 C - - - - -
2′ 159.0 C - - - - -
3′ 107.4 CH 5.87 d (2.3) 5′, 2′-OMe 1′, 2′, 4′, 5′ 2′-OMe
4′ 188.0 C - - - - -
5′ 133.01 CH 6.47 q (1.9) 1, 5′ 1, 1′, 3′ 1, 2
6′ 147.0 C - - - - -
2′-OMe 56.5 CH3 3.81 s 5
′ (1′), 2′, 3′ 3′
O
O
MeO
1211
13
9
3
5
14
151'2'
4'
1
189
the genus Ircinia.192
Variabilin-type compounds exhibit a variety of biological activities, including
antiviral, cytotoxic and antimicrobial activities.194,198 As with many sponge-
derived compounds, they also show ichthyotoxic properties and therefore may
act to deter predators.198
Variabilin as a chemotaxonomic marker for the family
Irciniidae
Variabilin (190) and its various isomers are quite widespread, although the ma-
jority are reported from the genera Ircinia, Psammocinia and Sarcotragus (all
belonging to the familiy Irciniidae).198 An examination of New Zealand sponges
of the order Dictyoceratida revealed 190 to be the major component of 10 Ircinia,
Psammocinia and Sarcotragus extracts.201 Sesterterpene tetronic acids were not
detected in the other five dictyoceratid genera examined in that study. Based on
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the prevalence of furanosesterterpenes (especially variabilin and its analogues)
in irciniid sponges, Liu et al. propose variabilin and other variabilin-type com-
pounds as a chemotaxonomic marker for the family Irciniidae.202
5.4 Quinones
Terpenoid quinones and hydroquinones are quite common sponge metabolites,
with most examples possessing the drimane or 4,9-friedodrimane sesquiterpene
skeletons.92,203 Avarol (195) and avarone (196), isolated from the sponge Dysi-
dea avara in 1974, were the first examples of 4,9-friedo-rearranged drimanes.204
Since then, a myriad of related compounds has been isolated, most displaying
pronounced biological activity.203
The linear polyprenyl benzoquinones (and their corresponding hydroqui-
nones) that are thought to be the precursors of the more complex, cyclic quinone
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metabolites, have long been known from marine organisms. The most common
sources are brown algae of the order Fucales and sponges of the order Dictyocer-
atida, but a few examples have also been isolated from soft coral and ascidians.196
The marine sponges Ircinia muscarum and Dysidea pallescens were found
to contain the linear tetra- (197) and pentaprenylated (198) quinones respec-
tively.205,206 The higher homologues 199–201 were isolated from I. spinosula to-
gether with furospinosulin-1 (187).191 Subsequently a New Caledonian sponge,
Ircinia sp., yielded 197 and 198.207
The corresponding hydroquinones (quinols) (202–206) are almost always
co-isolated with the benzoquinones.191,200,205 Bonny and Capon, who first iso-
lated quinone 188, used silica gel for purification, co-isolating the corresponding
hydroquinone (207).195 Pouchus et al. suggest that the quinones are actually
artifacts of isolation, produced through oxidation of the hydroquinones on silica
gel.208 They examined a Tunesian Hippospongia communis sponge and isolated
the hepta- and octaprenyl hydroquinones 205 and 206 and the corresponding
quinones 200 and 201 through purification on silica gel. They found that on
re-injecting one of the hydroquinones onto a silica gel column, more of the cor-
responding quinone could be isolated.208
Two studies did not use silica gel for chromatography. Lumsdon et al. ex-
amined an extract of an Australian marine sponge of the genus Spongia using
size-exclusion choromatography and reversed-phase HPLC. They report the pres-
ence of tetronic acid 193 and the pentaprenylated hydroquinone 203.200 West
isolated the hexaprenylated hydroquinone 204 from a sponge identified as Sar-
cotragus sp., using only reversed-phase chromatography.127 The absence of the
corresponding pentaprenylated and hexaprenylated quinones (198, 199) in both
studies is noteworthy.
The majority of the linear polyprenyl quinones and hydroquinones isolated
have the more stable all E configuration of their double bonds. One example
with a Z geometry is the diprenylquinone 208, isolated with its E isomer 209
from an ascidian.196
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5.5 Concluding remarks
Terpenoid quinones are widespread in nature and include such essential com-
pounds as the vitamins K and the ubiquinones.191 They are utilized in photo-
synthesis and electron transport relays in biological systems because of the low
oxidation/reduction potentials of the hydroquinone/quinone interconversion.209
Silica gel, already implicated as a possible catalyst, may catalyze the ox-
idation of hydroquinones during their purification.208 If that is true, many of
the reported quinones, including compounds 188 and 189 isolated during this
study, may be isolation artifacts. Pouchus et al. recommend less reactive sta-
tionary phases such as DIOL for the purification of hydroquinones.208
Furano and lactone terpenes have been implicated as taxonomic markers of
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the Dictyoceratid and Dendrocaratid sponges.210 In a subsequent review, how-
ever, Erpenbeck and van Soest do not believe they are a suitable marker, as
such compounds have also been found from sponges of other orders.202 More
recently, the presence of variabilin and its analogues has been proposed as a spe-
cific chemotaxonomic marker for the dictyoceratid family Irciniidae.211 While
the vast majority of variabilin-type compounds have been found from Irciniidae
sponges, a few examples have also been reported from the other three Dictyocer-
atid families.198
Chemotaxonomy is fraught with pitfalls, including a clear bias in the lit-
erature towards reporting only new compounds, the possible symbiont origins
of metabolites, taxonomic misidentification, and sponge-sponge contamination
(such as that seen with the cyclostelletamines).202 Unless the presence of varia-
bilin-type compounds in the other three Dictyoceratid families is explained by
misidentification or sponge-sponge contamination, it seriously weakens the reli-
ability of the variabilins as a marker for the family Irciniidae. Nevertheless, the
preponderance of variabilin-type metabolites isolated from the family Irciniidae
suggests the sponge examined in this study may well be an irciniid.
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Chapter 6
The Oxeatamides: New
Nitrogenous Diterpenes from
Darwinella oxeata
6.1 Secondary metabolites reported from the
genus Darwinella
The Dendroceratida are one of the three orders of Demospongiae which lack
any siliceous spicules. The family Darwinellidae has a dendritic, fibrous spongin
skeleton instead. Four genera, found throughout the world, belong to this family:
Darwinella, Chelonaplysilla, Aplysilla and Dendrilla. Because of similar surface
morphologies and ranges of pigmentation, Darwinella species (especially small
specimens) are often confused with Aplysilla.43
Only seven new compounds have been reported from Darwinella sponges.
Examination of a hexane extract of D. oxeata resulted in the isolation of the por-
phyrin 210.212 The structure of this chlorophyll A derivative was solved through
X-ray diffraction and is the first example of a porphyrin isolated from a sponge.
A sponge identified as D. australensis has yielded three new sulfated sestert-
erpenes, the halisulfates 8–10 (211–213).213 Molecules of this class have previ-
ously been isolated from a taxonomically quite different halichondriidae sponge.
They have shown antimicrobial and cytotoxic activities.214
Finally, four diterpenes with a rearranged spongian diterpene skeleton have
been isolated from D. oxeata. They will be detailed in Section 6.4 together with
other metabolites of this class.
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6.2 The oxeatamides
Darwinella oxeata (see Figure 6.1 for taxonomy) is found frequently around New
Zealand rocky coasts. It is a bright yellow, encrusting sponge with a surface
marked by conules as shown in Figure 6.2. The common, thin, encrusting form
is often confused with Aplysilla sulphurea. D. oxeatea is soft, fleshy and slimy,
exuding a mucous when damaged. When removed from the water it rapidly
turns a dark red/brown to black colour, as do all sulfur-yellow dendroceratid
and verongid sponges.215
Order Dendroceratida
Family Darwinellidae
Genus Aplysilla
Genus Chelonaplysilla
Genus Darwinella
D. aurea (type species)
D. oxeata
Genus Dendrilla
Family Dictyodendrillidae
Figure 6.1. Taxonomic classification of D. oxeata, after Hooper and van
Soest.43
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Figure 6.2. Underwater photo of D. oxeata (courtesy of Kel Nairn).
Isolation of the oxeatamides
The bright yellow D. oxeata was collected from Port Hardy, D’Urville Island,
New Zealand in April 2000. It was extracted in MeOH, and the extracts were
cyclic loaded onto reversed-phase HP20 beads. The column was eluted with
increasing concentrations of Me2CO in H2O. Fraction 1 (20% Me2CO in H2O)
showed the presence of one major compound by NMR spectroscopy and was
further purified on a DIOL column (eluted with MeOH/CH2Cl2 mixtures). The
chromatographic separation was poor, with the major compound “streaking”
accross several fractions, but the 10% MeOH in CH2Cl2 fraction had the major
compound in sufficient purity for preliminary structure elucidation. The poor
chromatography and partial NMR data suggested the molecule contained one or
more carboxylic acids. Final purification was therefore achieved through HPLC
on a semi-preparative C18 reversed-phase column eluted with 70% MeOH/0.1 M
HCOOH. Oxeatamide A (214) was the major compound, with a retention time
of 21 minutes.
Fraction 2 from the cyclic loading (40% Me2CO in H2O) had NMR signals
characteristic of 214 together with related compounds, and was fractionated
on a DIOL column in a similar fashion. The 10% MeOH in CH2Cl2 fraction
was subjected to HPLC using identical conditions as described above. Three
fractions were collected, corresponding to oxeatamide B (217), oxeatamide A
(214), and iso-oxeatamide A (215) with retention times of 5–8, 21.0 and 25.1
minutes respectively.
Fractions that eluted after 214 from the HPLC injections (and showed fur-
ther interesting 1H NMR signals) were combinded, concentrated, and re-injected
onto the HPLC under the same conditions. This resulted in the isolation of
oxeatamide A 23-methyl ester (216) which had a retention time of 27.4 min.
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Structure elucidation of oxeatamide A
The observation of pseudomolecular ions by positive ion mode HRESIMS in-
dicated a molecular formula of C22H29NO5 for oxeatamide A (214) (388.2115
[M + H]+, ∆ 2.3 ppm; 410.1940 [M + Na]+, ∆ 0.9 ppm), requiring nine dou-
ble bond equivalents. Analysis of the 13C NMR spectrum revealed the presence
of 22 distinct carbons, and the 1H spectrum accounted for 27 of the 29 pro-
tons. The salient features of the 1H, 13C and HSQC-DEPT spectra were the
presence of three methyl singlets (one of which ahd an unusual, highly shielded
proton signal), six aromatic carbons, three carbonyls, and six methylenes. Most
of the methylenes had protons with significantly unequal chemical shifts (with
differences of up to 0.87 ppm) indicating chirality and/or restricted rotation.
The first spin system, a chain of three methylenes CH2-1 (δC 41.0, δHa 2.31,
δHb 1.44), CH2-2 (δC 20.1, δHa 1.80, δHb 1.44), and CH2-3 (δC 39.8, δHa 1.32,
δHb 1.27), was identified through COSY correlations between their respective
protons. A further (long range) COSY correlation was observed between H2-3
and the methyl H3-18 (δC 27.4, δH 0.40)
HMBC correlations observed from two of the methyl singlets H3-18 and H3-19
(δC 33.1, δH 0.91) to the same three carbons (δC 39.8, 31.9, 50.9) as well as to each
other’s carbons clearly established them as gem-dimethyls. Two carbons had a
chemical shift of 39.8 ppm (the methylene CH2-3 and the quaternary carbon
C-10), making assignment difficult. Observation of HMBC correlations from H-
3a, H-3b to the gem-dimethyls, as well as to δC 31.9 (C-4) and δC 50.9 (C-5),
however, clearly placed CH2-3 next to the gem-dimethyl moiety and established
the C-3/C-4 bond.
Observation of a correlation in the HMBC spectrum between the third methyl
singlet H3-20 (δC 32.9, δH 1.40) and C-5 extended the fragment further. H3-20
also showed a correlation to an aromatic carbon and δC 39.8, but this now
could not be the methylene CH2-3, as it was too far away. This correlation was
attributed to C-10, which had to be the attachment point of CH3-20. Finally,
an HMBC correlation from H3-20 to C-1 completed a cyclohexane ring, depicted
in Figure 6.3.
The presence of six sp2 carbons C-8 (δC 135.2), C-9 (δC 151.5), CH-11
(δC 127.8, δH 7.58), CH-12 (δC 122.7, δH 7.63), C-13 (δC 130.2), C-14 (δC 142.0)
suggested an aromatic ring, and the large (ortho) coupling constant of the two
aromatic methines (H-11 and H-12: J = 8.1 Hz) indicated a 1,2,3,4-tetrasub-
stituted benzene moiety. H-11, but not H-12, showed an HMBC cross peak to
δC 39.8 (which had to be C-10), establishing the C-9/C-10 bond and placing the
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Figure 6.3. Key COSY and HMBC correlations establishing the structure of
the cyclohexane ring of oxeatamide A (214).
cyclohexane ring ortho to CH-11. HMBC correlations from H3-20 and H-5b to
the aromatic carbon C-9 established the attachment of C-10 of the cyclohexane
ring to C-9 of the aromatic ring.
The fourth methyl CH3-17 (δC 15.5, δH 1.58) was a doublet, showing a COSY
correlation to the methine CH-7 (δC 40.9, δH 4.71). HMBC correlations from
H3-17 to C-7 and from H-7 to C-17 confirmed their attachment. Both proton
resonances also showed HMBC cross peaks to one of the ester/acid carbonyl
resonances C-6 (δC 179.2), establishing the C-6/C-7 bond. The HMBC spectrum
showed correlations from H-7 to the three aromatic carbons C-8, C-9 and C-14,
and from H3-17 to C-8, establishing the connection between C-7 and C-8 and
placing this substructure next to the cyclohexane ring on the aromatic ring as
shown in Figure 6.4.
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Figure 6.4. Key COSY and HMBC correlations extending the substructure of
oxeatamide A (214).
HMBC correlations from H-11 and H-12 allowed the assignment of the re-
maining aromatic positions. Although both protons showed correlations to all
four remaining non-protonated aromatic carbons, the strength of the correla-
tions was used as an indication of whether a carbon was two or three bonds
away. For HMBC experiments which are optimized for 8 Hz (the usual case),
aromatic systems show stronger three-bond than two-bond correlations, as their
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3JCH is about 7–8 Hz while
2JCH is only 1.0 Hz.
216 H-11 had strong (three bond)
correlations to C-8 and C-13, placing them meta to CH-11. Strong (three bond)
HMBC correlations from H-12 to C-9 and C-14 confirmed their assignments as
meta to CH-12. Both H-11 and H-12 showed HMBC correlations to carbonyl C-
16 (δC 169.4), placing it ortho to CH-12, while H2-15 (δC 50.2, δHa 4.40, δHb 4.31)
showed correlations to C-8 and C-9, establishing its connection to the aromatic
position C-14 (see Figure 6.5).
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Figure 6.5. Key HMBC correlations further extending the partial structure of
oxeatamide A (214).
A review of the literature at this point revealed that the proposed partial
diterpenoid skeleton has precedence in the literature. The chemical shifts of the
closely related membranolides217,218 (discussed further in Section 6.4) compared
favourably with the structure of oxeatamide A (214) constructed so far. None
of the known compounds contained a nitrogen, however.
A methylene, the nitrogen, a carbonyl, two oxygens and a proton remained
unaccounted for, as well as one degree of unsaturation. Methylene H2-22 (δC 43.8,
δHa 4.77, δHb 3.97) showed a strong HMBC correlation to the remaining carbonyl
carbon C-23 (δC 173.9), which was most likely an acid. Both methylene CH2-
22 and CH2-15 had unusually large
1JCH coupling constants (140–142 Hz, as
compared to 120–127 Hz for a standard methylene), suggesting attachment to a
heteroatom, most likely a nitrogen as the 1H and 13C chemical shifts were too
shielded for an adjacent oxygen. Both methylenes also showed correlations to
C-16 (δC 169.4), which suggested a tertiary amide in a five-membered ring. The
ring satisfied the final degree of unsaturation, and the nitrogen evidenced by the
molecular formula was confirmed through the observation of correlations from
H-15a, H-15b to N-21 in a 1H–15N HMBC experiment (see Figure 6.6). The
chemical shift of the nitrogen (δN −264.5
∗) was consistent with an amide.113
With the entire molecular formula except two protons, and all degrees of
∗15N chemical shift referenced to nitromethane (CH3NO2).
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Figure 6.6. Key HMBC correlations establishing the lactam moiety of oxeata-
mide A (214).
unsaturation accounted for, the final structure was proposed to be a di-acid. To
unequivocally confirm the presence of two acidic functionalities, a methylation
of 214 was undertaken. A portion of 214 was subjected to TMSCHN2, yielding
the expected dimethyl ester derivative of oxeatamide A (218). The 1H NMR
spectrum (Figure 6.7) showed the appearance of two new O-methyl signals as
expected, and HRESIMS confirmed C24H33NO5 as the new molecular formula
(416.2434 [M + H]+, ∆ 0.6 ppm; 438.2254 [M + Na]+, ∆ 0.7 ppm), confirming
the presence of the two carboxylic acids in 214. For the full NMR assignment
of oxeatamide A dimethyl ester (218) see Table 6.2.
Figure 6.7. 1H NMR spectrum (600 MHz, CDCl3) of oxeatamide A dimethyl
ester (218).
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Figure 6.8. 2D-NOESY spectrum (600 MHz, CDCl3) of oxeatamide A (214).
With the connectivity of 214 established, the question remained of the con-
figuration of CH-7 and C-10. To answer this, a 2D-NOESY experiment was run
on the compound, but surprisingly, all the enhancements were negative. The
sign and magnitude of an NOE is dependent on molecular tumbling rates, which
are affected by size and shape of the molecule, the solution conditions (viscosity,
temperature, pH etc.) and spectrometer strength.219 Generally, though, nega-
tive NOEs are only observed for larger (more slowly tumbling) molecules. The
observation of negative enhancements for oxeatamide A (established to have a
molecular weight of only 387) is therefore most unusual. Furthermore, closer
examination of the 2D-NOESY spectrum (Figure 6.8) revealed a plethora of
correlations, many of which (e.g. H-22a and H-22b showing multiple cross-peaks
to the cyclohexane ring protons) were at odds with the proposed structure.
Carboxylic acids exist largely as dimers in solution, due to the formation of
two strong hydrogen bonds in the dimeric form.220 As oxeatamide A (214) has
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two carboxylic acid functionalities and therefore has two sites for hydrogen bond
formation, it can quite feasibly form an extensive network. Such an oligomer
would explain the anomalous NOE enhancements observed: they are negative
because the hydrogen-bonded netwok is very large, and some correlations are in
fact inter -molecular enhancements.
To avoid this problem, a 2D-NOESY experiment was run on the dimethyl
ester derivative 218. Its NOE enhancements were all positive, as expected for
a molecule of its molecular mass: having no free carboxylic acid groups, oxe-
atamide A dimethyl ester (218) could not form a hydrogen-bonded, oligomeric
network.
The relative configuration of 218 and selected key NOE enhancement are
depicted in Figure 6.9. NOE enhancements between H3-18 and H-2a established
them in a 1,3-diaxial relationship. A further enhancement between H-2a and
H-11 indicated that the aromatic ring was also axial. The axial positioning of
the benzene ring has literature precedent, and explains the anomalous high-field
chemical shift (δH 0.42) of H3-18, which lies in the anisotropic shielding zone
of the aromatic ring.218,221,222 This resonance is a distinctive signature of these
types of 1-aryl-1,3,3-trimethylcyclohexane moieties.
NOE enhancements from H-3b to H-5b and H-1b placed them axially on
the other face, as shown in Figure 6.9. While some weak NOE enhancements
(e.g. H-1a to H-3a and H-5a) indicative of the other cyclohexane conformer were
observed, four long-range (W-coupling) correlations in the COSY (between H-1a
and H-5a; H-3a and H-5a, H-3b and H3-18 and H-5b and H3-18) established the
predominant conformer. In addition, H-1b (ddd 14.3, 12.2, 2.9 Hz) showed both
geminal coupling and large axial-axial coupling, as did H-2a (q 11.2 Hz) and
H-3b (ddd 12.8, 11.6, 4.2 Hz), supporting their axial positioning. Therefore the
relative configuration of C-10 is assigned as S ∗.
The configuration of CH-7 was assigned as R∗, based on observed NOE en-
hancements from H3-18 to H3-17, H-15a to H3-17, and from H-7 to and H3-20.
A 10S ∗ and 7R∗ configuration is consistent with previously reported metabolites
with this skeleton, discussed in detail in Section 6.4 and 6.6 below. The final
structure of oxeatamide A is therefore assigned as 214, with full NMR data
presented in Table 6.1.
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Figure 6.9. Key NOE enhancements of oxeatamide A dimethyl ester (218)
establishing the relative configuration. W-coupling is shown in red.
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Table 6.1. NMR data (600 MHz, CDCl3) for oxeatamide A (214).
δC/δN mult
1JCH δH mult, COSY HMBC
pos. (ppm) (ppm) J (Hz)
1a
41.0 CH2
127 2.31 d (13.9) 1b, 2a, 2b, 5a 10 (2, 5)
1b 127 1.44 dd (14.2, 2.7) 1a, 2a, 2b 2, 5, 10
2a
20.1 CH2
124 1.80 m 1a, 1b, 2b, 3a, 3b (1, 3)
2b 122 1.65 m 1a, 1b, 2a, 3a, 3b 1, 3, 4
3a
39.8 CH2
125 1.32 dt (12.8, 3.6) 2a, 2b, 3b, (5a) 1, 2, 4, 5, 18, 19
3b 123 1.27 td (12.6, 3.9) 2a, 2b, 3a, 17 1, 2, 4, 5, 18, 19
4 31.9 C - - - - -
5a
50.9 CH2
124 2.04 d (13.9) 1a, (3a), 5b 1, 10or3, 10, 4, (18)
5b 120 1.49 d (14.2) 5a, 18 (1), 4, 9, 10, 18, 19
6 179.2 C - - - - -
7 40.9 CH 120 4.71 q (7.2) 17 6, 8, 9, (13), 14, 17
8 135.2 C - - - - -
9 151.5 C - - - - -
10 39.8 C - - - - -
11 127.8 CH 159 7.58 d (8.1) 12, (15a) 8, (9), 10, 13, (14), 16
12 122.7 CH 160 7.63 d (8.1) 11, (15a) (8), 9, (11, 13), 14, 16
13 130.2 C - - - - -
14 142.0 C - - - - -
15a
50.2 CH2
142 4.40 d (16.5) (11, 12), 15b 8, (9), 13, 14, 16, 21
15b 142 4.31 d (16.5) 15a (8, 13), 14, (16), 21
16 169.4 C - - - - -
17 15.5 CH3 128 1.58 d (7.1) 7 6, 7, 8
18 27.4 CH3 124 0.40 s 5b, 19, (3b) 3, 4, 5, 19
19 33.1 CH3 125 0.91 s 18 (2), 3, 4, 5, 18
20 32.9 CH3 126 1.40 s - 1, 5, 9, 10
21 −264.5 N - - - - -
22a
43.8 CH2
140 4.77 d (18.1) 22b 15, (16), 23
22b 140 3.97 d (18.1) 22a 16, 23
23 173.9 C - - - - -
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Table 6.2. NMR data (600 MHz, CDCl3) for oxeatamide A dimethyl ester (218).
δC/δN mult
1JCH δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1a (eq)
41.0 CH2
124 2.35 d (14.2) 1b, 2a, 2b, (3a), 5a 1b, (2a, 2b, 3a, 5a), 11
1b (ax) 124 1.46 ddd (14.3, 12.2, 2.9) 1a, 2a, 2b
2a (ax)
20.0 CH2
124 1.84 qt (11.2, 3.6) 1a, 1b, 2b, 3a, 3b 1a, 2b, (3a), 11, 18
2b (eq) 123 1.68 dt (14.2, 4.6) 1a, 1b, 2b, 3a, 3b, 18
3a (eq)
39.7 CH2
125 1.34 dt (12.8, 3.6) (1a), 2a, 2b, 3b, (5a) 2
3b (ax) 122 1.27 ddd (12.8, 11.6, 4.2) 2a, 2b, 3a 2 (1b, 2a, 2b, 5b, 18, 19)
4 31.8 C - - - - - -
5a (ax)
50.7 CH2
125 2.07 d (13.8) 1a, (3a), 5b 1, 3, 4, (9, 13) 5b, 7, 17, 18. 19, (20)
5b (eq) 122 1.51 d (14.0) 5a, 18 9
6 174.7 C - - - - - -
7 40.7 CH 126 4.69 q (7.1) 17 6, 8, 9, (13), 14, 17 5a, 5b, 17, 20, 6-OMe
8 135.3 C - - - - - -
9 151.1 C - - - - - -
10 39.7 C - - - - - -
11 127.7 CH 160 7.64 d (8.2) 12 8, (9), 10, (12), 13, (14), 16 1a, 2a, 12, (20)
12 122.6 CH 166 7.71 d (8.2) 11 (8), 9, (11, 13), 14, 16 11
13 130.6 C - - - - - -
14 141.8 C - - - - - -
15a
49.9 CH2
143 4.50 d (16.5) 15b (7), 8, 9 (11, 12) 13, 14, 16, (22) 15b, 17, 22a, 22b
15b 142 4.14 d (16.5) 15a (7), 8, 9 (11, 12) 13, 14, 16, (22) 15a, 22a, 22b, (17), 6-OMe
16 168.6 C - - - - - -
17 15.6 CH3 127 1.61 d (7.1) 6 6, 7, 8
18 27.3 CH3 124 0.42 s (3b) 5b, 19 3, 4, 5, 19 2a, 3a, 3b, 5a, 17, 19
19 33.0 CH3 124 0.92 s 18 3, 4, 5, 18 (2b), 3a, 3b, 5a, 5b, (17), 18, 20
20 33.0 CH3 124 1.45 s 1, (2), 5, 9, 10 15a, 15b, 23-OMe
21 −267.6 N - - - - - -
22a
43.8 CH2
140 4.38 d (17.5) 22b 15, 16, 23
22b 140 4.36 d (17.5) 22a 15, 16, 23
23 169.6 C - - - - - -
6-OMe 52.5 CH3 149 3.65 s (22), 23
23-OMe 52.3 CH3 148 3.75 s 6, (7)
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Methylation with trimethylsilydiazomethane
Interestingly, examination of the NMR spectrum of the methylation reaction
revealed the presence of three minor by-products in addition to the expected
dimethyl ester derivative of oxeatamide A (218). After HPLC separation, the
three compounds were analyzed by NMR spectroscopy.
The 1H NMR spectrum of the first compound (Figure 6.10) had a new singlet
at 0.05 ppm, a new OMe signal at 3.64 ppm and two new AB doublets at 3.84
and 3.79 ppm. The 1H spectrum of the second compound (Figure 6.11) was
very similar, with a singlet at −0.18 ppm, an OMe signal at 3.75 ppm, and two
AB doublets at 3.71 and 3.75 ppm. The 1H spectrum of the third compound
(Figure 6.12) had both singlets at around 0 ppm, both AB doublet pairs and
neither of the OMe signals. The upfield resonances integrated for nine protons—
clearly they were TMS groups. The two AB doublets coupled to each other with
a coupling constant of 14 Hz, indicating they were a pair of methylene protons
with unequal chemical shifts. Their chemical shift indicated they were attached
to an oxygen. The OMe signals corresponded to one or the other of the OMe
resonances of 218. These data suggested the three compounds were the 6-methyl
ester, 23-trimethylsilylmethyl ester derivative (219), the 6-trimethylsilymethyl
ester, 23-methyl ester derivative (220), and 6,23-ditrimethylsilylmethyl ester
derivative (221).
Methylation by diazomethane is independent of solvent, proceeding via the
deprotonation of an acidic hydrogen by the diazomethane, and then SN2 at-
tack by the carboxylate oxygen (see Scheme 6.1).149 This is not the case for
TMSCHN2.
223 As can be seen in Scheme 6.2, the protic solvent participates in
the reaction through attack on the silyl group, generating the resonance stabi-
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Figure 6.10. 1H NMR spectrum (600 MHz, CDCl3) of oxeatamide A 6-methyl
ester, 23-TMSmethyl ester (219).
Figure 6.11. 1H NMR spectrum (600 MHz, CDCl3) of oxeatamide A 6-
TMSmethyl, 23-methyl ester (220).
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Figure 6.12. 1H NMR spectrum (600 MHz, CDCl3) of oxeatmide A 6,23-
diTMSmethyl ester (221).
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Scheme 6.1. Mechanism of carboxylic acid methylation with diazomethane.
lized diazomethane species in situ. The diazomethane then undergoes an SN2
attack by the carboxylate oxygen. The formation of 219–221 during the meth-
ylation reaction of oxeatamide A (which was done in dry CH2Cl2) confirms that
methanol or a similar protic solvent is in fact essential to successfully displace the
TMS group and to deliver the second proton equivalent. Without it, the TMS
group remains, the SN2 attack by the carboxylate oxygen happens regardless,
and the result is a TMSmethyl ester derivative instead of the expected methyl
ester.
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Scheme 6.2. Mechanism of carboxylic acid methylation with TMSCHN2, with
or without a protic solvent present.
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Structure elucidation of iso-oxeatamide A
Two pseudomolecular ions observed by positive ion mode HRESIMS (388.2131
[M + H]+, ∆ 1.8 ppm; 410.1949 [M + Na]+, ∆ 1.5 ppm) indicated a molecular
formula of C22H29NO5 for iso-oxeatamide A (215), suggesting it was a structural
isomer of oxeatamide A (214). The NMR features of 215 were almost identical
to that of 214, with three methyl singlets, six aromatic carbons, three carbonyls,
and six methylenes apparent as before. The only significant differences were
chemical shift changes of certain signals, for example the two aromatic protons
(H-11 and H-12) now resonated at δH 7.61 and 7.23 (compared to δH 7.58 and
7.63 for 214), the methyl doublet (H3-17) at δH 1.77 (compared to δH 1.58) and
the methine quartet (H-7) at δH 4.53 (compared to δH 4.71).
A cyclohexane ring was established in a similar manner to that of oxeata-
mide A. COSY correlations between H2-1 (δC 41.1, δHa 2.27, δHb 1.42), H2-2
(δC 20.2, δHa 1.80, δHb 1.66), and H2-3 (δC 39.9, δHa 1.31, δHb 1.26) established the
three contiguous methylenes. HMBC correlations from H3-18 (δC 27.3, δH 0.43)
and H3-19 (δC 33.1, δH 0.91) to each other as well as to C-3, C-4 (δC 31.9), C-5
(δC 51.0, δHa 2.10, δHb 1.49) established the gem-dimethyl moiety. The rest of
the cyclohexane ring was put together through further HMBC correlations from
H3-20 (δC 33.1, δH 1.32) to C-1, C-10 (δC 39.4) and C-5.
Once again, the two aromatic methines (CH-11: δC 130.4, δH 7.61; CH-12:
δC 121.4, δH 7.23) displayed a large ortho coupling (8.3 Hz), placing them next
to each other. An HMBC correlation from H3-20 to the aromatic carbon C-
9 (δC 146.8) and from H-11 to the quaternary alkyl carbon C-10 placed the
cyclohexane ring ortho to CH-11, as before. The methyl doublet H3-17 (δC 18.3,
δH 1.77) showed a COSY correlation to H-7 (δC 40.6, δH 4.53), and HMBC
correlations to C-6 (δC 181.0), C-7, and the aromatic carbon δC 139.4 (assigned
as C-8) suggesting the carboxylic acid functionality was also conserved.
All aromatic positions showed chemical shift differences from those of oxe-
atamide A (214), suggesting the structural difference was located nearby. The
aromatic carbons were assigned on the basis of HMBC correlations from H-11
and H-12. Strong (three bond) correlations from H-11 were observed to C-8 and
C-13. H-12 showed weak (two bond) correlations to C-8 and C-13, and a strong
correlation to C-9, supporting their assignment. Position C-14 (δC 130.4) was
assigned based on a strong HMBC correlation from H-12.
So far, the connectivity of iso-oxeatamide A (215) was identical to that of oxe-
atamide A (214). Instead of H-11 and H-12 showing correlations to a carbonyl
resonance (the amide carbonyl carbon of oxeatamide A), however, they corre-
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Figure 6.13. Key HMBC correlations and NOE enhancements establishing the
lactam orientation of iso-oxeatamide A (215).
lated to the methylene carbon which was therefore assigned as CH2-16 (δC 49.8,
δHa 4.37, δHb 4.28). Both proton resonances of CH2-16 showed weak HMBC cor-
relations to C-12 (whereas before they had correlated to C-8), supporting this
assignment.
The remainder of the molecule remained the same: the 1JCH of CH2-16 was
once again large, (142 and 144 Hz), suggesting attachment to the nitrogen, and
both H-16a and H-16b showed correlations to δC 170.0, now assigned as C-15,
implying the amide linkage was still there. HMBC correlations from the other
methylene CH2-22 (δC 44.5, δHa 4.78, δHb 3.75), to C-15, C-16 (weakly) and the
last carbonyl C-23 (δC 175.3) established the presence of the N -linked glycine
residue, as before.
Iso-oxeatamide A (215) is an isomer of oxeatamide A, with the amide func-
tionality in opposite orientation causing perceptable chemical shift differences for
CH-12, CH-7 and CH3-17. Final confirmation of this assignment was obtained
from a weak but clearly perceptable NOE enhancement from H-12 to H-16a and
H-16b (see Figure 6.13).
As with oxeatamide A, coupling constants and long-range W-couplings ob-
served in the COSY spectrum indicated the cyclohexane ring was again in the
same chair conformation with the aromatic ring axial. Although the NOEs ob-
served for 215 were once again negative, no inter-molecular enhancements were
apparent (perhaps due to a dilution effect). The NOE enhancements were con-
sistent with the relative configuration of 7R∗, 10S ∗ and so iso-oxeatamide A can
be assigned with some assurity as 215. Full NMR data for 215 are presented in
Table 6.3.
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Table 6.3. NMR data (600 MHz, CDCl3) for iso-oxeatamide A (215).
δC/δN mult
1JCH δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1a
41.1 CH2
126 2.27 d (14.8) 1b, 2b, (5a) (10) 1b, 11
1b 122 1.42 m 1a, 2a, (2b) (2, 3, 5, 10) 1a
2a
20.2 CH2
124 1.80 m 1b, 2b, 3a, 3b 11
2b 124 1.66 dd (10.0, 7.3) 1a, (1b), 2a 1, 3, 4, (10)
3a
39.9 CH2
126 1.31 m 2b, 3b 2, 4, 18, (19)
3b 124 1.26 td (11.3, 3.8) 2a, 3a, (18) 1, 2, 4, 18, (19)
4 31.9 C - - - - - -
5a
51.0 CH2
124 2.10 d (13.9) (1a), 5b 1, 3, 10, 20 5b, 7 18
5b 122 1.49 d (14.2) 5a, (18) 1, 4, 9, 10, 18, 19 5a, 7
6 181.0 C - - - - - -
7 40.6 CH 115 4.53 q (6.8) 17 6, 8, 9, 14, 17 5a, 5b, 17, 20
8 139.4 C - - - - - -
9 146.8 C - - - - - -
10 39.4 C - - - - - -
11 130.4 CH 158 7.61 d (8.3) 12 (1), 8, 10, 14, (16) 1a, 2b, 12
12 121.4 CH 166 7.23 d (8.2) 11 16 12
13 140.9 C - - - - - -
14 130.4 C - - - - - -
15 170.0 C - - - - - -
16a
49.8 CH2
144 4.37 d (16.0) 16b (12), 13, 14, (15) 16b
16b 142 4.28 d (16.0) 16a (9, 12), 13, 14, 15 16a
17 18.3 CH3 127 1.77 d (6.8) 7 7, 8 7, 18
18 27.3 CH3 123 0.43 s (3b, 5a) 3, 4, 5, 19 5a, 17, 19
19 33.1 CH3 124 0.91 s (5a) 3, 4, 5, 18 3b, 5b, 18
20 33.1 CH3 127 1.32 s 1, 5, 9, 10 7
21 a N - - - - - -
22a
44.5 CH2
140 4.78 d (17.5) 22b 22b
22b 139 3.75 d (18.3) 22a 15, 23 22a
23 175.3 C - - - - - -
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Structure elucidation of oxeatamide A 23-methyl ester
Positive-ion mode HRESIMS analysis of oxeatamide A 23 methyl ester (216)
gave rise to pseudomolecular ions indicative of a molecular formula of C23H31NO5
(402.2289 [M + H]+, ∆ 2.2 ppm; 424.2112 [M + Na]+, ∆ 2.8 ppm). Once
again, the NMR spectra of 216 were very similar to oxeatamide A (214); the
immediately obvious difference was the presence of a new OMe resonance at
δC 53.5, δH 3.73. The proposed molecular formula differs by 14 Da from that of
214, and can be accounted for by the additional oxymethyl.
In addition, the 1H chemical shifts of the H2-22 methylene pair had converged.
In oxeatamide A, the H2-22 pair is 0.80 ppm apart; in 216 they are an AB pair of
doublets separated by only 0.04 ppm. This sort of behaviour was seen previously
in oxeatamide A dimethyl ester (218), where H-22a is only 0.02 ppm away from
H-22b.
A very small (or no) chemical shift difference between the methylene protons
is to be expected if there is free rotation around the N-21/C-22 bond. The very
large difference observed for 214 is therefore highly unusual. It can be explained
by the dimerization of the C-23 carboxylic acid which would effectively stop free
rotation, placing H-22a and H-22b in very different environments. Methylation
of the acid disrupts this effect, as was seen for 218. These data suggested that
216 is the 23-methyl ester of oxeatamide A.
The majority of the molecule was identical to oxeatamide A, and was estab-
lished through a series of COSY and HMBC correlations, detailed in Table 6.4.
HMBC correlations from H-11 and H-12 to C-16, from H-15a to C-8, and the
almost identical chemical shifts of the molecule suggested the orientation of the
amide was as for 214, shown in Figure 6.14.
CH2-22 showed HMBC correlations to the amide carbonyl C-16, the methy-
lene C-15 carbon, and a third carbonyl, C-23 (δC 169.8). C-23 was further upfield
than in oxeatamide A (δC 173.9), consistent with esterification. The new OMe
resonance showed a strong HMBC correlation to C-23, confirming the structure
as oxeatamide A 23-methyl ester (216).
Compound 216 has nearly identical 1H and 13C chemical shifts to oxeata-
mide A (214) as well as similar (positive) NOE enhancements to oxeatamide A
dimethyl ester (218), consistent once again with the relative configuration of
7R∗, 10S ∗, as was established above. The final structure, therefore, is assigned
as oxeatamide A 23-methyl ester (216), with full NMR data presented in Ta-
ble 6.4.
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Figure 6.14. Key HMBC correlations establishing the orientation of the lactam
moiety and the methyl ester of oxeatamide A 23-methyl ester (216).
Table 6.4. NMR data (600 MHz, CDCl3) for oxeatamide A 23-methyl ester
(216).
δC/δN mult
1JCH δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1a
41.1 CH2
126 2.36 d (13.7) 1b, (2a), 2b, (5a) 1b, 11
1b 123 1.47 m 1a, 2a, 2b 1a, (11)
2a
20.1 CH2
125 1.83 m 1a, 1b, 2b, 3a, 3b 11, 18
2b 123 1.68 m 1a, 1b, 2a, 3a, 3b
3a
39.9 CH2
126 1.34 dt (12.8,4.1) 2a, 2b, 3b, (5a) 4, (5) 18
3b 123 1.28 td (12.3,3.9) 2a, 2b, 3a 1, 2, 4, 18 19
4 31.9 C - - - - - -
5a
50.9 CH2
124 2.07 d (13.8) (1a, 3a), 5b 1, 4, 10 5b, 7, 18, 19
5b 123 1.51 d (14.2) 5a, (18) (1), 4, 9, 10, 18 5a, 19
6 175.4 C - - - - - -
7 40.6 CH 120 4.74 q (7.5) 17 6, 8, 9, 14, 17 5a, 17, 10
8 134.7 C - - - - - -
9 151.1 C - - - - - -
10 39.8 C - - - - - -
11 127.8 CH 161 7.64 d (8.3) 12 8, (9), 10, 13, (14, 16) 1a, (1b), 2a, 12
12 122.8 CH 164 7.71 d (8.3) 11 (8), 9, 14, 16 11
13 130.7 C - - - - - -
14 142.0 C - - - - - -
15a
50.1 CH2
142 4.53 d (16.3) 15b (8, 13), 14, 16 15b, 17
15b 141 4.33 d (16.3) 15a 8, 13), 14, 16 15a
16 168.6 C - - - - - -
17 15.6 CH3 129 1.62 d (7.0) 7 6, 7, 8 7, 15a, 18
18 27.4 CH3 123 0.41 s (5b), 19 (1), 4, 5, 10, 19 2a, 3a, 5a, 17, 19
19 33.1 CH3 122 0.92 s 18 (1), 4, 5, 10, 18 3b, 5a, 5b, 18
20 33.0 CH3 128 1.46 s 1, 5, 9, 10 7
21 a N - - - - - -
22a
43.6 CH2
140 4.39 d (17.7) 22b 15, 16, 23
22b 140 4.35 d (17.6) 22a 15, 16, 23
23 169.8 C - - - - - -
23-OMe 52.5 CH3 148 3.73 s 23
anot observed
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Figure 6.15. Diode array trace from the HPLC separation of the oxeatamides.
Structure elucidation of oxeatamide B
Oxeatamide B (217) eluted quite early off the reversed-phase HPLC column,
streaking over several minutes (as can be seen in Figure 6.15). This immediately
indicated a significant difference somewhere in its structure, perhaps a basic
group that was charged under the acidic conditions of the HPLC. Compound
217 was sparingly soluble in CDCl3, showing several new, broadened resonances
(Figure 6.16).
A pseudomolecular ion was observed by positive ion mode HRESIMS indi-
cating a molecular formula of C25H34N3O3 for oxeatamide B (217) (424.2585
[M + H]+, ∆ 1.7 ppm), requiring 11 double bond equivalents. Inspection of
the 13C spectrum revealed the presence of only 24 carbons, two of them (in the
aromatic region) highly broadened. Suspecting some sort of solubility issue, the
solvent was changed to DMSO-d6, resulting in a significant sharpening of the
1H
resonances, as can be seen in Figure 6.17. The 13C NMR spectrum still showed
two broadened resonances, but all 25 carbons were now visible.
Analysis of the NMR spectra revealed that most signals were consistent with
the diterpene portion of oxeatamide A (214) as detailed in Table 6.5. The ma-
jority of the molecule was constructed similarly to oxeatamide A. COSY corre-
lations established three contiguous methylenes, while HMBC correlations from
the methyls established the gem-dimethyl moiety and allowed the construction
of the cyclohexane ring as before. Large ortho coupling of the aromatic methines
once again implied a 1,2,3,4-tetrasubstituted benzene ring moiety; HMBC cor-
relations allowed the placement of the aromatic carbons.
Figure 6.18 shows selected COSY and HMBC correlations that were used to
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Figure 6.16. 1H NMR spectrum (600 MHz) of oxeatamide B (217) in CDCl3.
Figure 6.17. 1H NMR spectrum (600 MHz) of oxeatamide B (217) in
DMSO-d6.
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construct the majority of oxeatamide B (217), the diterpene portion conserved
in all the oxeatamides. Once again, the presence of a lactam was confirmed
through observation of an HMBC correlation from H2-15 to N-21. The lactam
was placed in the same orientation as for oxeatamide A (214), based on observed
HMBC correlations from H-11 and H-12 to the amide carbonyl carbon C-16.
CH3
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H3C COOH
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Figure 6.18. Selected COSY and HMBC correlations establishing the diterpene
fragment of oxeatamide B (217).
The diterpene lactam accounted for 20 of the carbons, 26 of the protons,
the three oxygens, one of the nitrogens and eight degrees of unsaturation. The
remaining carbons and protons consisted of two methylenes (CH2-22: δC 41.8,
δHa 3.73, δHb 3.69; CH2-23: δC 26.0, δHa 2.82, δHb 2.78), two aromatic methines
(CH-26: δC 116.8, δH 6.82; CH-28: δC 134.9, δH 7.56), whose carbons were broad-
ened, and the aromatic carbon C-24 (δC 134.4). The two methylenes showed
COSY and HMBC correlations to each other, placing them adjacent to one an-
other. A correlation from H2-22 in the
1H–15N HMBC to N-21, as well as HMBC
correlations to C-15 and C-16 and large 1JCH coupling constants (138 Hz) indi-
cated CH2-22 was attached to the nitrogen of the lactam. Both methylenes also
showed HMBC correlations to the non-protonated aromatic carbon C-24. The
remaining two aromatic methines were singlets in the 1H spectrum, and showed
HMBC correlations to each other as well as C-24. The three aromatic carbons,
as well as the two nitrogens and three degrees of unsaturation that remained
unaccounted for suggested an imidazole moiety linked to the methylenes.
NMR data were in accordance with this proposal. H-26 and H-28 showed
COSY correlations to each other and HMBC correlations to C-28 and C-26 re-
spectively (see Figure 6.19). The chemical shifts were consistent with average
shifts reported for histidine residues in proteins,224 and 1JCH coupling constants
(188 and 210 Hz) were consistent with calculated and observed coupling con-
stants of imidazole rings.225,226
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Figure 6.19. Key COSY and HMBC correlations establishing the histamine
moiety of oxeatamide B (217).
The imidazole moiety can exist in several ionic and tautomeric forms, de-
picted in Scheme 6.3. This phenomenon may explain the distinct broadening of
the imidazole carbons seen in the 13C NMR spectrum of oxeatamide B (217),
and why N-25 and N-27 were not observed in the 1H–15N HMBC. This is not
unusual: of over 5000 histadine residues in the Biological Magnetic Resonance
Data Bank, only about 3% of the imidazole nitrogens’ chemical shifts were ob-
served.224
NH
H
N
NH
H
N
N
H
N
NH
N
H+ H+ H+ H+- -
Scheme 6.3. Ionic and tautomeric forms of the imidazole moiety.
A basic group like the imidazole is consistent with the behaviour observed
during HPLC, with the charged form of 217 eluting rapidly off reversed-phase
packing material under acidic conditions. Oxeatamide B is therefore assigned as
217, with a N -linked histamine group instead of a glycine.
Chemical shift considerations, proton coupling constants, W-coupling ob-
served in the COSY as well as NOE enhancements∗ were once again consistent
with a 7R∗, 10S ∗ configuration. The structure is therefore given as 217 with
NMR data presented in Table 6.5.
∗The NOE enhancements were again negative, most likely due to the viscous solvent
(DMSO-d6) reducing tumbling rates.
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Table 6.5. NMR data (600 MHz, d6-DMSO) for oxeatamide B (217).
δC/δN mult
1JCH δH mult, COSY HMBC NOE
pos. (ppm) (ppm) J (Hz)
1a
40.8 CH2
126 2.30 d (13.5) 1b, 2a, 2b, 5a (2, 5), 10 1b, 2a, 2b
1b 124 1.38 m 1a, 2a, 2b 2, 10, (20) 1a, 2a, 2b, 5b
2a
19.7 CH2
124 1.75 m 1a, 1b, 2b, 3 (1, 3, 4) 1a, 1b, 2b, 3
2b 124 1.61 m 1a, 1b, 2a, 3 1, 3, 10 1a, 1b, 2a, 5b
3 39.7 CH2 124 1.24 m 2a, 2b, (5a) 1, 2, 4, 5, 18, 19 2a, 2b, 5b, 19
4 31.4 C - - - - - -
5a
50.0 CH2
123 2.08 d (14.0) 1a, 5b, (3) 1, 4, (9), 10, (18), 19 5b, 7
5b 119 1.45 m 5a 1, 4, 9, 10, 18, 19 1b, 3, 5a
6 174.7 C - - - - - -
7 40.8 CH 123 4.55 q (7.1) 17 6, 8, 9, (13), 14, 17 5a, 17, 20
8 136.3 C - - - - - -
9 149.6 C - - - - - -
10 39.2 C - - - - - -
11 126.9 CH 159 7.56 d (8.3) 12 (1), 8, 9, 10, (12, 14), 16, 22 1a, 1b, 2a, 12
12 120.9 CH 165 7.49 d (8.1) 11 6, 8, 9, (10, 11, 13), 14, 22 11
13 131.0 C - - - - - -
14 141.8 C - - - - - -
15a
49.1 CH2
143 4.47 d (17.1) 15b 8, (9, 11, 12), 13, 14, 16, 21 15b, 17, 22a, 22b
15b 142 4.10 d (17.2 15a 8, (9, 11, 12), 13, 14, 16, 21 15a, 17, 22a, 22b
16 166.8 C - - - - - -
17 15.5 CH3 127 1.48 d (7.2) 7 6, 7, 8 7, 15a, 15b, 20
18 26.7 CH3 123 0.34 s - 3, 4, 5, 19 19, 20
19 32.9 CH3 124 0.89 s - 3, 4, 5, 18 3, 18
20 32.7 CH3 128 1.38 s - 1, (2, 4), 5, 9, 10 1, 18
21 −257.7 N - - - - - -
22a
41.8 CH2
138 3.73 dt (13.7,7.8) 22b, 23a, 23b 15, 16, 21, 23, 24 15a, 15b, 22b, 28
22b 138 3.69 dt (13.5,7.6) 22a, 23a, 23b 15, 16, 21, 23, 24 15a, 15b, 22a, 28
23a
26.0 CH2
127 2.82 dt (14.7,7.7) 22, 23b 21, 24, (26), 28 18
23b 127 2.78 dt (14.5,7.4) 22, 23a 21, 22, 24, (28) 28
24 134.4 C - - - - - -
25 a N - - - - - -
26 134.9 CH 210 7.56 br s 26 24, 26
27 a N - - - - - -
28 116.3 CH 188 6.82 br s 28 24, 28 22a, 22b
anot observed
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6.3 Biological activity
The oxeatamides were submitted for cytotoxicity and antimicrobial testing at
the School of Biological Sciences, VUW. They were tested in a 48 hour MTT
assay against HL-60 (leukemia) cells, but were inactive up to 10 µM.227 Results
suggest they may be active above the 10 µM threshold tested, but an IC50 was
not determined.
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Oxeatamide A (214), iso-oxeatamide A (215) and oxeatamide B (217) were
also tested for antimicrobial activity againstMycobacterium smegmatis MC2155.
They showed good activity with IC50 values of 15.1 µM, 61.2 µM, and 11.8 µM
respectively.228
6.4 The aplysulphuranes
Spongian metabolites (compounds possessing the basic spongian skeleton) are
common and often biologically active metabolites of sponges of the orders Dic-
tyoceratida and Dendroceratida.229 A plethora of related metabolites has been
isolated, possessing varying levels and patterns of oxygenation. Dictyoceratid
and Dendroceratid sponges are two orders that do not produce any silicaceous
spicules, which often makes their taxonomic identification problematic. The two
orders do show certain trends in the type of spongian diterpenes they produce,
making chemotaxonomy a valuable tool in the taxonomic assignment of these
sponges.229
The largest group of spongian diterpenes are ones that have undergone some
kind of skeletal rearrangement. For example, a Nametkin shift∗ of the angular
C-17 methyl, followed by oxidative cleavage of the C-5/C-6 bond, leads to the
aplysulphurane skeleton, as depicted in Scheme 6.4.229 Aplysulphurane metabo-
lites have only been found from sponges of the order Dendroceratida.229,231
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Scheme 6.4. Proposed biogenesis of the aplysulphurane skeleton, adapted from
Karuso et al.221
∗the specific 1,2-Wagner-Meerwein shift of a methyl group230
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The first aplysulphurane to be isolated was aplysulphurin (222) by Karuso
et al. from a Dendroceratid sponge identified as Aplysilla sulphurea collected in
eastern Australian waters.221 Its structure was determined by NMR spectroscopy
and confirmed by X-ray crystallography. Compound 222 contains an aromatic
ring, an unusual feature in terpenoids, seen again in macfarladins A and B (223,
224), the first aromatic norditerpenes described from marine sources.232
In a subsequent publication233 Karuso et al. report the isolation of 222 as
well as three tetrahydroaplysulphurin isomers (225–227) from the same sponge
species (collected in New Zealand), now identified as Darwinella oxeata. Com-
pounds 225–227 do not possess an aromatic ring, but a single olefin in various
positions. The proposed biogenesis shown in Scheme 6.4 suggests the “default”
location for the double bond is between positions 8 and 9, and indeed, that motif
appears multiple times as in the cadlinolides A–D (228–231).234,235
Cadlinolide A and B (228, 229) were isolated from the marine sponge
Aplysilla glacialis collected off the coast of British Columbia, Canada. Com-
pounds 228, 229 as well as 222 were also isolated from specimens of the nudi-
branch Cadlina luteomarginata found grazing on the sponge.234 Keyzers et al.
examined the New Zealand sponge Chelonaplysilla violacea, isolating cadlino-
lides C and D (230, 231). Compound 231 is the methyl acetal version of 229,
and may be an artifact of isolation (as the sponge was extracted in MeOH).235
C. violacea also yielded pourewic acid (232), 15-methoxypourewic acid B
(233) and the isomeric methyl ester of pourewic acid B (234).235 Concurrently
with the New Zealand study of C. violacea, Dı´az-Marrero et al. report the iso-
lation of 230, 232 and compound 235 from the Antarctic sponge Dendrilla
membranosa.231 NOE data collected by Dı´az-Marrero et al. for 232 is consistent
with the 15S structure depicted, rather than the 15R configuration proposed
by Keyzers et al.231,235 The presence of a free C-17 carboxylic acid in pourewic
acid (232) and 15-methoxypourewic acid B (233) lends credence to the pro-
posed biogenesis of the aplysulphuranes, which suggests a free carboxylic acid
intermediate.
Molinski and Faulkner had previously examined D. membranosa, isolating
the mildly antibacterial membranolide (236) whose aromatic ring harks back to
aplysulphurin (222).217 Subsequently, Ankisetty and co-workers report the isola-
tion of further aromatized aplysulphuranes, the membranolides B–D (237–239)
from another collection of D. membranosa.218 The acetal functional groups of
237–239 were not prone to hydrolysis, and were not artifacts of isolation. Mem-
branolides C and D showed modest but broad spectrum antibacterial activity.218
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6.5 Nitrogenous terpenes
An abundance of nitrogenous terpenes has been isolated from marine inverte-
brates and their predators.236 The majority of them, however, are isocyanides
and the related isothiocyanides, thiocyanates, isocyanates, formamides and the
(uniquely marine) dichloroimines. Many of the isocyanide terpenes are isolated
together with their corresponding isothiocyanates and formamides. The first
examples were axisonitrile-3 (240) and axisothiocyanate-3 (241), isolated from
the sponge Axinella cannabina, followed by the formamide axamide-3 (242).237
More recently, the isocyanate version 243 has also been reported from the sponge
Acanthella cavernosa.238 Such frequent co-isolation has led researchers to pro-
pose a common biosynthetic pathway for these functional groups, and indeed,
incorporation experiments with radio-labelled compounds have established that
inorganic cyanide is the common precursor of various isocyano, isothiocyanato,
thiocyanato and dichloroimine metabolites.236
Amino acid derived nitrogenous terpenoids
For some terpenes the source of nitrogen is not easy to determine; for many,
however, amino acids seem a likely precursor. As the boneratamides A–C (244–
246)∗ share the same sesquiterpenoid fragment with axisonitrile-3 (240) and
related compounds,239 the nitrogen at position 16 most likely comes from inor-
ganic cyanide. The remaining nitrogenous portion is proposed to be of amino
acid origin.239
R
240 R = NC
241 R = NCS
242 R = NHCHO
243 R = NCO
N
H
N
O
O
COOH
16
244
N
H
N
O
O
COOH
16
245, 246
∗Boneratamides B and C differ in the relative configuration at one or both of the positions
indicated.
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NROAc OAc CHO
CHO
247 R = dcIle
249 R = dcVal
250 R = dcPhe
251 R = dcGly
252
dcPhe =dcIle = dcVal =
(decarboxylated isoleucine) (decarboxylated valine) (decarboxylated phenylalanine)
NOAc N OAc
248
Molliorins A–E (247–251) are scalarin-like pyrroloterpenes isolated from the
sponge Cacospongia mollior.240–243 They are proposed to originate from a ses-
terterpenoid intermediate (for example scalaradial (252)244) and an amino acid
precursor: decarboxylated isoleucine, valine, phenylalanine and glycine for 247,
249, 250 and 251 respectively. The central portion of the dimer molliorin B
(248) is thought to come from ornithine (2,5-diaminopentanoic acid, a metabo-
lite of the amino acid arginine in the urea cycle).241
The sarcotrines, isolated from a marine sponge of the genus Sarcotragus,
are another class of nitrogenous sesterterpenes, closely related to such furano
compounds as sarcotin A (253) and the variabilin-type compounds previously
discussed in Section 5.3 on page 124. In place of the furan the sarcotrines
have a lactam moiety, substituted at the nitrogen with a decarboxylated leucine,
phenylalanine or isoleucine, as well as the sodium salt form of the amino acid
glycine.245,246
The tetronic acid moiety of sarcotrines A–C (254–256) is quite labile and
epimerizes easily at C-21, giving rise to the epi -sarcotrines A–C (257–259).246
Quite often, both types of lactam ring (α- and β-substituted) are present, as
in the pairs sarcotrine A (254) and sarcotrine D (260), sarcotrine E (261) and
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isosarcotrine E (262), and sarcotrine F (263) and isosarcotrine F (264).
Complete degradation of the tetronic acid could explain sarcotrine F (263)
and isosarcotrine F (264), highly unusual C24 norsesterterpenes. Their presence
supports the biogenetic hypothesis that C21 furanoterpenes are derived from
sesterterpenes, with C24 norsesterterpenes being the first step in the degradation
process.245 The trisnorsesterterpenes sarcotragins A and B (265, 266)247 may
be further degradation products.
The sarcotragins and sarcotrins may be biosynthesized from a furan precursor
through attack by an amino acid derivative. Such a biocatalytic transformation
from furan to amide was performed on the (previously mentioned) linear fura-
nosesterterpene palinurin (192). The fungus Cunninghamella sp. NRLL 5695
was able to bioconvert 192 to palinurine A and B (267, 268), whose nitroge-
nous moiety (2-aminoethanol) can be considered decarboxylated serine.199 Both
electron-deficient oxymethine carbons of the furan ring are vulnerable to nucle-
ophilic attack, giving rise to two possible products: the α- and β-substituted
lactam rings already seen for the sarcotrines.246
This biogenetic mechanism may explain the formation of other nitrogenous
terpenes. The sesquiterpene pyrodysinoic acid (269), isolated from a Dysidea
sponge,121 can conceivably be formed from the common metabolite furodysin (86)
and the amino acid glycine. Haumanamide (270) and the related spongolactams
A–C (271–273) were isolated from a sponge of the genus Spongia, together with
a possible precursor: the known spongia-13(16),14-dien-19-oic acid (274).248,249
Haumanamide (270) is active against KB cancer cells (MIC 5 µ/mL) and LoVO
(colon cancer) cells (MIC 10 µ/mL),248 while the spongolactams inhibited the
farnesyl transferase enzyme and also show cytotoxicity against a human tumour
cell line.249 To the best of our knowledge, apart from the oxeatamides compounds
270–273 are the only nitrogenous spongian diterpenes reported.
6.6 Biogenesis and proposed absolute configu-
ration of the oxeatamides
The oxeatamides are new members of the aplysulphurane family of rearranged
spongian diterpenes. Their relative configuration was assigned based on observed
NOE enhancements as 7R∗, 10S ∗ consistent with various other aplysulphurane
compounds whose relative configurations have been established through a com-
bination of single crystal X-ray diffraction analysis,221,234,250,251 conformational
studies,231 NMR data,217,218,221,235 or chemical degradation experiments.217
161
O
O
OH
O
21
253
RN O
O
OH
O
254 R = dcLeu
255 R = dcPhe
256 R = dcIle
RN
O
OH
O
O
260 R = dcLeu
RN O
O
OH
O
257 R = dcLeu
258 R = dcPhe
259 R = dcIle
261 R = GlyNa
RN
O
OH
O
O
262 R = GlyNa
RN O
OH
OH
O
263 R = GlyNa
RN
OH
OH
O
O
264 R = GlyNa
RN O
OH
OCH3
O
265 R = dcPhe
266 R = GlyNa
dcPhe =dcLeu = dcIle = GlyNa = COONa
(decarboxylated phenylalanine) (decarboxylated isoleucine)(decarboxylated leucine)
162
O O
OH
O
192
N O
OH
O
HO O
267
N O
OH
O
O
HO
268
N
O
COOH
269
O
H
H
86
NR
O
HOOC H
H
NR
HOOC
O
H
H
O
HOOC H
H
270 R = dcPhe
271 R = dcHis
273 R = Gly
272 R = dcHis 274
dcPhe = Gly = COOHdcHis =
N
H
N
(decarboxylated phenylalanine) (decarboxylated histidine)
163
NR
COOH
O
214 R = Gly
217 R = dcHis
275 R = CH2CH2NH2
276 R = dcVal
277 R = dcPhe
278 R = dcIle
279 R = dcLeu
dcPhe =
Gly = COOH dcHis =
N
H
N
dcVal =
dcIle = dcLeu =
(decarboxylated phenylalanine) (decarboxylated isoleucine) (decarboxylated leucine)
(decarboxylated histidine) (decarboxylated valine)
The conservation of the chirality at those centres in multiple aplysulphu-
ranes lends support to the proposed biogenetic mechanism from the spongian
precursor. The proposed mechanism (Scheme 6.4) does not involve the centre at
C-10 at all, which should therefore be identical (that is S ) to that of the spon-
gian precursor.231 Additionally, the stereospecific Nametkin shift of the CH3-17
methyl and the subsequent oxidative cleavage of the C-5/C-6 bond results in an
R configuration at C-7. Therefore the absolute configuration of the oxeatamides
is proposed to be 7R, 10S, as has been established for various spongian and re-
lated compounds.229 Degradation reactions or total synthesis, however, will be
necessary for unequivocal proof.
The unusual nitrogenous portion of the oxeatamides is most likely amino
acid derived. For oxeatamide A (214) it is from the amino acid glycine, while
for oxeatamide B (217) it is decarboxylated histadine (histamine). Recent work
by Dowle supports this theory: further investigation of D. oxeata has resulted
in the isolation of oxeatamide A (214), iso-oxeatamide A (215), oxeatamide B
(217), membranolide C and D (238, 239) as well as the new oxeatamides C–G
(275–279).252 Their nitrogenous moieties are 1,2-diaminoethane, 2-methylpro-
pan-1-amine, 2-phenylethylamine, 2-methylbutan-1-amine and 3-methylbutan-
1-amine respectively. For 276–279, the nitrogenous portions can be considered
decarboxylated valine, phenylalanine, isoleucine or leucine respectively. The
origin of the 1,2-diaminoethane moiety of 275 is more difficult to determine.
The existence of iso-oxeatamide A (215), the isomer of oxeatamide A (214)
with the lactam in the other orientation, is in concordance with previously iso-
lated, nitrogenous terpenes of mixed biogenesis. Such isomeric pairs have been
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seen with the sarcotragins and sarcotrins, and also with spongolactam A and B
(271, 272). El Sayed et al. propose they arise through a nucleophilic attack of
an amino acid derivative on either of the methine carbons of a furan ring, lead-
ing to two possible isomers.229,246 As depicted in Scheme 6.5, the nucleophilic
attack results in the formation of an aldehyde intermediate, which on subsequent
cyclization and oxidation leads to the formation of the lactam.
O N R
H
H
N
O
H
N
OH
R R
N
O
R
[O]
Scheme 6.5. Proposed mechanism for the formation of the lactam moiety,
adapted from El Sayed et al.199
An alternate biogenetic pathway is depicted in Scheme 6.6 below. The furan
precursor may be oxidized by singlet oxygen to γ-hydroxy butenolide, which
contains a masked aldehyde. Imine formation with an appropriate amino acid
derivative, followed by reduction and subsequent amide formation leads to the
five-membered lactam ring.
O O
O
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O
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H
OH
O
O
H2NR
H
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R
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R
1O2*
Scheme 6.6. Alternative biogenetic pathway for the formation of the lactam
moiety.
Although no furan-containing aplysulphuranes have been found to date, sev-
eral metabolites of spongian skeleton with a furan D-ring have been isolated.229
Such a spongian furan may undergo oxidation, followed by aromatization of the
C-ring and skeletal rearrangement to give a putative oxeatamide precursor (the
aromatized version of compound 228). This may then follow a similar route
(Scheme 6.7) to give the oxeatamides.
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Scheme 6.7. Proposed biogenetic mechanism for the formation of the lactam
of the oxeatamides.
6.7 Concluding remarks
Sponges of the orders Dictyoceratida and Dendroceratida often produce spongian
diterpenes. The aplysulphurane skeleton is one example of a rearranged spon-
gian backbone, with aplysulphurane metabolites only reported from dendrocer-
atid sponges. Examination of the New Zealand dendroceratid sponge D. oxeata
yielded four new aplysulphurane metabolites, which contained two unusual fea-
tures: an aromatic ring (rarely seen in terpenes) and an N -substituted lactam
moiety.
The oxeatamides also all possess a carboxylic acid at C-6, and so lend fur-
ther weight to the proposed biogenetic pathway of the aplysulphurane skeleton,
which proceeds through an oxidative cleavage of the C-5/C-6 bond. In solu-
tion, these carboxylic acids dimerize; in the case of oxeatamide A (214) and
iso-oxeatamide A (215)—which possess a second carboxylic acid as part of the
nitrogenous moiety—they may even form larger, hydrogen-bonded, oligomeric
networks. As a consequence, the compounds 214 and 215 display negative
NOE enhancements.
The majority of nitrogenous terpenes reported are isocyanides and related
compounds; inorganic cyanide has been shown to be the common precursor of
their nitrogen. The oxeatamides are therefore unusual in that the nitrogenous
moiety is proposed to arise from nucleophilic attack of an amino acid derivative
onto one of the methine carbons of a furan ring. The oxeatamides are therefore
one of the few examples of compounds of mixed terpene/amino acid origins.
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Chapter 7
Conclusion
Natural products have played a major role in the development of medicine and
remain the major source of new pharmaceutical lead compounds. The oceans,
still mostly unexplored, have high biological diversity which makes them a lu-
crative bioprospecting environment.
Nudibranchs are known to sequester defensive metabolties from their prey,
and this “preconcentration” by the nudibranch can lead to rapid isolation of the
main constituents by the natural product chemist. Indeed, this study resulted
in the isolation (often within one or two chromatographic steps) of a range of
secondary metabolites. The majority of the compounds have previously been
reported in the literature, although this is the first time, to our knowledge, a
polymeric 3-alkyl pyridinium salt has been described from a nudibranch. Other,
less common New Zealand nudibranch species may also be worthy of chemical
investigation.
A method to monitor chromatographic separation of compounds is essential
for their efficient isolation and purification. In this study, the use of MS was
found to be a useful, alternate monitoring method when separating related gly-
colipid congeners which did not have a chromophore. It resulted in the isolation
of five members of a novel family of glycolipids from the marine sponge Raspailia
agminata, the first reported glycolipids from the genus Raspailia.
While the most common strategy for screening organisms and guiding isola-
tion remains bioassay, for a number of years the Marine Natural Products Group
at Victoria University has used an NMR based screening method in order to iden-
tify promising organisms worthy of further investigation. This method has been
extended during the course of this research: a computer program was developed
to facilitate the analysis of HSQC spectra of crude sponge extracts and aid in the
identification of the presence of interesting secondary metabolites. The use of the
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digital mask program successfully identified several sponges showing interesting
and unusual correlations in the HSQC spectrum of their crude extract. Two
of those sponges were investigated in detail, resulting in the isolation of some
known and a series of new metabolites further validating the utility of NMR in
natural product discovery. Scope for further development of the digital mask
program includes implementing pattern recognition for early-stage dereplication
of known compounds in crude sponge extracts.
The compounds isolated were not particularly active in a general cytotoxicity
assay, however cytotoxicity is only one of many possible biological activities.
The celluar target of the compounds is yet to be determined; biological activity
testing is ongoing.
The real future of biological activity testing lies in genome-wide screening
systems such as the yeast single deletion set assay and similar cell-based assays
which are currently gaining popularity over single-target bioassays. These high
content screening systems are now maturing and libraries of pure natural prod-
ucts, regardless of reported bioactivity, are sought after. The metabolites isolated
in this research therefore contribute to the feedstock for these new techniques.
Several of the compounds are currently awaiting chemical genetics screening at
the School of Biological Sciences, VUW.
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Chapter 8
Experimental
8.1 General experimental
NMR spectra were obtained using either a Varian Unity Inova 300 (300 MHz
for 1H and 75 MHz for 13C), or a Varian DirectDrive 600 (600 MHz for 1H
and 150 MHz for 13C) equipped with a Varian inverse-detected triple resonance
HCN probe operating at 25 K. 1H and 13C chemical shifts (δ) were internally
referenced to the residual solvent peak,253 15N chemical shifts were externally
referenced to nitromethane (CH3NO2) as 0 ppm. HRESIMS were run on either
a PE Biosystem Mariner 5158 TOF or a Micromass Q-TOF Premier mass spec-
trometer. MALDI-TOF analysis was performed using an Applied Biosystems
DePro MALDI-TOF mass spectrometer. Optical rotations were performed on
a Perkin-Elmer 241 polarimeter. UV spectra were recorded on a Varian Carey
100 Scan UV-visible spectrophotometer.
All solvent mixtures for chromatography are reported as % v/v. HPLC
and MPLC was performed on a Rainin Dynamax SD-200 HPLC system with
25 mL pump heads, equipped with a Varian ProStar 335 Diode Array detec-
tor. All organic solvents used were HPLC grade and H2O was glass-distilled and
deionised using a MilliQ system. Normal phase HPLC was performed using a
Rainin Instrument Microsorb-MV analytical (4.6 × 250 mm, 5µ) or a Dynamax
semi-preparative (10 × 250 mm, 8µ) silica column, or a custom-packed Phe-
nomenex analytical DIOL column (5.0 × 250 mm, 5µ). Reversed-phase HPLC
was performed using Phenomenex Prodigy C18 analytical (4.6 × 250 mm, 5µ)
or semi-preparative (10 × 250 mm, 10µ) columns.
Normal phase flash chromatography was carried out using Kieselgel 60 (230–
400 mesh ASTM) silica gel or YMC Co. Ltd. DIOL chromatographic resin.
Reversed-phase chromatography was carried out using Supelco Diaion HP20
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and HP20SS PSDVB chromatographic resin. Size exclusion chromatography
was performed using Sephadex LH-20. All solvents used for benchtop chromato-
graphy were glass distilled. All other reagents were purchased commercially (at
least reagent grade) and distilled prior to use when necessary.
TLC analyses were performed using Machery-Nagel Alugram Sil G/UV254
plates. The plates were analysed by (1) fluorescence quenching under UV light
(λ = 254 nm), (2) dipping in 5% H2SO4 in MeOH then heating, (3) dipping
in 5% H2SO4 in MeOH, dipping in 0.1% vanillin in EtOH and heating, or a
combination of the above.
8.2 Isolation of cembranoid diterpenes from the
nudibranch T. incerta and the soft coral A.
aurantiacum
Nineteen T. incerta individuals were collected by hand using SCUBA from Rau-
homaumau Island, Tutukaka, New Zealand (35◦ 37.5′ S, 174◦ 32.9′ E) in Decem-
ber 2003. The specimens were frozen immediately and stored at −18 ◦C until
extraction.
The nudibranchs (41 g wet weight) were extracted whole twice overnight with
MeOH (100 mL). The extracts were cyclic loaded∗ onto a 40 mL HP20 column
(2 × 12 cm). The column was then washed with H2O (120 mL) and eluted with
120 mL fractions as follows: (1) 30% Me2CO/H2O, (2) 75% Me2CO/H2O, and
(3) Me2CO.
Fraction 2 was backloaded∗ onto a 20 mL HP20 column (2× 6 cm), and eluted
with 60 mL Me2CO. The eluent was concentrated under reduced pressure. The
resulting material (90 mg) was separated chromatographically in two portions
by adsorbing onto 2 mL of DIOL and dry-loading onto a 20 mL DIOL column
(1.3 × 17 cm). The column was eluted with 80 mL volumes of: pet. ether,
10%, 20%, 30%, 40%, 50% CH2Cl2 in pet. ether, CH2Cl2 and finally with 50%
MeOH/CH2Cl2. Fractions eluted with pet. ether were combined based on TLC
to afford 2.5 mg of (−)-epi -thunbergol (25).
Fractions eluting with 30% CH2Cl2 were combined and loaded onto a silica
gel column (20 mL, 1.3 cm × 17 cm). The column was eluted with 80 mL
volumes of: CH2Cl2, 2%, 4%, 6%, 8%, 10% EtOAc in CH2Cl2 and 10% MeOH
∗Please see Appendix A on page 186 for a detailed discussion of cyclic loading and back-
loading.
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in CH2Cl2. Fractions (approx. 6 mL) of the 2–10% EtOAc solvent mixtures
were collected. The fractions were combined on the basis of TLC and as only
partial separation was achieved, the column was repeated multiple times on the
mixture to eventually afford 13α-acetoxypukalide (26) (17.4 mg) and lopholide
(27) (3.8 mg) in about 90–95% purity.
The less polar fractions of the DIOL column (eluting with 20% CH2Cl2)
were combined and further purified on a DIOL column (5 mL, 1.3 × 4 cm). The
column was eluted with 20 mL of pet. ether, 10%, 20%, 30% CH2Cl2 in pet.
ether and finally with 50% MeOH/CH2Cl2. Fractions eluting with 20% and 30%
CH2Cl2 were combined on the basis of TLC to afford pukalide (28) (0.5 mg) and
11β, 12β-epoxypukalide (29) (0.9 mg).
The 10% MeOH/CH2Cl2 elutions from the multiple silica columns were a mix
of two compounds and were separated on an analytical DIOL HPLC column
which was eluted with 20% IPA in hexane at a flow rate of 1 mL/min. Two
fractions were collected (retention times 11.5 and 13.6 minutes) to give 13α-
acetoxypukalide diol (30) (1.2 mg) and lopholide diol (31) (1.4 mg) respectively.
Fraction 3 from the cyclic loading was concentrated under reduced pressure
and the material (62.7 mg) was purified on a silica gel column (50 mL, 2.1 ×
15 cm). The column was eluted with 200 mL volumes of 50%, 75% CH2Cl2
in pet. ether, CH2Cl2 and 50% MeOH in CH2Cl2. Fractions of 10 mL were
collected, and those eluted with the 75% CH2Cl2 were combined on the basis of
TLC to yield a further 3.4 mg of (−)-epi -thunbergol (25).
Isolation of (−)-epi -thunbergol from A. aurantiacum
Samples of the soft coral A. Aurantiacum were collected by hand using SCUBA
from Elizabeth Reef and Rimariki Island, Tutukaka, New Zealand in April
2003. They were frozen immediately and kept at −18 ◦C until extraction.
Voucher specimens (PTN2 45F, PTN2 54J, PTN2 55A) have been deposited at
the School of Chemical and Physical Sciences, Victoria University of Wellington,
New Zealand.
The soft coral (400 g wet weight) was cut up and extracted overnight with
MeOH (800 mL). The coral was filtered, then blended with a further 800 mL
MeOH in a Warring blender and left to extract overnight. The extracts were
cyclic loaded onto a column of HP20 (130 mL, 2.5 × 27 cm). The column was
then washed with H2O (400 mL) and then eluted with 400 mL fractions of:
(1) 20% Me2CO/H2O, (2) 40% Me2CO/H2O, (3) 60% Me2CO/H2O, (4) 80%
Me2CO/H2O and (5) Me2CO.
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Fraction 4 was backloaded onto a 40 mL HP20 column (2 × 12 cm), which
was eluted with 120 mL Me2CO and concentrated under reduced pressure to
afford 265.3 mg of material. This was further purified in portions on a DIOL
column: the material was adsorbed onto 2 mL DIOL and dry loaded onto a
column of 20 mL (3 × 17 cm). The column was eluted with 80 mL volumes
of pet. ether, 20%, 40%, 60% CH2Cl2 in pet. ether, CH2Cl2 and 50% MeOH in
CH2Cl2. Late eluting pet. ether fractions were combined on the basis of TLC to
afford 10.4 mg of (−)-epi -thunbergol (25).
(−)-epi-Thunbergol (25): Clear oil; [α]20D −7.2 (c 1.0, MeOH); all spectro-
scopic data were in agreement with those reported.76
13α-Acetoxypukalide (26): Clear glass; all spectroscopic data were in agree-
ment with those reported.73
Lopholide (27): White solid; all spectroscopic data were in agreement with
those reported.73
Pukalide (28): White solid; all spectroscopic data were in agreement with
those reported.74
11β, 12β-Epoxypukalide (29): White solid; all spectroscopic data were in
agreement with those reported.75
13α-Acetoxypukalide diol (30): White solid; UV (MeOH) λmax, nm (ε): 202
(19,900), 219 (sh, 9,340), 250 (3,900); [α]20D +8.3 (c 0.1, MeOH); NMR data see
Table 2.1; HRESIMS m/z 471.1623 [M + Na]+, C23H28O9Na requires 471.1631,
∆ 1.7 ppm.
Lopholide diol (31): White solid; UV (MeOH) λmax, nm (ε): 202 (8,130),
222 (3,210), 250 (2,170); [α]20D −9.3 (c 0.1, MeOH); NMR data see Table 2.2;
HRESIMSm/z 487.1579 [M + Na]+, C23H28O10Na requires 487.1580, ∆ 0.2 ppm.
8.3 Isolation of two drimane sesquiterpenes
from the nudibranch D. denisoni
Two D. denisoni individuals were collected by hand using SCUBA from Rauho-
maumau Island, Tutukaka, New Zealand (35◦ 37.5′ S, 174◦ 32.9′ E) in December
2003. The specimens were frozen immediately and stored at −18 ◦C until ex-
traction.
172
The nudibranchs (40 g wet weight) were extracted twice overnight with
MeOH (80 mL) and the extracts were cyclic loaded onto a 40 mL HP20 col-
umn (2 × 12 cm). The column was then washed with H2O (120 mL) and eluted
with 120 mL fractions as follows: (1) 30% Me2CO/H2O, (2) 70% Me2CO/H2O,
and (3) Me2CO.
Fraction 2 was backloaded onto a 20 mL HP20 column (2 × 6 cm) and eluted
with 60 mL Me2CO. The sample was concentrated under reduced pressure, and
the resulting material (73.1 mg) was separated in portions on DIOL (20 mL,
1.3 × 17 cm). The column was eluted successively with 80 mL volumes of pet.
ether, 10%, 20%, 50% CH2Cl2 in pet. ether, CH2Cl2 and 50% MeOH in CH2Cl2.
Several fractions eluted with 10% CH2Cl2 in pet. ether were combined on the
basis of TLC char and UV absorbance to give 11.5 mg of cinnamolide (35).
Other fractions eluted with 50% CH2Cl2 in pet. ether were also combined
and further purified on a silica gel column (15 mL, 1.3 × 12 cm). The column
was eluted with 30 mL pet. ether, 60 mL 25%, 40% Et2O in pet. ether, 80 mL
50% Et2O in pet. ether, 60 mL 75% Et2O in pet. ether and Et2O. 100 fractions
(5 mL each) were collected. Fractions 46–55 were combined based on TLC to
afford 1.3 mg of dendocarbin A (36).
Cinnamolide (35): White solid; all spectroscopic data were in agreement with
those reported.88,89
Dendocarbin A (36): White solid; all spectroscopic data were in agreement
with those reported.90
8.4 Isolation of a polymeric alkyl-pyridinium
salt from the nudibranch A. luctuosa
Eleven A. luctuosa individuals were collected by hand using SCUBA from various
locations off the coast of Northland, New Zealand (between Cape Brett and Cape
Karikari, 35◦ 11.5′ – 34◦ 48.8 S, 174◦ 20.3′ – 173◦ 25.8 E) in December 2003. The
specimens were frozen immediately and stored at −18 ◦C until extraction.
The nudibranchs were extracted whole in two portions (44 and 53 g wet
weight) twice overnight with MeOH (100 mL each) and the extracts were cyclic
loaded onto 40 mL HP20 columns (2 × 12 cm). The columns were then washed
with H2O (120 mL) and eluted with 120 mL fractions as follows: (1) 30%
Me2CO/H2O, (2) 75% Me2CO/H2O, and (3) Me2CO.
Fraction 1 from one of the columns was backloaded onto a 20 mL HP20
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column (2 × 6 cm) and eluted with 60 mL MeOH. It was concentrated under
reduced pressure to afford 217 mg of a brown oil. This was dissolved in approx.
2 mL of 10% H2O/MeOH, and insoluble particulates were filtered through cotton
wool. The filtrate was loaded onto a 220 mL LH-20 size exclusion column (2 ×
70 cm), and eluted with 10% H2O/MeOH. Early eluting fractions yielded the
polymeric alkyl-pyridinium salt (53).
Polymeric APS (53): Yellow-orange glass; NMR data see Table 8.1.
Table 8.1. NMR data (600 MHz, CD3OD) for the polymeric 3-alkyl pyridinium
salt (53).
δC/δN mult
1JXH δH mult, COSY HMBC
pos. (ppm) (ppm) J (Hz)
1 −67.4 N - - - - -
2 145.3 CH 194 8.96 br s 4, 5, 6, 7, 14 1, 4, 6, 7, 14
3 145.7 C - - - - -
4 146.6 CH 174 8.46 d (8.2) 2, 5, 6, 7, 14 2, 6, 14
5 129.0 CH 180 8.03 t (6.5) 2, 4, 6 1, 3, 6, 7
6 143.4 CH 197 8.87 d (5.4) 2, 4, 5, 7, 14 1, 2, 4, 5
7 62.9 CH2 143 4.63 t (7.3) 2, 4, 5, 8 1, 2, 6, 8, 9
8 32.6 CH2 129 2.03 m 7, 9 7, 9
9 27.1 CH2 125 1.40 m 7, 8
10–12 30.0 CH2 123 1.40 m
13 31.5 CH2 125 1.74 m 12, 14 12, 14
14 33.5 CH2 132 2.88 t (7.5) 2, 4, 6, 13 3, 12, 13
N
X
n1
3
4 6
7
14
53
8.5 Isolation of a pyrrole alkaloid from the nu-
dibranch T. morosa
Three T. morosa specimens were collected by hand using SCUBA from Rauho-
maumau Island, Tutukaka (35◦ 37.5′ S, 174◦ 32.9′ E) and West Chicken Island,
Hen and Chickens (35◦ 53.79′ S, 174◦ 42.17′ E), New Zealand in December 2003.
The specimens were frozen immediately and stored at −18 ◦C until extraction.
The three nudibranchs (14 g wet weight) were extracted whole twice overnight
with MeOH (50 mL) and the extracts were cyclic loaded onto a 40 mL HP20 col-
umn (2 × 12 cm). The column was then washed with H2O (120 mL) and eluted
with 120 mL fractions as follows: (1) 30% Me2CO/H2O, (2) 75% Me2CO/H2O,
and (3) Me2CO.
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Fraction 1 was backloaded onto a 20 mL HP20 column (2 × 12 cm), eluted
with 60 mL MeOH, and concentrated under reduced pressure to give 39.6 mg of
material. The sample was dissolved in a minimum amount of MeOH, and cyclic
loaded onto 2 mL HP20SS. The coloured cyclic loading eluent was concentrated
under reduced pressure to afford tambjamine A (67a) (12.2 mg).
Tambjamine A (67a): Dark green solid; NMR data see Table 2.3.
8.6 Isolation of three terpenes from the nudi-
branch C. amoenum
Twenty eight individuals identified as C. amoenum were collected by hand using
SCUBA from various locations off the coast of Northland, New Zealand (between
Tutukaka and Cape Karikari, 35◦ 37.5′ – 34◦ 48.8′ S, 174◦ 32.9′ – 173◦ 25.8′ E) in
December 2003. The specimens were frozen immediately and stored at −18 ◦C
until extraction.
The nudibranchs (26 g wet weight) were extracted whole twice overnight with
MeOH (50 mL) and the extracts were cyclic loaded onto a 20 mL HP20 column
(2 × 6 cm). The column was then washed with H2O (60 mL) and eluted with
60 mL fractions as follows: (1) 30% Me2CO/H2O, (2) 75% Me2CO/H2O, and
(3) Me2CO.
The 100% Me2CO fraction was concentrated under reduced pressure to give
122.7 mg of material. This was adsorbed onto 3 mL silica gel, and dry-loaded
onto a silica gel column (50 ml, 2.1 × 18 cm). The column was eluted with
200 mL volumes of pet. ether, 10%, 25%, 50% CH2Cl3 in pet. ether, CH2Cl2 and
50% MeOH in CH2Cl2, collecting 10 mL fractions. Fractions eluting with pet.
ether were combined on the basis of TLC to afford 25.2 mg of furodysinin (83).
The 75% Me2CO/H2O fraction from the cyclic loading was backloaded onto
20 mL HP20 column (2 × 6 cm) and eluted with 60 mL of Me2CO. The sample
was concentrated under reduced pressure to give 111.1 mg of material that was
adsorbed onto 2 mL DIOL, and dry-loaded onto a 20 mL DIOL column (1.4 ×
18 cm). The column was eluted with 60 mL volumes of pet. ether, 50% CH2Cl2 in
pet. ether, CH2Cl2, 50% EtOAc in CH2Cl2, EtOAc and 50% MeOH in CH2Cl2.
Fractions of 15 mL were collected. When concentrated under reduced pressure,
fraction 2 contained 7.1 mg of 83, and fraction 4 contained 2.4 mg of (semi-pure)
O-methyl-furodysinin lactone (84).
Fraction 6 (29.3 mg) was further purified on a 15 mL silica gel column (1.5 ×
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12 cm) eluted with 60 mL volumes of pet. ether, 25%, 50%, 75% CH2Cl2 in pet.
ether, CH2Cl2 and 50% MeOH in CH2Cl2. The CH2Cl2 fraction (6.6 mg) was
purified on another 20 mL silica gel column (1.4 × 17 cm) eluted with 50%, 70%,
80%, 90% CH2Cl2 in pet. ether, and CH2Cl2, collecting 5 mL fractions. Fractions
were combined based on TLC to give 8.7 mg (−)-tetradehydrofurospongin-1
(85).
Furodysinin (83): Pale yellow glass; all spectroscopic data were in agreement
with those reported.114,117
O-methyl-furodysinin lactone (84): Clear glass; all spectroscopic data were
in agreement with those reported.114,122
(−)-Tetradehydrofurospongin-1 (85): Pale yellow solid; [α]20D −63.1 (c 0.35,
CH2Cl2); all spectroscopic data were in agreement with those reported.
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8.7 Isolation of five glycolipids from the sponge
R. agminata
The sponge R. agminata was collected by hand using SCUBA from Taheke Reef,
Cavalli Islands, New Zealand (34◦ 57.8′ S, 173◦ 59.0′ E at a depth of 10–15 m)
in December 2003. The sample was frozen immediately and kept at −18 ◦C
until extraction. A voucher specimen (PTN2 79D) has been deposited at the
School of Chemical and Physical Sciences, Victoria University of Wellington,
New Zealand.
Isolation of agminosides A–E (145–149)
The sponge (251 g wet weight) was cut up and extracted twice overnight with
MeOH (900 mL). The extracts were cyclic loaded onto a 200 mL column of HP20
(5.5 × 8.5 cm). The column was then washed with H2O (600 mL) and eluted
with 600 mL fractions of (1) 20% Me2CO/H2O, (2) 40% Me2CO/H2O, (3) 60%
Me2CO/H2O, (4) 80% Me2CO/H2O and (5) Me2CO. Fraction 3 was backloaded
onto a 80 mL column of HP20 (2.5 × 18 cm) and eluted with 250 mL MeOH.
Upon concentration under reduced pressure, this fraction yielded 450 mg of ma-
terial that was purified in three portions on LH-20 (200 mL, 2 × 67 cm) in
MeOH. Early eluting fractions were combined (on the basis of TLC char) to
afford a mixture of glycolipids (344 mg). Portions of this were repeatedly chro-
matographed on benchtop and HPLC silica columns using CH2Cl2/MeOH/H2O
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mixtures to yield: 11.0 mg agminoside A (145), 2.5 mg agminoside B (146),
1.3 mg agminoside C (147), 3.1 mg agminoside D (148), and 0.5 mg agmi-
noside E (149).
Agminoside A (145): Clear glass; [α]20D −3.0 (c 1.0, MeOH); NMR data
see Table 3.9; HRMALDI-TOF-MS m/z 1943.7707 [M + Na]+, C85H132O48Na
requires 1943.7780, ∆ 3.8 ppm.
Agminoside B (146): Clear glass; NMR data see Table 3.12; HRESIMS m/z
1877.7734 [M − H]−, C83H130O47 requires 1877.7704, ∆ 1.6 ppm.
Agminoside C (147): Clear glass; NMR data see Table 3.13; HRESIMS m/z
1877.7721 [M − H]−, C83H130O47 requires 1877.7704, ∆ 0.9 ppm.
Agminoside D (148): Clear glass; NMR data see Table 3.14; HRESIMS m/z
1835.7599 [M − H]−, C81H128O46 requires 1835.7599, ∆ 0.4 ppm.
Agminoside E (149): Clear glass; NMR data see Table 3.15; HRESIMS m/z
1715.7176 [M − H]−, C77H119O42 requires 1715.7176, ∆ 1.2 ppm.
Methanolysis of a crude mixture of glycolipids
A portion of the crude mixture of glycolipids (60 mg) was heated in MeOH (1 mL)
with 3 drops of conc. HCl in a screw-cap vial at 80–90 ◦C for 48 hours. The
sample was diluted with H2O (1 mL) and cyclic loaded onto a column of HP20SS
(1 × 2 cm). The column was then eluted with 6 mL fractions of (1) H2O and
(2) MeOH. The MeOH fraction was evaporated to dryness to yield 12.0 mg of
aglycon methyl ester (151). The H2O fraction was concentrated under reduced
pressure to yield 50.8 mg of 1-O-methyl-α-d-glucose and 1-O-methyl-β-d-glucose
(49:1).
The methyl glucoside (5.0 mg) was treated with 2 mL 1:1 pyridine/Ac2O
under argon with stirring. After 18 h, the reaction was quenched with 2 mL
H2O and the sample was cyclic loaded onto 2 mL HP20SS. The column was
then washed with H2O, and eluted with 6 mL MeOH, giving 2,3,4,6-tetra-O-
acetyl-1-O-methyl-α-d-glucose (5.0 mg).
Aglycon methyl ester (151): White solid; [α]20D −19.5 (c 0.99, MeOH); NMR
data see Table 3.8; HRESIMS m/z 439.3381 [M + Na]+, C24H48O5Na requires
439.3394, ∆ 3.0 ppm.
1-O-Methyl-d-glucose: White solid; [α]20D +209 (c 0.65, H2O).
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2,3,4,6-Tetra-O-acetyl-1-O-methyl-α-d-glucose: White solid; NMR data
(CDCl3, 600 MHz) δ 5.48 (1H, t, 10.0 Hz, H-3), 5.07 (1H, t, 10.3 Hz, H-4), 4.95
(1H, d, 3.9 Hz, H-1), 4.90 (1H, dd, 10.3, 3.9 Hz, H-2), 4.26 (1H, dd, 12.3, 5.0 Hz,
H-6a), 4.11 (1H, dd, 12.3, 2.5 Hz, H-6b), 3.98 (1H, ddd, 10.3, 4.5, 2.3 Hz, H-5),
3.41 (3H, s, 1-OMe), 2.10 (3H, s, OAc), 2.08 (3H, s, OAc), 2.03 (3H, s, OAc),
2.01 (3H, s, OAc).
Methylation of a crude mixture of glycolipids
TMSCHN2 (50 µL, 2 M in hexanes) was added to 8.8 mg of a crude mixture of
glycolipids dissolved in dry MeOH (1 mL) under argon at 0 ◦C. After 1 hour,
the reaction was quenched with 2% (v/v) acetic acid in H2O (1 mL), and was
allowed to warm up to room temperature. After the disappearance of all yellow
colour from the solution (30 min), the sample was cyclic loaded onto a column
of HP20SS (1 × 2 cm). The column was then eluted with 6 mL fractions of (1)
H2O, (2) 50% Me2CO/H2O, (3) 80% Me2CO/H2O and (4) Me2CO. Fraction 3
was evaporated to dryness to yield 7.4 mg of methylated glycolipids.
Preparation of Mosher’s esters of 151
To a solution of 151 (2 mg, 4.8 µmol) in 2 mL CH2Cl2 was added DMAP (4.5 mg,
36.8 µmol) and either (R)- or (S )-MTPACl (3 µL, 16.1 µmol) under argon, and
the mixture was stirred overnight. The reaction was quenched with 1 mL H2O
and the solution was washed with 4 mL of 1 M HCl, 1 M NaOH, and finally
brine. The organic layer was concentrated to yield the R-Mosher’s ester (5.0 mg)
and S -Mosher’s ester (4.7 mg) derivative.
Mosher’s ester derivatives of the aglycon methyl ester: White solids;
NMR data see Table 3.7.
Peracetylation reactions
To either 145 (0.5 mg) or a mixture of glycolipids (0.6 mg) was added 500 µL
pyridine and 500 µL acetic anhydride under argon. The mixtures were stirred
at room temperature overnight. The reactions were quenched by the addition of
1 mL H2O, and were cyclic loaded onto 2 mL HP20SS. The columns were washed
with H2O, and eluted with 6 mL Me2CO. Concentration of the Me2CO under re-
duced pressure afforded peracetylated agminoside A (0.8 mg) and peracetylated
glycolipid mixture (0.7 mg).
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Peracetylated agminoside A: Clear glass; ESIMS m/z 2172.8, 2214.8.
Peracetylated glycolipid mixture: Clear glass; ESIMS m/z 1349.6, 1595.7,
1637.7, 1884.8, 1926.8, 2172.8, 2214.8.
Acid hydrolysis and chiral derivatization of sugars
A portion of the crude mixture of glycolipids (7.3 mg) was heated in 2 M TFA
(2 mL) in a screw-cap vial at 100 ◦C overnight. The aglycon was extracted with
CH2Cl2 and the aqueous residue was evaporated to dryness under reduced pres-
sure. A 1.7 mg portion of these hydrolysed sugars was subjected to reductive
amination with (S )-1-amino-2-propanol, as previously described.157 The follow-
ing reagents were added: 40 µL of 1:8 (S )-1-amino-2-propanol in MeOH, 34 µL
of 1:4 glacial acetic acid in MeOH and 26 µL of 3% NaBH3CN in MeOH. The
capped vial was allowed to react for 1 hour at 65 ◦C. TFA (2 M) was added
dropwise until the pH dropped to 1–2. The mixture was evaporated and co-
evaporated with H2O (3 × 0.5 mL) and MeOH (5 × 0.5 mL). The sample was
dried under high vacuum, then treated with 2 mL 1:1 pyridine/Ac2O (2 hours,
90 ◦C). The reaction was quenched with 2 mL H2O and cyclic loaded onto a
column of HP20SS (1 × 2 cm). The column was then eluted with 6 mL fractions
of (1) H2O and (2) MeOH. Fraction 2 was evaporated to dryness to yield the
1-deoxy-1-(2-hydroxypropylamino) alditol acetate derivative.
GC was carried out on a Hewlett Packard 5890 Series II gas chromatograph,
with a flame ionization detector, operating in split mode (15:1). The column
used was HP5 (30 m × 0.32 nm, 0.25 µm film thickness) with N2 as the gas
carrier (1 mL/min), and a head pressure of 12 psi. The program started at
180 ◦C (1 min), 2 ◦C/min to 220 ◦C (2 min), then 4 ◦C to 250 ◦C (5 min).
The retention time of the sugar derivative and the d-glucose standard (prepared
under the same derivatization conditions) was 16.5 min.
8.8 Screening protocol
Preparation of screen sample
A voucher sample (ca. 10 g) of the sponge is preserved in 75% IPA in H2O.
Approximately 100 g (wet weight) of sponge is diced and extracted twice with
400 mL MeOH overnight. The extracts are cyclic loaded onto a column of HP20
(80 mL, 2.5 × 18 cm). The column is washed with 250 mL H2O and then eluted
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with 250 mL volumes of: (1) 30% Me2CO/H2O, (2) 75% Me2CO/H2O, and (3)
Me2CO. Fractions 1 and 2 are backloaded onto a column of 40 mL HP20 (2
× 12 cm), washed with water, and eluted with MeOH (fraction 1) or Me2CO
(fraction 2). All fractions are concentrated under reduced pressure, and approx.
30 mg portions are subjected to NMR analysis.
8.9 Bulk extraction of sponge MNP998
The sponge MNP998 was obtained from the National Institute of Water and
Atmospheric Research (NIWA). It had been frozen immediately after collection
and kept at −18 ◦C until extraction. A voucher sample (MNP998) has been
deposited at the School of Chemical and Physical Sciences, Victoria University
of Wellington, New Zealand.
The sponge (505 g wet weight) was diced and extracted twice overnight with
MeOH (2.5 L). The extracts were cyclic loaded onto a 400 mL column of HP20
beads (8 × 8 cm). The column was then washed with 1.2 L H2O and eluted
with 1.2 L fractions of: (1) 20% Me2CO/H2O, (2) 40% Me2CO/H2O, (3) 60%
Me2CO/H2O, (4) 80% Me2CO/H2O and (5) Me2CO.
Fractions 1–4 were backloaded onto 150 mL HP20, and eluted with 450 mL
of MeOH (fractions 1 and 2) or Me2CO (fractions 3 and 4). Concentration of
fraction 3 under reduced pressure and subsequent lyophilization yielded 2.56 g
of a beige powder.
8.10 Isolation of terpenes from a dictyoceratid
sponge
The sponge (order Dictyoceratida) was collected by hand using SCUBA from
Dowd Rock, Tutukaka, New Zealand in December 2003. The sample was frozen
immediately and kept at −18 ◦C until extraction. Voucher samples (PTN2 47E
and PTN2 48C) have been deposited at the School of Chemical and Physical
Sciences, Victoria University of Wellington, New Zealand.
The sponge (250 g wet weight) was cut up and extracted twice overnight
with MeOH (1.25 L). The extracts were cyclic loaded onto a column of HP20
(200 mL, 8 × 4 cm). The column was then washed with 600 mL H2O and eluted
with 600 mL fractions of (1) 20% Me2CO/H2O, (2) 40% Me2CO/H2O, (3) 60%
Me2CO/H2O, (4) 80% Me2CO/H2O and (5) Me2CO.
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Fraction 3 was backloaded onto 80 mL HP20 (2.5 × 18 cm), eluted with
240 mL MeOH and concentrated under reduced pressure to yield 199.5 mg of
material. Approximately half of this was loaded onto a silica gel column (40 mL,
1.3 × 30 cm). The column was eluted sequentially with 160 mL volumes of
CH2Cl2, 1%, 2.5%, 5% and 50% MeOH in CH2Cl2. Fractions eluting with 2.5%
MeOH were combined on the basis of TLC to give ∆18,20-isovariabilin (186)
(33.1 mg).
Fraction 5 from the cyclic loading was concentrated under reduced pressure
to give 1.28 g of material. Approximately 400 mg of this was loaded onto a
silica gel column (75 mL, 2.5 × 21 cm). The column was eluted with 300 mL
fractions of (1) pet. ether, (2) CH2Cl2 and (3) 50% MeOH/CH2Cl2. The pet.
ether fraction was concentrated under reduced pressure to yield furospinosulin-1
(187) (107.4 mg).
The CH2Cl2 fraction was concentrated under reduced pressure, and the re-
sulting material (111 mg) was loaded onto a silica gel column (40 mL, 1.3 ×
30 cm). The column was eluted with 160 mL volumes of 50% and 75% CH2Cl2
in pet. ether, CH2Cl2 and 50% MeOH/CH2Cl2. The 50% CH2Cl2 in pet. ether
fraction was further purified on a silica gel column (20 mL, 1.3 × 17 cm). This
column was eluted with 60 mL of pet. ether, then 80 mL volumes of 10%,
20%, 30%, 40%, 50% and 60% CH2Cl2 in pet. ether, CH2Cl2 and finally 50%
MeOH/CH2Cl2. Fractions eluted with 50% CH2Cl2 in pet. ether were combined
based on TLC. The resulting sample (9.1 mg) was subjected to HPLC on a semi-
preparative C18 reversed-phase column which was eluted with 85% MeCN/H2O
at a flow rate of 5 mL/min. Two fractions were collected (retention times
15.9 and 16.7 min) to yield 6-((2Z,6E )-3,7,11-trimethyl-2,6,10-dodecatrienyl)-2-
methoxy-p-quinone (189) (0.5 mg) and 6-((2E,6E )-3,7,11-trimethyl-2,6,10-do-
decatrienyl)-2-methoxy-p-quinone (188) (2.7 mg) respectively.
∆18,20-Isovariabilin (186): Pale yellow solid; UV (MeOH) λmax, nm (ε): 204
(18,900), 227 (sh, 8,580); [α]20D −8.9 (c 0.9, MeOH); NMR data see Table 5.1;
HRESIMS m/z 421.2354 [M + Na]+, C25H34O4Na requires 421.2355, ∆ 0.2 ppm.
Furospinosulin-1 (187): Pale yellow oil; all spectroscopic data were in agree-
ment with those reported.191
6-((2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-qui-
none (188): Orange solid; all spectroscopic data were in agreement with those
reported.195
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6-((2E,6Z )-3,7,11-trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-qui-
none (189): Orange solid; UV (MeOH) λmax, nm (ε): 204 (23,500), 222 (sh,
11,000), 277 (sh, 4,690); NMR data see Table 5.2; HRESIMS m/z 365.2095
[M + Na]+, C22H30O3Na requires 365.2093, ∆ 0.5 ppm, m/z 397.2341 [M +
MeOH + Na]+, C23H34O4Na requires 397.2355, ∆ 3.5 ppm.
8.11 Isolation of four aplysulphurane diter-
penes from the sponge D. oxeata
The sponge identified as D. oxeata was collected by hand using SCUBA from
Port Hardy, D’Urville Island, New Zealand (40◦ 46.2′ S, 173◦ 59.7′ E) in April
2000. The sample was frozen immediately and kept at −18 ◦C until extraction.
A voucher specimen (MNP1002) has been deposited at the School of Chemical
and Physical Sciences, Victoria University of Wellington, New Zealand.
The sponge (505 g wet weight) was cut up and extracted twice overnight with
MeOH (2.5 L). The extracts were cyclic loaded onto a column of HP20 (400 mL,
8 × 8 cm). The column was then washed with 1.2 L H2O and eluted with 1.2 L
fractions of (1) 20% Me2CO/H2O, (2) 40% Me2CO/H2O, (3) 60% Me2CO/H2O,
(4) 80% Me2CO/H2O and (5) Me2CO.
Fraction 1 was backloaded onto 150 mL HP20, eluted with 450 mL MeOH
and concentrated under reduced pressure to yield 125.7 mg of an amorphous
solid. Approximately half of this material was adsorbed onto DIOL, and was
dry-loaded onto a 20 mL DIOL column (1.3 × 17 cm). The column was eluted
with fractions of: (1) 60 mL of CH2Cl2, 80 mL of (2) 10% MeOH/CH2Cl2, (3)
20% MeOH/CH2Cl2, (4) 50% MeOH/CH2Cl2 and (5) MeOH.
The 10% MeOH fraction was further purified on a semi-preparative C18
reversed-phase HPLC column which was eluted with 70% MeOH/0.1 M HCOOH
at a flow rate of 5 mL/min. A major compound with a retention time of 21 min-
utes was collected. This fraction was backloaded onto 2 mL HP20SS to de-salt,
and eluted with 10 mL MeOH. The sample was concentrated under reduced
pressure to afford oxeatamide A (214) (17.2 mg).
Fraction 2 from the cyclic loading was backloaded onto 150 mL HP20, eluted
with 450 mL MeOH and concentrated under reduced pressure to afford 234.1 mg
of a red gum. A portion of this material (approx. 80 mg) was adsorbed onto
DIOL and was dry-loaded onto a 20 mL DIOL column (1.3 × 17 cm). The
column was eluted with 80 mL fractions of: (1) CH2Cl2, (2) 1% MeOH/CH2Cl2,
(3) 5% MeOH/CH2Cl2, (4) 10% MeOH/CH2Cl2 and (5) 20% MeOH/CH2Cl2,
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(6) 30% MeOH/CH2Cl2 and (7) 50% MeOH/CH2Cl2.
The 10% MeOH in CH2Cl2 fraction from this column was further purified on
reversed-phase HPLC using identical conditions as above. Three fractions were
collected (retention times 5–8, 21.0 and 25.1 minutes) to afford (after de-salting)
oxeatamide B (217) (6.2 mg) oxeatamide A (214) (7.8 mg) and iso-oxeatamide
A (215) (0.9 mg) respectively.
Fractions eluting from the HPLC after oxeatamide A (214) were combined,
backloaded onto 2 mL HP20SS to de-salt, eluted with 10 mL MeOH, and con-
centrated under reduced pressure. The resulting sample (2.8 mg) was re-injected
onto the C18 reversed-phase HPLC and eluted under the same conditions, yield-
ing oxeatamide A 23-methyl ester (0.5 mg) with a retention time of 27.4 min.
Oxeatamide A (214): White solid; UV (MeOH) λmax, nm (ε): 206 (45,100)
250 (18,800); [α]20D −60.3 (c 1.0, MeOH); NMR data see Table 6.1; HRESIMS
m/z 388.2115 [M + H]+, C22H30O5 requires 388.2124, ∆ 2.3 ppm, m/z 410.1940
[M + Na]+, C22H29NO5Na requires 410.1943, ∆ 0.9 ppm.
Iso-oxeatamide A (215): White solid; UV (MeOH) λmax, nm (ε): 209 (36,800)
248 (11,200); [α]20D −59.6 (c 0.22, MeOH); NMR data see Table 6.3; HRESIMS
m/z 388.2131 [M + H]+, C22H30NO5 requires 388.2124, ∆ 1.8 ppm, m/z 410.1949
[M + Na]+, C22H29NO5Na requires 410.1943, ∆ 1.5 ppm.
Oxeatamide A 23-methyl ester (216): White solid; UV (MeOH) λmax,
nm (ε): 203 (43,500) 239 (18,100); [α]20D −62.0 (c 0.05, MeOH); NMR data see
Table 6.4; HRESIMS m/z 424.2112 [M + Na]+, C23H31NO5Na requires 424.2100,
∆ 2.8 ppm.
Oxeatamide B (217): White solid; UV (MeOH) λmax, nm (ε): 207 (24,300)
243 (9,030); [α]20D −60.2 (c 0.5, MeOH); NMR data see Table 6.5; HRESIMS
m/z 424.2592 [M + H]+, C25H34N3O3 requires 424.2600, ∆ 1.7 ppm.
Methylation of 214
TMSCHN2 (50 µL, 2 M in hexanes) was added to 5 mg of 214 dissolved in dry
CH2Cl2 (1 mL) under argon. After 1 hour, the reaction was opened and left
overnight. To the dry residue, 1 mL of MeOH was added, followed by 1 mL
of 2% (v/v) aqueous acetic acid (1 mL). The sample was backloaded onto a
column of HP20SS (1 × 2 cm). The column was then washed with H2O (1 mL)
and eluted with 6 mL fractions of (1) 20% Me2CO/H2O, (2) 40% Me2CO/H2O,
(3) 60% Me2CO/H2O, (4) 80% Me2CO/H2O and (5) Me2CO. Fraction 5 was
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concetrated under reduced pressure and further purified on a semi-preparative
C18 reversed-phase HPLC column which was eluted with 90% MeOH in H2O at
a flow rate of 5 mL/min. Four compounds, with retention times of 5.8, 8.5, 9.8
and 18.6 minutes, were collected to afford oxeatamide A dimethyl ester (218)
(1.1 mg), oxeatamide A 6-methyl ester, 23-TMSmethyl ester (219) (1.3 mg),
oxeatamide A 6-TMSmethyl, 23-methyl ester (220) (1.2 mg), and oxeatamide A
6,23-diTMSmethyl ester (221) (1.0 mg).
Oxeatamide A dimethyl ester (218): White solid; UV (MeOH) λmax, nm
(ε): 207 (42,100) 241 (17,700); [α]20D −118 (c 0.1, MeOH); NMR data see
Table 6.2; HRESIMS m/z 416.2434 [M + H]+, C24H34NO5 requires 416.2431
∆ 0.7 ppm, m/z 438.2254 [M + Na]+, C24H33NO5Na requires 438.2251, ∆ 0.6
ppm.
Oxeatamide A 6-methyl ester, 23-TMSmethyl ester (219): White solid;
1H NMR data (CDCl3, 600 MHz) δ 7.70 (1H, d, 8.3 Hz, H-12), 7.64 (1H, d,
8.3 Hz, H-11), 4.69 (1H, q, 7.3 Hz, H-7), 4.50 (1H, d, 16.0 Hz, H-15a), 4.43
(1H, d, 17.6 Hz, H-22a), 4.28 (1H, d, 17.5 Hz, H-22b), 4.14 (1H, d, 16.2 Hz,
H-15b), 3.84 (1H, d, 13.9 Hz, 23-CH2[a]Si(CH3)3), 3.79 (1H, d, 13.9 Hz, 23-
CH2[b]Si(CH3)3), 3.75 (3H, s, 6-methyl ester) 2.36 (1H, d, 13.9 Hz, H-1a), 2.08
(1H, d, 13.9 Hz, H-5a), 1.84 (1H, qt, 11.5, 3.0 Hz, H-2a), 1.68 (1H, dt, 14.2,
4.2 Hz, H-2b), 1.61 (3H, d, 7.2 Hz, H3-17), 1.50 (1H, d, 14.1 Hz, H-5b), 1.47
(3H, s, H3-20), 1.45 (1H, m H-1b), 1.34 (1H, dt, 13.0, 4.2 Hz, H-3a), 1.27 (1H,
ddd, 15.2, 11.3, 4.1 Hz, H-3b), 0.92 (3H, s, H3-19), 0.41 (3H, s, H3-18), 0.05 (9H,
s, 23-CH2Si(CH3)3).
Oxeatamide A 6-TMSmethyl, 23-methyl ester (220): White solid; 1H
NMR data (CDCl3, 600 MHz) δ 7.69 (1H, d, 8.2 Hz, H-12), 7.62 (1H, d, 8.2 Hz,
H-11), 4.66 (1H, q, 7.2 Hz, H-7), 4.49 (1H, d, 16.8 Hz, H-15a), 4.40 (1H, d,
17.5 Hz, H-22a), 4.32 (1H, d, 17.5 Hz, H-22b), 4.11 (1H, d, 16.5 Hz, H-15b), 3.75
(3H, s, 23-methyl ester), 3.72 (1H, d, 14.3 Hz, 6-CH2[a]Si(CH3)3), 3.65 (1H, d,
14.3 Hz, 6-CH2[b]Si(CH3)3), 2.37 (1H, d, 14.7 Hz, H-1a), 2.09 (1H, d, 14.2 Hz,
H-5a), 1.83 (1H, qt, 11.5, 3.1 Hz, H-2a), 1.67 (1H, dt, 14.1, 4.5 Hz, H-2b), 1.62
(3H, d, 7.4 Hz, H3-17), 1.50 (1H, d, 14.4 Hz, H-5b), 1.45 (3H, s, H3-20), 1.45 (1H,
m, H-1b), 1.34 (1H, dt, 13.8, 4.2 Hz, H-3a), 1.26 (1H, ddd, 15.2, 11.5, 3.8 Hz,
H-3b), 0.92 (3H, s, H3-19), 0.40 (3H, s, H3-18), −0.18 (9H, s, 6-CH2Si(CH3)3).
Oxeatamide A 6,23-diTMSmethyl ester (221): White solid; 1H NMR data
(CDCl3, 600 MHz) δ 7.69 (1H, d, 8.4 Hz, H-12), 7.62 (1H, d, 8.4 Hz, H-11), 4.66
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(1H, q, 7.5 Hz, H-7), 4.50 (1H, d, 16.3 Hz, H-15a), 4.47 (1H, d, 17.8 Hz, H-
22a), 4.22 (1H, d, 17.8 Hz, H-22b), 4.11 (1H, d, 16.2 Hz, H-15b), 3.84 (1H, d,
14.0 Hz, 23-CH2[a]Si(CH3)3), 3.79 (1H, d, 14.0 Hz, 23-CH2[b]Si(CH3)3), 3.72
(1H, d, 14.2 Hz, 6-CH2[a]Si(CH3)3), 3.65 (1H, d, 14.2 Hz, 6-CH2[b]Si(CH3)3),
2.38 (1H, d, 13.4 Hz, H-1a), 2.11 (1H, d, 14.0 Hz, H-5a), 1.83 (1H, qt, 13.0,
3.5 Hz, H-2a), 1.67 (1H, dt, 13.9, 4.4 Hz, H-2b), 1.62 (3H, d, 7.3 Hz, H3-17),
1.49 (1H, d, 13.9 Hz, H-5b), 1.45 (3H, s, H3-20), 1.44 (1H, m H-1b), 1.34 (1H, dt,
13.0, 3.9 Hz, H-3a), 1.26 (1H, m H-3b), 0.91 (3H, s, H3-19), 0.39 (3H, s, H3-18),
0.06 (9H, s, 23-CH2Si(CH3)3), −0.18 (9H, s, 6-CH2Si(CH3)3).
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Appendix A
Cyclic Loading and Backloading
Cyclic loading is a technique developed by Northcote and West127 and commonly
used during this research. It was first used to fractionate crude extracts of
organisms being examined by separating the undesirable highly polar salts and
non-polar fats from the intermediate polarity compounds of interest.127,190 More
recently, cyclic loading has found utility as an alternative workup to liquid-liquid
partitioning for some synthetic reactions.254
Cyclic loading can conceptually be thought of as opposite to chromatography.
Instead of increasing amounts of non-polar modifier used to elute compounds
off reversed-phase, polar modifier is used to make compounds adsorb onto the
column. In the same way, this technique can be extended to normal phase, with
increasing amounts of non-polar modifier used to dilute a sample and so cyclic
loading it onto normal phase packing material.
While any stationary phase can be used for cyclic loading, our group utilizes
PSDVB (poly(styrene-divinylbenzene)) beads, an inexpensive, polymeric, cross-
linked, styrenic adsorbent resin as the stationary phase. The resin is highly
porous and fully reusable. In addition, it is stable over a large range of pH
values, and does not irreversibly bind polar solutes.
A crude extract contains a wide variety of compounds of very different polari-
ties. To use column chromatography, traditional techniques require the evapora-
tion of solvent from the crude extract (a task often made difficult by“bumping”of
the sample) and then redissolving it in a small volume of running solvent—often
unachievable due to the large range of component polarities. The advantage of
cyclic loading lies in that such a crude extract can easily be loaded onto a column
for fractionation.
An organic extract of an organism is passed through the PSDVB column, and
the most non-polar constituents will adsorb to the column. The eluent is diluted
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Figure A.1. Cyclic loading diagram.
by half with water and passed through the column again. Usually addition
of water to a crude extract would result in the precipitation of the non-polar
compounds. This does not happen with cyclic loading, as the most non-polar
fats and triglycerides have adsorbed to the column during the first pass.
The dilution and loading cycle is repeated until the organic concentration
is 25% or even 12.5% (v/v). As the polarity of the mobile phase increases
with each dilution, increasing amounts of the extract constituents lose affinity
for the mobile phase and adsorb to the column—see Figure A.1 for a pictorial
representation. The column is then washed with water to remove any remaining
salts, and can be eluted with water/organic solvent mixtures (step-wise or as a
gradient).
Backloading is an extension of the cylic loading technique. Reversed-phase
chromatography often generates many samples with high water content, which
are time-consuming and sometimes difficult to evaporate under reduced pressure.
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By cyclic loading such samples onto a smaller column (backloading), they can
then be eluted with a smaller amount of pure organic solvent which is much
easier to evaporate. This technique can also be used to de-salt samples: after
backloading, the column is washed with water to remove any salts, and the
sample eluted with organic solvent as described.
Synthetic reaction mixtures also frequently contain many compounds with
widely differing polarities, and as long as the reaction solvent is water-miscible,
can be cyclic loaded in a similar fashion. Any salts or other highly polar mole-
cules will not adsorb to the column, and rather than obtaining a single organic
layer from a liquid-liquid partitioning workup, the other compounds can be fur-
ther fractionated by sequential elution with water/organic solvent mixtures.
The major drawback of the cyclic loading technique is the large volumes of
eluent generated, requiring large glassware and increasing periods of time to load
onto the column. With each dilution step, the volume of the eluent is doubled—a
1 L extract, for example, would have to be diluted to 2 L in the first cycle, then
to 4 L, and perhaps even to 8 L in the end, requiring a total volume of 15 L to
be passed through the column. Nevertheless, the advantage of reversed-phase
cyclic loading is that it uses solvents (water, methanol and acetone) that are
cheap and better for the environment than most others, and means it is more
easily adaptable to industrial scale.
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(−)-epi-Thunbergol
Figure B.1. 1H NMR spectrum (300 MHz, CDCl3) of (−)-epi -thunbergol (25).
192
13α-Acetoxypukalide
Figure B.2. 1H NMR spectrum (300 MHz, CDCl3) of 13α-acetoxypukalide
(26).
193
Lopholide
Figure B.3. 1H NMR spectrum (300 MHz, CDCl3) of lopholide (27).
194
Pukalide
Figure B.4. 1H NMR spectrum (300 MHz, CDCl3) of pukalide (28).
195
11β,12β-Epoxypukalide
Figure B.5. 1H NMR spectrum (300 MHz, CDCl3) of 11β, 12β-epoxypukalide
(29).
196
13α-Acetoxypukalide diol
Figure B.6. 1H NMR spectrum (600 MHz, CDCl3) of 13α-acetoxypukalide diol
(30).
197
Figure B.7. 13C NMR spectrum (150 MHz, CDCl3) of 13α-acetoxypukalide
diol (31).
198
Figure B.8. COSY spectrum (600 MHz, CDCl3) of 13α-acetoxypukalide diol
(30).
199
Figure B.9. HSQC spectrum (600 MHz, CDCl3) of 13α-acetoxypukalide diol
(30).
200
Figure B.10. HMBC spectrum (600 MHz, CDCl3) of 13α-acetoxypukalide diol
(30).
201
Lopholide diol
Figure B.11. 1H NMR spectrum (600 MHz, CDCl3) of lopholide diol (31).
202
Figure B.12. 13C NMR spectrum (150 MHz, CDCl3) of lopholide diol (31).
203
Figure B.13. COSY spectrum (600 MHz, CDCl3) of lopholide diol (31).
204
Figure B.14. HSQC spectrum (600 MHz, CDCl3) of lopholide diol (31).
205
Figure B.15. HMBC spectrum (600 MHz, CDCl3) of lopholide diol (31).
206
Cinnamolide
Figure B.16. 1H NMR spectrum (300 MHz, CDCl3) of cinnamolide (35).
207
Dendocarbin A
Figure B.17. 1H NMR spectrum (300 MHz, CDCl3) of dendocarbin A (36).
208
Polymeric alkyl-pyridinium salt
Figure B.18. 1H NMR spectrum (300 MHz, CD3OD) of the polymeric alkyl-
pyridinium salt (53).
209
Tambjamine A
Figure B.19. 1H NMR spectrum (300 MHz, DMSO-d6) of tambjamine A
(67a).
210
Furodysinin
Figure B.20. 1H NMR spectrum (300 MHz, CDCl3) of furodysinin (83).
211
O-methyl-furodysinin lactone
Figure B.21. 1H NMR spectrum (300 MHz, CDCl3) of O-methyl-furodysinin
lactone (84).
212
(−)-Tetradehydrofurospongin-1
Figure B.22. 1H NMR spectrum (300 MHz, CDCl3) of (−)-tetradehydrofuro-
spongin-1 (85).
213
Agminoside A
Figure B.23. 1H NMR spectrum (600 MHz, CD3OD) of agminoside A (145).
214
Figure B.24. 13C NMR spectrum (150 MHz, CD3OD) of agminoside A (145).
215
Figure B.25. COSY spectrum (600 MHz, CD3OD) of agminoside A (145).
216
Figure B.26. HSQC spectrum (600 MHz, CD3OD) of agminoside A (145).
217
Figure B.27. HSQC-TOCSY spectrum (600 MHz, CD3OD) of agminoside A
(145).
218
Figure B.28. HMBC spectrum (600 MHz, CD3OD) of agminoside A (145).
219
Figure B.29. ROESY spectrum (600 MHz, CD3OD) of agminoside A (145).
220
Agminoside B
Figure B.30. 1H NMR spectrum (600 MHz, CD3OD) of agminoside B (146).
221
Figure B.31. COSY spectrum (600 MHz, CD3OD) of agminoside B (146).
222
Figure B.32. HMBC spectrum (600 MHz, CD3OD) of agminoside B (146).
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Agminoside C
Figure B.33. 1H NMR spectrum (600 MHz, CD3OD) of agminoside C (147).
224
Figure B.34. COSY spectrum (600 MHz, CD3OD) of agminoside C (147).
225
Figure B.35. HMBC spectrum (600 MHz, CD3OD) of agminoside C (147).
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Agminoside D
Figure B.36. 1H NMR spectrum (600 MHz, CD3OD) of agminoside D (148).
227
Figure B.37. COSY spectrum (600 MHz, CD3OD) of agminoside D (148).
228
Figure B.38. HMBC spectrum (600 MHz, CD3OD) of agminoside D (148).
229
Agminoside E
Figure B.39. 1H NMR spectrum (600 MHz, CD3OD) of agminoside E (149).
230
Figure B.40. COSY spectrum (600 MHz, CD3OD) of agminoside E (149).
231
Figure B.41. HMBC spectrum (600 MHz, CD3OD) of agminoside E (149).
232
Aglycon methyl ester
Figure B.42. 1H NMR spectrum (600 MHz, CDCl3) of aglycon methyl ester
(151).
233
∆18,20-Isovariabilin
Figure B.43. 1H NMR spectrum (600 MHz, CDCl3) of ∆18,20-isovariabilin
(186).
234
Figure B.44. 13C NMR spectrum (150 MHz, CDCl3) of ∆18,20-isovariabilin
(186).
235
Figure B.45. COSY spectrum (600 MHz, CDCl3) of ∆18,20-isovariabilin (186).
236
Figure B.46. HSQC spectrum (600 MHz, CDCl3) of ∆18,20-isovariabilin (186).
237
Figure B.47. HMBC spectrum (600 MHz, CDCl3) of ∆18,20-isovariabilin (186).
238
Furospinosulin-1
Figure B.48. 1H NMR spectrum (600 MHz, CDCl3) of furospinosulin-1 (187).
239
6-((2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-
yl)-2-methoxy-p-quinone
Figure B.49. 1H NMR spectrum (600 MHz, CDCl3) of 6-((2E,6E )-3,7,11-
trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-quinone (188).
240
6-((2E,6Z )-3,7,11-trimethyl-2,6,10-dodecatrien-
yl)-2-methoxy-p-quinone
Figure B.50. 1H NMR spectrum (600 MHz, CDCl3) of 6-((2E,6Z )-3,7,11-
trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-quinone (189).
241
Figure B.51. COSY spectrum (600 MHz, CDCl3) of 6-((2E,6Z )-3,7,11-
trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-quinone (189).
242
Figure B.52. HSQC spectrum (600 MHz, CDCl3) of 6-((2E,6Z )-3,7,11-
trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-quinone (189).
243
Figure B.53. HMBC spectrum (600 MHz, CDCl3) of 6-((2E,6Z )-3,7,11-
trimethyl-2,6,10-dodecatrienyl)-2-methoxy-p-quinone (189).
244
Oxeatamide A
Figure B.54. 1H NMR spectrum (600 MHz, CDCl3) of oxeatamide A (214).
245
Figure B.55. 13C NMR spectrum (150 MHz, CDCl3) of oxeatamide A (214).
246
Figure B.56. COSY spectrum (600 MHz, CDCl3) of oxeatamide A (214).
247
Figure B.57. HSQC spectrum (600 MHz, CDCl3) of oxeatamide A (214).
248
Figure B.58. HMBC spectrum (600 MHz, CDCl3) of oxeatamide A (214).
249
Iso-oxeatamide A
Figure B.59. 1H NMR spectrum (600 MHz, CDCl3) of iso-oxeatamide A (215).
250
Figure B.60. 13C NMR spectrum (150 MHz, CDCl3) of iso-oxeatamide A
(215).
251
Figure B.61. COSY spectrum (600 MHz, CDCl3) of iso-oxeatamide A (215).
252
Figure B.62. HSQC spectrum (600 MHz, CDCl3) of iso-oxeatamide A (215).
253
Figure B.63. HMBC spectrum (600 MHz, CDCl3) of iso-oxeatamide A (215).
254
Oxeatamide A 23-methyl ester
Figure B.64. 1H NMR spectrum (600 MHz, CDCl3) of oxeatamide A 23-methyl
ester (216).
255
Figure B.65. COSY spectrum (600 MHz, CDCl3) of oxeatamide A 23-methyl
ester (216).
256
Figure B.66. HSQC spectrum (600 MHz, CDCl3) of oxeatamide A 23-methyl
ester (216).
257
Figure B.67. HMBC spectrum (600 MHz, CDCl3) of oxeatamide A 23-methyl
ester (216).
258
Oxeatamide B
Figure B.68. 1H NMR spectrum (600 MHz, DMSO-d6) of oxeatamide B (217).
259
Figure B.69. 13C NMR spectrum (150 MHz, DMSO-d6) of oxeatamide B
(217).
260
Figure B.70. COSY spectrum (600 MHz, DMSO-d6) of oxeatamide B (217).
261
Figure B.71. HSQC spectrum of oxeatamide B (217).
262
Figure B.72. HMBC spectrum (600 MHz, DMSO-d6) of oxeatamide B (217).
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Glossary
()
Weak correlations indicated by brackets in NMR data
tables
br Broad
13C NMR Carbon-13 nuclear magnetic resonance
C18 Octadecyl derivatized silica gel
CDCl3 Deuterated chloroform
CD3OD Deuterated methanol
CH2Cl2 Dichloromethane
COSY
Correlation spectroscopy (1H to 1H correlations depicted
by )
d Doublet
δ Chemical shift (ppm)
Da Daltons
DAD Diode array detector
d6-DMSO Deuterated DMSO
DEPT Distortionless enhancement by polarisation transfer
DIOL 2,3-Dihydroxy-1-propoxypropyl-derivatized silica gel
DMSO Dimethyl sulfoxide
DOSY Diffusion-ordered spectroscopy
DQF-COSY Double quantum filtered correlation spectroscopy
ED50 Dose that is effective in 50% of test subjects
ESIMS Electrospray ionization mass spectroscopy
EtOAc Ethyl acetate
EU European Union
FAB-MS Fast atom bombardment mass spectrometry
FDA United States Food and Drug Administration
GC Gas chromatography
1H NMR Proton nuclear magnetic resonance
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HMBC
Heteronuclear multiple-bond correlation (1H to 13C cor-
relations depicted by )
H2O Water
HPLC High pressure (performance) liquid chromatography
HP20/HP20SS PSDVB stationary support
HRESIMS High resolution electrospray ionization mass spectrum
IC50 Concentration that is inhibitory in 50% of test subjects
IPA Isopropyl alcohol (2-propanol)
FABMS Fast atom bombardment mass spectrum
HSQC Gradient heteronuclear single-quantum correlation
J Scalar coupling constant
LC-NMR HPLC coupled with NMR detection
LD50 Dose that is lethal to 50% of test subjects
LH-20 Crosslinked dextran-based size exclusion resin
m Multiplet
m/z Mass to charge ratio
MALDI-TOF Matrix-assisted laser desorption/ionization time of flight
Me2CO Acetone
MIC Minimum inhibitory concentration
MPLC Medium pressure (performance) liquid chromatography
mult. Multiplicity
MS Mass spectrometry
MTT assay
Colourmetric cytotoxicity assay using 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide
NOE
Nuclear Overhauser effect (1H to 1H enhancements de-
picted by )
NOESY Nuclear Overhauser enhancement spectroscopy
pet. ether Petroleum ether (hexanes)
pos. Position
ppm Parts per million
PSDVB Poly(styrene-divinylbenzene)
q Quartet
quin Quintet
ROESY Rotating frame Overhauser enhancement spectroscopy
s Singlet
SEM Scanning electron microscope
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SCUBA Self contained underwater breathing apparatus
SPE Solid phase extraction
t Triplet
TLC Thin layer chromatography
TMS Trimethylsilyl
TMSCHN2 Trimethylsilyldiazomethane
TOCSY
Total correlation spectroscopy (1H to 1H correlations de-
picted by )
VUW Victoria University of Wellington
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